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ABSTRACT
ANTIGENIC ANALYSIS OF EQUINE INFECTIOUS ANEMIA 
VIRUS USING MONOCLONAL ANTIBODIES
By
Khalid Abdullah Hussain
Monoclonal a n t i b o d i e s  (MCAbs) produced a g a i n s t  t h e  p ro to ty p e  
c e l l - a d a p t e d  Wyoming s t r a i n  o f  equine  i n f e c t i o u s  anemia v i r u s  (EIAV), 
a l e n t i v i r u s ,  were s t u d i e d  f o r  r e a c t i v i t y  with  th e  homologous 
p ro to ty p e  and 16 he te ro lo g o u s  i s o l a t e s .  Eighteen hybridomas 
producing MCAbs were i s o l a t e d .  Western b l o t  (immunoblot) ana ly se s  
i n d i c a t e d  t h a t  10 were s p e c i f i c  f o r  the  major  envelope g ly c o p ro te in  
(gp90) and 8 f o r  th e  transmembrane g ly c o p ro te in  (gp45) .  Four MCAbs 
s p e c i f i c  to  e p i to p e s  o f  gp90 n e u t r a l i z e d  p ro to ty p e  EIAV i n f e c t i v i t y .  
These n e u t r a l i z i n g  MCAbs a p p a r e n t ly  r e a c te d  with  v a r i a b l e  r eg io n s  of  
the  envelope gp90, as ev idenced  by t h e i r  unique r e a c t i v i t y  with  the  
panel o f  i s o l a t e s ,  su g g es t in g  r e c o g n i t i o n  o f  a t  l e a s t  t h r e e  d i f f e r e n t  
n e u t r a l i z a t i o n  e p i t o p e s .  The conformation  o f  t h e se  e p i to p e s  appears  
to  be c o n t in u o u s ,  as they  r e s i s t e d  t r e a tm e n t  with  sodium dodecyl 
s u l f a t e  and reduc ing  r e a g e n t s .  Monoclonal a n t ib o d ie s  t h a t  r e a c t e d  
with  conserved e p i to p e s  on gp90 o r  gp45 f a i l e d  to  n e u t r a l i z e  EIAV. 
Our d a ta  a l s o  demonstra ted  t h a t  t h e r e  was a l a r g e  spec trum of  
p o s s i b l e  EIAV se ro ty p es  and confi rmed t h a t  a n t i g e n i c  v a r i a t i o n  occurs  
with  high f requency  in  EIAV. Moreover, the  da ta  showed t h a t
x i i
v a r i a t i o n  i s  a r a p id  and random p r o c e s s ,  as no p a t t e r n  o f  v a r i a n t  
e v o lu t io n  was e v i d e n t  by comparison o f  13 i s o l a t e s  from p a r a l l e l  
i n f e c t i o n s .  These r e s u l t s  r e p r e s e n t  th e  f i r s t  p roduc t ion  of 
n e u t r a l i z i n g  MCAbs s p e c i f i c  f o r  a l e n t i v i r u s  g ly c o p r o t e in  and 
document a l t e r a t i o n s  in  one o r  more n e u t r a l i z a t i o n  e p i to p e s  o f  the  
major  s u r f a c e  g l y c o p r o t e in  among s e q u e n t i a l  i s o l a t e s  o f  EIAV 
recovered  dur ing  p e r s i s t e n t  i n f e c t i o n .
Monoclonal a n t i b o d i e s  were used to  d i s s e c t  the  a n t i g e n i c  s i t e s  
o f  th e  s u r f a c e  g ly c o p r o t e in s  o f  th e  p ro to ty p e  c e l l - a d a p t e d  Wyoming 
s t r a i n  o f  EIAV. S e ro lo g ic  r e a c t i v i t i e s  o f  t h e se  MCAbs were 
dete rmined  by ELISA, a d d i t i v e  ELISA, c o m p e t i t iv e  ELISA, and Western 
b l o t  a s s a y s .  The r e s u l t s  i n d i c a t e d  t h a t  a n t i g e n i c  r e a c t i v i t y  o f  gp90 
was l o c a l i z e d  on a t  l e a s t  fo u r  d i s t i n c t  e p i t o p e s ,  two o f  which were 
im por tan t  in n e u t r a l i z a t i o n .  Our s t u d i e s  a l s o  revea led  t h a t  th e se  
e p i to p e s  were l o c a l i z e d  on o v e r lapp ing  a n t i g e n i c  s i t e s  on gp90. On 
th e  o t h e r  hand, only  two d i s t i n c t  non-over lapp ing  e p i to p e s  were 
i d e n t i f i e d  on gp45. Competi t ive  b ind ing  s t u d i e s  o f  n e u t r a l i z i n g  
MCAbs and r e f e r e n c e  E IA -p o s i t iv e  horse  serum d e l i n e a t e d  th e  presence  
o f  a n e u t r a l i z a t i o n  domain on gp90 t h a t  appears  to  be immunodominant 
both in  n a t u r a l l y  i n f e c t e d  horses  and in  mice immunized with  EIAV. 
Limited p r o t e o l y t i c  f r ag m en ta t io n  o f  th e  gp90 component o f  severa l  
s e r o l o g i c a l l y  d i s t i n c t  EIAV i s o l a t e s  produced common 12K 
immunoreactive fragments  t h a t  con ta ined  a conserved e p i t o p e .  These 
r e s u l t s  i n d i c a t e  the  occu r rence  o f  conserved a n t i g e n i c  reg ions  on 
EIAV g l y c o p r o t e in s  as well as a n e u t r a l i z a t i o n  domain on gp90, which 
can be used as p o t e n t i a l  t a r g e t s  f o r  vacc ine  development.
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I . A . I .  Equine i n f e c t i o u s  anemia: e t i o l o g y  and c l i n i c a l  d i s e a s e
Equine i n f e c t i o u s  anemia v i r u s  causes  a n a t u r a l l y  o c cu r r in g  
d i s e a s e  in  members of  th e  fam i ly  Equidae and i s  o f  worldwide 
d i s t r i b u t i o n  (6 0 ) .  Equine i n f e c t i o u s  anemia v i r u s  i s  c u r r e n t l y  
con s id e red  to  be a member of  th e  subfamily  L e n t i v i r i n a e  in  th e  family  
R e t r o v i r i d a e .  C h a r a c t e r i s t i c s  common to  a l l  r e t r o v i r u s e s  in c lu d e  th e  
n a tu re  o f  t h e i r  genomes (RNA), t h e i r  s t r u c t u r e  ( s i m i l a r  o v e r a l l  
chemical co m p o s i t io n ) ,  and t h e i r  mode o f  r e p l i c a t i o n  through a DNA 
i n t e r m e d i a t e .  The l a s t  c r i t e r i o n ,  r e p l i c a t i o n  through a DNA 
i n t e r m e d i a t e ,  d i s t i n g u i s h e s  t h i s  RNA family  o f  v i r u s e s  from o t h e r  RNA 
v i r u s e s  because any v i ru s  u t i l i z i n g  a v i ru s -co d ed  RNA-dependent DNA 
polymerase ( r e v e r s e  t r a n s c r i p t a s e )  f o r  r e p l i c a t i o n  o f  i t s  genome i s  
inc luded  in  the  fam i ly  R e t r o v i r i d a e .  The unique  p r o p e r t i e s  o f  EIAV 
a re  c l o s e r  to  th o se  o f  v i s n a ,  maedi and p ro g r e s s i v e  pneumonia v i r u s e s  
and human immunodeficiency v i r u s  (HIV) than o t h e r  r e t r o v i r u s e s .  The 
d i s e a s e  equine  i n f e c t i o u s  anemia (EIA) i s  c h a r a c t e r i z e d  by v i r a l  
p e r s i s t e n c e ,  r e c u r r e n t  ep isodes  o f  f e v e r ,  hemoly tic  anemia,  bone 
marrow d e p r e s s io n ,  l y m p h o p r o l i t e r a t i o n ,  and immune complex 
g lo m e ru lo n e p h r i t i s  (52 ,  57,  60,  97) .  However, to  d a t e ,  no neoplasms 
appear  t o  be caused by EIAV.
Transmission occurs  n a t u r a l l y  through th e  t r a n s f e r  o f  blood 
from th e  i n f e c t e d  horse  by blood feed ing  i n s e c t s ,  p a r t i c u l a r l y  horse  
f l i e s  and d ee r  f l i e s .  Experimental  d i s e a s e  i s  r e a d i l y  induced by the  
i n j e c t i o n  of  i n f e c t e d  blood or  plasma by any p a r e n t e r a l  r o u t e .  The
incu b a t io n  pe r iod  v a r i e s  from f i v e  days to  seve ra l  months,  and the  
same inoculum given to  a group of  horses  w i l l  o f t e n  r e s u l t  in  acu te  
dea th s  in  some, whi le  o t h e r s  develop ch ron ic  d i s e a s e  o f  e p i so d ic  
n a tu re  dur ing  which t h e r e  a re  minimal c l i n i c a l  m a n i f e s t a t i o n s  (62) .  
Upon i n i t i a l  i n f e c t i o n  o r  a f t e r  exper im enta l  i n o c u l a t i o n ,  t h e r e  i s  
ra p id  v i r u s  r e p l i c a t i o n  p a r t i c u l a r l y  in c i r c u l a t i n g  and r e s i d e n t  
macrophages and th e  v i r u s  can be found in  high c o n c e n t r a t i o n  in  the  
plasma. I f  horses  d ie  with  a cu te  EIA, lymphoid n e c r o s i s  w i th  lack  of 
mature  c e l l s  in th e  lymphoid germinal c e n t e r s  i s  a prominent  f i n d i n g .  
The v iremia  with EIAV p e r s i s t s  f o r  the  l i f e t i m e  o f  th e  animal and 
in c r e a s e s  in v i r u s  t i t e r s  a r e  a s s o c i a t e d  with  th e  r e c u r r e n c e  and
e x ac e rb a t io n  o f  th e  a cu te  i l l n e s s ,  i . e . ,  th e  ch ron ic  form o f  the
d i s e a s e  (9 5 ) .  H i s to lo g ic a l  l e s i o n s  in acu te  EIAV inc lude  
splenomegaly ,  lymphadenopathy, g lo m e r u lo n e p h r i t i s ,  and a l t e r a t i o n  in 
the  a r c h i t e c t u r e  o f  the  l i v e r  due to  foca l  d e g e n e r a t io n ,  in c lu d in g  
accumula tion o f  lymphocytes and h i s t i o c y t e s  (58,  73) .  N e u t r a l i z i n g  
a n t ib o d ie s  to  EIAV are  d e t e c t e d  in horse  s e ra  y e a r s  a f t e r  th e  i n i t i a l  
i n f e c t i o n  (2 6 ) ,  and most o f  th e  c i r c u l a t i n g  v i r u s  i s  found as
i n f e c t i o u s  complexes with  an t ibody  (9 6 ) .  G lo m e ru l i t i s  occurs  in
horses  with  the  a c t i v e  d i s e a s e  because o f  d e p o s i t i o n  o f  c i r c u l a t i n g  
v i r u s - a n t i  body complexes ( 5 ) .  The e r y t h r o c y t e s  o f  i n f e c t e d  horses  
a re  coated  with complement and a n t ib o d ie s  (6 7 ) .  The immunological ly  
mediated a c t i v e  hemolys is  most l i k e l y  in vo lves  a n t i v i r a l  a n t i b o d ie s  
which a re  r e s p o n s ib l e  f o r  complement b inding  t h a t  r e s u l t s  in 
decreased  e r y t h r o c y t e  l i f e  span , in c re a se d  osmotic  f r a g i l i t y ,  and 
e r y th ro p h a g o c y to s i s  cu lmina ted  by seve re  anemia (9 6 ) .  Equine 
i n f e c t i o u s  anemia v i r u s  appears  to  r e p l i c a t e  in  vivo mainly  in horse
p e r ip h e r a l  blood leu k o cy tes  o r  bone marrow which causes  c e l l u l a r  
d e g en e ra t io n  (64) .  However, i t  i s  i n t e r e s t i n g  to  note  t h a t  a l though  
v i r a l  a n t ig e n s  can be d e t e c t e d  in  v i r t u a l l y  a l l  t i s s u e s  of  i n f e c t e d  
h o r s e s ,  macrophages a re  th e  predominant p o pu la t ion  o f  i n f e c t e d  c e l l s  
( 9 5 ) . -  The r e p l i c a t i o n  o f  EIAV in  r e s i d e n t  and c i r c u l a t i n g  
macrophages could account  f o r  the  p resence  o f  th e  v i r u s  in  a lmost a l l  
t i s s u e s  o f  i n f e c t e d  ho rses  (9 7 ) .  The agar  gel  immunodiffusion (AGID) 
t e s t  has been the  t e s t  o f  cho ice  f o r  t h e  d ia g n o s i s  o f  EIAV (27,  28,  
105, 123, 128) by dem ons t ra t ing  th e  p resence  o f  p r e c i p i t a t i n g
a n t i b o d i e s  t h a t  r e a c t  w ith  the  group s p e c i f i c  a n t ig e n  which were 
demonst ra ted  to  be c o r r e l a t e d  with EIAV v iremia  (2 8 ) .
I . A . 2. Viral  C h a r a c t e r i s t i c s
I . A . 2 . a .  Physicochemical p r o p e r t i e s
Equine i n f e c t i o u s  anemia v i r u s  has a l i p i d - c o n t a i n i n g  envelope 
w ith  buoyant d e n s i t y  o f  about 1.16 gm/cm (18, 92 ) .  I t  i s  s e n s i t i v e  
t o  l i p i d  s o lv e n t s  but r e s i s t a n t  to  t r y p s i n ,  RNAase, and DNAase. The 
genome c o n s i s t s  o f  RNA which i s  demonstra ted  by in c o r p o r a t io n  of  
u r i d i n e  but not thym id ine .  The r e p l i c a t i o n  i s  a l s o  s e n s i t i v e  t o  DNA 
i n h i b i t o r s  in  th e  e a r l y  phases (52,  57 ) .  The RNA i s  s i n g l e  s t r an d ed  
w i th  a m olecu la r  weight  o f  about  5 .5  X 10^ and sediments  a t  60S to  
70S. The v i r i o n  c o n ta in s  4S RNA which i s  p robably  h o s t  d e r ived  tRNA, 
and a small amount o f  5S RNA o f  u n c e r t a in  o r i g i n  (1 8 ) .  The genome i s  
composed o f  two s i n g l e - s t r a n d e d  su b u n i t s  o f  approx im ate ly  34S with
C
m olecu la r  weight o f  about  2 .8  X 10 d a l t o n .
I . A . 2 . b .  Reverse t r a n s c r i p t a s e
The EIA v i r i o n  c o n ta i n s  a r e v e r s e  t r a n s c r i p t a s e  (RT) t h a t  can 
c a t a l y z e  s y n th e s i s  o f  DNA from a s y n t h e t i c  RNA tem pla te  or  from the
EIAV genome. The r e v e r s e  t r a n s c r i p t a s e  has a m o lecu la r  weight o f  
about 70,000 d a l to n  and r e q u i r e s  Mg++ as  i t s  d i v a l e n t  c a t i o n  ( 2 ,  16, 
17) .  S ince  EIAV c o n ta i n s  a high m o lecu la r  weight RNA genome, RT, 
from f i v e  to  e i g h t  s t r u c t u r a l  p r o t e i n s ,  and matures  by budding from 
th e  c e l l  s u r f a c e ,  i t  has been t e n t a t i v e l y  c l a s s i f i e d  as  a member o f  
th e  fam i ly  R e t r o v i r id a e  (16 ,  29,  60,  138).
I .A .2 .C .  Morphology
Equine i n f e c t i o u s  anemia v i r u s  d i s p l a y s  a complex morphology 
c o n s i s t e n t  with  t h a t  o f  most r e t r o v i r u s e s .  E lec t ro n  microscopy 
s t u d i e s  confirmed t h a t  most r e t r o v i r u s e s  a r e  roughly  s p h e r i c a l  
s t r u c t u r e s  o f  about 100 nm in  d iam ete r  (151) .  A core  o r  nuc leo id  i s  
enc losed  in an o u te r  envelope  made of  a u n i t  membrane, w ith  sp ikes  
p r o j e c t i n g  from th e  o u t e r  s u r f a c e s .  These sp ik e s  a r e  p a r t i c u l a r l y  
prominent in  some r e t r o v i r u s e s  and a re  made o f  g ly c o p r o t e in s  (127) .  
The s i z e  and shape of  t h e  EIA v i r i o n  v a r i e s ,  bu t i s  g e n e r a l l y  
s p h e r i c a l  in  n a tu re  rang ing  from 80 to  120 nm in  d i a m e te r ,  w ith  a 
ro d-  or  cube-shaped e l e c t r o n - d e n s e  nuc leo id  o f  about 40 to  60 nm 
(150,  151) .  I t  i s  bounded by a d o u b le - l a y e r e d  envelope w i th  s u r f a c e  
p r o j e c t i o n s  o f  about 6 t o  8 nm in d iam e te r  (106, 139, 150) which a re  
acq u i red  from modif ied  c e l l u l a r  plasma membrane dur ing  budding o f  th e  
v i r u s  (9 3 ) .  M orpho log ica l ly ,  EIAV i s  v i r t u a l l y  i n d i s t i n g u i s h a b l e  
from th e  l e n t i v i r u s  which causes  acq u i red  immune d e f i c i e n c y  syndrome 
(AIDS) in  man (98) .
I . A . 2 . d .  Genomic and a n t i g e n i c  c l a s s i f i c a t i o n
Nucle ic  ac id  sequence homology was no t  d e t e c t e d  between EIAV and 
members o f  th e  fam i ly  Equidae ,  a v a r i e t y  o f  o t h e r  mammals (126) and 
th e  fo l low ing  r e t r o v i r u s e s :  murine leukemia v i r u s  (MLF), mouse
mammary tumor v i r u s  (MMTV), r a t  leukemia v i r u s ,  the  endogenous f e l i n e  
r e t r o v i r u s  (RD114), f e l i n e  leukemia v i r u s  (FeLV), bovine leukemia 
v i r u s  (BLV), th e  endogenous hamster  v i r u s  (HaLV), av ian  
m y e lo b la s to s i s  v i r u s  (AMV), baboon r e t r o v i r u s  (BaEV), s q u i r r e l  monkey 
r e t r o v i r u s  (SMRV), and Mason-Pf izer  monkey v i r u s  (MPMV) (151) .  Thus,  
EIAV i s  no t  thought  to  be an endogenous v i r u s  o f  th e  horse  and i s  
q u i t e  d i s t i n c t  from o t h e r  r e t r o v i r u s e s  (151) .  Using b road ly  r e a c t i v e  
a n t i  s e r a  to  group s p e c i f i c  a n t ig e n  ( gag) s t r u c t u r a l  components,  EIAV 
f a i l e d  to  r e a c t  w ith  a v a r i e t y  o f  o ncov i ru ses  (1 6 ) .  M o rpho log ica l ly ,  
EIAV resembles  th e  l e n t i v i r u s e s  (4 7 ) ;  i t  a l s o  sh a re s  with  them the  
t r a i t  o f  a n t i g e n i c  v a r i a t i o n  in  th e  i n f e c t e d  h o s t  (72 ,  102, 110, 
129) .  Stowring e t  a l .  (138) p r e v io u s ly  r e p o r t e d  no c ro s s  r e a c t i v i t y  
o f  EIAV group s p e c i f i c  a n t ig e n s  with  th e  l e n t i v i r u s e s  v i s n a ,  m aed i , 
p r o g r e s s i v e  pneumonia v i r u s ,  and zw o eg e rz iek t e ,  u s ing  b road ly  
r e a c t i v e  a n t i s e r a .  However, new s i g n i f i c a n c e  a ro s e  by th e  i n c l u s i o n  
o f  human immunodeficiency v i r u s  (HIV) in  th e  l e n t i v i r u s  subfam ily  and 
t h e r e f o r e ,  l e n t i v i r u s e s  became a r a p i d l y  expanding f i e l d  o f  s tu d y .  
A p a r t i a l  c r o s s - r e a c t i o n  between th e  major i n t e r n a l  p r o t e i n  o f  EIAV 
and p25 o f  lymphoadenopathy-assoc ia ted  v i r u s  (LAV) has been observed 
(15 ,  98 ) .  Moreover, sequencing s t u d i e s  r e c e n t l y  demonst ra ted  t h a t  
EIAV gag and pol genes were found to  be r e l a t e d  t o  human 
T-lymphotropic  v i r u s  (HTLV) type  I I I  (HIV) and v isna  v i r u s ,  which 
i n d i c a t e d  t h a t  t h e se  v i r u s e s  c o n s t i t u t e d  a group o f  v i r u s e s  c l e a r l y  
d i s t i n c t  from t h a t  o f  type  C v i r u s e s  o r  th e  bovine leukemia v i r u s ,  
and HTLV types  I and I I  (137) .  Recen t ly  an i n t e r s p e c i e s  
radioimmunoassay (RIAs) was capab le  o f  dem ons t ra t ing  immunologic 
c ro s s  r e a c t i v i t y  among th e  major s t r u c t u r a l  p r o t e i n s  o f  EIAV, v i s n a ,
and cap r in e  a r t h r i t i s  e n c e p h a l i t i s  v i r u s  ( CAEV)(1 5 3 ) .
I . A . 2 . e .  S t r u c t u r a l  p r o t e i n s  and g ly c o p ro te in s
Equine i n f e c t i o u s  anemia v i ru s  p o sse sse s  a t  l e a s t  two 
immunologica lly  d i s t i n c t  components.  One i s  a s s o c i a t e d  with th e  
v i r a l  envelope  and i s  g ly c o p r o t e in  in n a tu r e  whi le  th e  o t h e r  i s  a 
n ong lycosy la ted  p r o t e i n  l o c a l i z e d  i n s id e  th e  v i r i o n  (17 ,  29,  59,  100, 
112, 120) .  The former i s  demonstrated  by n e u t r a l i z a t i o n  and
h aem agg lu t ina t ion  t e s t s  and i s  cons ide red  to  be type  s p e c i f i c  (69,  
133) .  The l a t t e r  i s  r e l e a s e d  from th e  p a r t i c l e  by e t h e r  t r e a tm e n t  
and i s  d e t e c t e d  by complement f i x a t i o n  and immunodiffusion t e s t s  (70,  
107),  has a m olecu la r  weight of  26,000 (p26) and shows g r o u p - s p e c i f i c  
a c t i v i t y .
D e ta i l ed  c a t a lo g in g  o f  the  v i r a l  p o ly p e p t id e s  o f  the  
c e l l - a d a p t e d  Wyoming s t r a i n  o f  EIAV was determined by high r e s o l u t i o n  
guanid ine  h y d roch lo r ide  gel f i l t r a t i o n  (GHCL-6F) and sodium dodecyl 
s u l f a t e - p o ly a c r y l a m id e  gel e l e c t r o p h o r e s i s  (SDS-PAGE) us ing  
r a d i o a c t i v e  l e u c i n e  o r  glucosamine l a b e l s  f o r  t h e  c e l l - a d a p t e d  
Wyoming s t r a i n  o f  EIAV (100, 120) .  The chromatographic  a n a l y s i s  o f  
EIAV rev ea led  s ix  d i s t i n c t  peaks o f  r a d i o a c t i v i t y .  The f i r s t  p r o t e i n  
e l u t e d  from GHCL-GF was c o n ta in ed  in th e  void volume f r a c t i o n s  of  the  
column with an app a ren t  m olecu lar  weight (MW) o f  100,000. The next 
EIAV p r o t e i n  e l u t e d  from th e  gel  has a MW o f  about  74 ,000.  This 
component was followed by th e  major  EIAV s t r u c t u r a l  po ly p ep t id e  (p26) 
which d i sp la y ed  a MW o f  26,000 and, in  s u c c e s s io n ,  by t h r e e  
a d d i t i o n a l  components o f  15,000 ( p l 5 ) ,  11,000 ( p l l )  and 9000 (p9) 
m o lecu la r  weight  r e s p e c t i v e l y .
Sodium dodecyl s u l f a t e - p o ly a c r y l a m id e  gel e l e c t r o p h o r e s i s
(SDS-PAGE) a n a l y s i s  o f  EIAV rev ea led  fou r  major low m olecu la r -w eigh t
po lyp ep t id e s  (p26, p l 5 ,  p l l ,  and p9) and s ix  minor components.  The
minor components in c lude  two g ly c o sy la te d  po lyp ep t id e s  o f  90,000 
(gp90) and 45,000 (gp45) m olecu la r  weight and fo u r  minor
n ong lycosy la ted  p r o t e i n s  d e s ig n a te d  as p70, p61, p30, and p23.
Comparisons o f  t h e  fo u r  major nong lycosy la ted  p r o t e i n s  p26, p l 5 ,  p l l ,  
and p9 by p e p t id e  mapping and enzyme-linked immunosorbent a ssays  
demonstra ted the  u n r e l a t e d n e s s  o f  t h e s e  fo u r  p r o t e i n s  (100) .  F u r the r  
c h a r a c t e r i z a t i o n  demonst ra ted  t h a t  p26 and p9 focus  a t  i s o e l e c t r i c  
p o in t s  (PI)  6 .2  and 5 .0  r e s p e c t i v e l y ,  and they  co n ta in  no unusual 
amino a c id s  whi le  p l5  d i sp la y ed  a hete rogeneous i s o e l e c t r i c  focus ing  
p a t t e r n ,  with a PI ranging  from 5 .7  to  8 . 3 ,  which was a t t r i b u t e d  to  
d i f f e r e n t  l e v e l s  o f  phosphory la ted  s e r i n e  o r  th re o n in e  o r  bo th .  The 
p l l  o f  EIAV focused a t  a PI o f  >10, which i n d i c a t e s  a high c o n te n t  of 
b a s ic  amino a c i d s .  The gp90 o f  EIAV appeared to  be the  more h e av i ly  
g ly c o sy la te d  p o ly p e p t id e ,  whi le  th e  gp45 component aggrega ted  in  6 M 
guanid ine  h y d r o c h lo r id e ,  r e f l e c t i n g  a hydrophobic c h a r a c t e r .  No
d i s u l f i d e  l in k a g e s  were d e t e c t e d  between the  EIAV g ly c o p ro te in s  
(120) .  L o c a l i z a t i o n  o f  th e  v i r i o n  p r o t e i n s  was done by s tan d a rd  
procedures  in  which p u r i f i e d  v i r u s  was t r e a t e d  with th e  p ro t e a se  
bromelain  and th e  r e s u l t i n g  s u b p a r t i c l e s  i s o l a t e d  and analyzed by 
SDS-PAGE. These s t u d i e s  demonstra ted  t h a t  gp90 and gp45 form the  
s u r f a c e  p r o t e i n s  o f  EIAV whereas p26, p l5 ,  p l l ,  and p9 c o n s t i t u t e  the  
i n t e r n a l  v i r i o n  components with p l l  c l o s e l y  a s s o c i a t e d  with the  v i r a l  
RNA genome (100) .
8
I . A . 3. V ir ion  s u r f a c e  g ly c o p r o t e in s  
I . A . 3 . a .  N e u t r a l i z a t i o n
The f i r s t  n e u t r a l i z i n g  a n t i b o d i e s  in  EIAV i n f e c t e d  horses  were 
demonstra ted  by t i t r a t i n g  su rv iv in g  v i r u s  in  s u s c e p t i b l e  horses  (136, 
140).  Kobayashi and Kono (64) found t h a t  EIAV could  be propagated  in 
horse  leukocy te  c u l t u r e ,  with  r e s u l t a n t  c y to p a t h i c  e f f e c t  (CPE). 
Horse leukocy tes  cannot be r o u t i n e l y  m ain ta ined  f o r  a long t ime and 
endpo in ts  o f  v i r u s  t i t r a t i o n s  were d i f f i c u l t  t o  e s t i m a t e .  Horse 
leukocy te  c u l t u r e s  were used f o r  v i r u s  n e u t r a l i z a t i o n  (51,  6 7 ) ,  and 
a n t i g e n i c  d i f f e r e n c e s  between v i r a l  i s o l a t e s  were demonst ra ted 
d e s p i t e  t h e se  t e c h n i c a l  d i f f i c u l t i e s  (6 8 ) .  There was no 
c r o s s - n e u t r a l i z a t i o n  between e i g h t  d i f f e r e n t  i s o l a t e s  from severa l  
d i f f e r e n t  c o u n t r i e s  when s t u d i e d  by v i r u s  n e t u r a l i z a t i o n  _in vivo 
(7 1 ) .  This o b se r v a t io n  was suppor ted  by s t u d i e s  in horses  where 
c r o s s - p r o t e c t i o n  was la ck in g  (73) .
N e u t r a l i z i n g  an t ibody  a g a i n s t  enveloped v i r u s e s  i s  u s u a l l y  
d i r e c t e d  a t  s u r f a c e  components (9 9 ) .  The v i r i o n  s u r f a c e  o f  EIAV is  
composed of  a h igh ly  g ly c o s y l a t e d  p r o t e in  o f  appa ren t  MW of  90,000 
d a l t o n ,  which probably  forms th e  knobs o f  th e  s u r f a c e  p r o j e c t i o n s  and 
a g ly c o sy la te d  45,000 d a l to n  hydrophobic p r o t e i n  which may span the  
l i p i d  b i l a y e r  forming th e  sp ike  o f  th e  p r o j e c t i o n s  (100, 120).  This 
model i s  suppor ted  by d a ta  i n d i c a t i n g  t h a t  gp45 i s  r e l e a s e d  by 
t r e a tm e n t  o f  th e  v i r u s  with  th e  p ro te a se  bromelain  as p re v io u s ly  
mentioned (100) .  In a d d i t i o n  t h i s  p r o t e i n  was not s u s c e p t i b l e  to  
l a c to p e r o x i d a s e  c a t a ly z e d  s u r f a c e  r a d i o i o d i n a t i o n  o f  whole i n t a c t  
v i r u s ,  bu t was l a b e l e d  a f t e r  d i s r u p t i o n  o f  th e  v i r u s  with  nonionic  
d e t e r g e n t  (20) .
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The c o n t r i b u t i o n s  o f  both the  ca rbohydra te  and pep t id e  p o r t i o n s  
of  d i f f e r e n t  r e t r o v i r u s  g ly c o p r o t e in s  was a s se s sed  by g ly c o s id a s e  and 
p ro te a se  t r e a tm e n t s  on t h e i r  r e a c t i v i t y  with  immune o r  hyperimmune 
se ra  (8 ,  124, 131, 145).  The r e s u l t s  o f  t h e se  s t u d i e s  i n d i c a t e d  t h a t  
th e  immunogenic p o r t i o n s  o f  Fr iend  murine leukemia v i r u s  gp71 (8) and 
avian B77 l e u k o s i s  v i r u s  gp85 (145) were e x c l u s i v e l y  p r o t e i n  in 
n a t u r e ,  i . e . ,  removal o f  the  c a rbohydra te s  from th e se  g ly c o p ro te in s  
had no s i g n i f i c a n t  e f f e c t  on t h e i r  r e a c t i v i t y .  In c o n t r a s t ,  the  
r e a c t i v i t y  of  bovine  leukemia v i r u s  gp51 (124, 131) and avian
m y e lo b la s to s i s  v i r u s  gp85 (145) with homologous immune s e ra  was 
comple te ly  ab o l i sh ed  when th e  carbohydra te  p o r t i o n  was s t r i p p e d  o f f  
by g ly c o s id a s e  t r e a tm e n t .  Recent s t u d i e s  with EIAV sugges ted  t h a t  
both ca rbohydra te  and p r o t e i n  m o ie t i e s  o f  gp90 c o n t r i b u t e  to  i t s  
r e a c t i v i t y .  The predominant r e a c t i v i t y ,  however,  appeared to  be 
a g a i n s t  i t s  p e p t id e  e p i to p e s  (103) .
Mechanisms in v o lv in g  an t ibody-m edia ted  v i r u s  n e u t r a l i z a t i o n  
have been s t u d i e d  e x t e n s i v e l y  (25,  31,  89 ,  90) .  Two general  pathways 
of  v i r u s  n e u t r a l i z a t i o n  have been p o s t u l a t e d .  The f i r s t  pathway 
invo lves  a phys ica l  r e d u c t io n  in the  number o f  v i ru s  p a r t i c l e s  e i t h e r  
by complement-mediated v i r o l y s i s  o r  by c r o s s - l i n k i n g  o f  v i ru s  
p a r t i c l e s  with  r e s u l t a n t  v i r u s  a g g re g a t io n .  The second pathway 
invo lves  mainly  the  b inding  o f  an t ibody  to  v i r a l  a n t ig e n s  which 
consequen t ly  i n h i b i t s  one o r  more o f  th e  e a r l y  s t e p s  ( a t t a ch m en t ,  
p e n e t r a t i o n ,  uncoa t ing )  n eces sa ry  to  e s t a b l i s h  a p ro d u c t iv e  v i r a l  
i n f e c t i o n .  However, a novel pathway f o r  n e u t r a l i z a t i o n  of  enveloped 
v i r u s e s  has r e c e n t l y  been proposed (4 6 ) .  I t  has been shown t h a t  many 
enveloped v i r u s e s  e n t e r  t h e i r  t a r g e t  c e l l s  by endocy tos is  and a re
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su bsequen t ly  l o c a t ed  in  c e l l u l a r  compartments o f  in c r e a s in g  a c i d i t y .  
Fusion between th e  membranes o f  th e  v i r u s  p a r t i c l e  and t h a t  o f  the  
pre lysosomal endosome must t ak e  p lace  be fo re  r e p l i c a t i o n  commences. 
G o l l in s  and P o r t e r f i e l d  (46) showed t h a t  a n t i v i r a l  an t ibody  can 
n e u t r a l i z e  West Ni le  v i r u s ,  a f l a v i v i r u s ,  by i n h i b i t i n g  t h i s  
in t ra-endosomal  a c i d - c a t a l y s e d  fu s io n  s t e p .
The i n t e r a c t i o n  o f  presumably “s imple"  v i r u s e s ,  e . g . ,  t h e  naked 
p i c o r n a v i r u s e s , with an t ibody  appears  to  invo lve  only  one s p e c i f i c  
a n t i g e n ,  as  an immunogenic e lement (89 ,  90 ) .  This i n t e r a c t i o n  i s  
r e l a t i v e l y  s t r a i g h t f o r w a r d  and i f  n e u t r a l i z i n g  a n t i b o d i e s  a re  
in v o lv e d ,  i n a c t i v a t i o n  o f  the  v i r u s  would be th e  outcome. However, 
w ith  in c r e a s in g  c o m p le x i t i e s  o f  v i r u s e s ,  t h e  number o f  de te rm inan ts  
in c r e a s e s  and the  i n t e r p r e t a t i o n  o f  th e  e f f e c t  o f  an t ibody  on such 
v i r u s e s  becomes more d i f f i c u l t .  C r i t i c a l ,  n o n c r i t i c a l ,  and p o s s ib ly  
q u a s i - c r i t i c a l  a n t i g e n i c  s i t e s  have been proposed (89 ,  9 0 ) .  The 
i n t e r a c t i o n  o f  t h e se  d i f f e r e n t  a n t i g e n i c  d e te rm in an ts  with a n t ib o d ie s  
o f  d i f f e r e n t  s p e c i f i c i t i e s  may no t  lead  to  i n a c t i v a t i o n  o f  some 
v i r u s e s .  For example,  i n f e c t i o u s  immune complexes have been 
demonst ra ted  in the  blood o f  EIAV-infected horses  (9 6 ) .  In view of 
th e  p receed ing  d i s c u s s i o n  on n e u t r a l i z a t i o n  o f  v i r u s e s ,  d iv e r s e  
mechanisms could  be hypothes ized  t h a t  might  e x p la in  why immune 
complexes r e t a i n  i n f e c t i v i t y .  The f i r s t  mechanism might invo lve  
b inding  o f  a n t ib o d ie s  ( i n t e r f e r i n g  an t ibody)  t o  n o n c r i t i c a l  s i t e s  
which in tu r n  might b lock  b ind ing  o f  p o t e n t i a l  n e u t r a l i z i n g  
a n t i b o d i e s  to  c r i t i c a l  s i t e s .  The second mechanism could  invo lve  
s a t u r a t i o n  o f  p o s s i b l e  a n t i g e n i c  de te rm in an ts  on EIAV o r  s imple  
ag g re g a t io n  o f  EIAV p a r t i c l e s  t h a t  may no t  r e s u l t  in  i n t r i n s i c
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n e u t r a l i z a t i o n .
I . A . 3 . b .  Use o f  monoclonal a n t i b o d i e s
The r e c e n t  advances  in  somat ic  c e l l  h y b r i d i z a t i o n  make i t
p o s s i b l e  t o  produce v i r t u a l l y  u n l im i t ed  q u a n t i t i e s  of  MCAbs of  
p re d e f in e d  s p e c i f i c i t y .  These t e c h n i q u e s ,  f i r s t  developed by Kohler 
and M i l s t e i n  ( 6 5 ,  6 6 ) ,  a r e  used e x t e n s i v e l y  to  produce hybridoma c j I I  
l i n e s  t h a t  s e c r e t e  MCAbs a g a i n s t  v i r a l  a n t ig e n s  (44 ,  74,  91,  113, 
147).
The s t r a t e g y  f o r  im m or ta l iz ing  s p e c i f i c  immunoglobul in-producing 
B lymphocytes in c u l t u r e  i s  t o  fu se  them with myeloma c e l l s .  The 
ensu ing  h yb r id s  a re  then  s e l e c t e d  in the  p resence  o f  hypoxanth ine ,  
a m in o p te r in ,  and thymid ine  (HAT) medium. The aminop te r in  component 
o f  HAT medium blocks  th e  de novo pathway o f  DNA s y n t h e s i s ,  which i s  a 
p r e r e q u i s i t e  f o r  c e l l  r e p l i c a t i o n .  There i s  an a l t e r n a t i v e  or
sa lvage  pathway by which normal c e l l s  a re  capab le  of  u t i l i z i n g  
hypoxanth ine  and thymid ine  as s u b s t r a t e s  to  s y n th e s i z e  DNA. This 
pathway r e q u i r e s  two key enzymes,  hypoxanth ine-guanine  phosphoribose  
t r a n s f e r a s e  (HGPRT) and thymid ine  k inase  (TK). Myeloma c e l l s  used 
f o r  fu s io n  lack  the  TK and HGPRT and a re  s e l e c t e d  f o r  t h i s  p ro p e r ty  
in  th e  p re sence  o f  e i t h e r  5-bromo-2-deoxyurid ine  (BUdR) o r  
8 -azaguan ine .  Unfused myeloma c e l l s  t h e r e f o r e  cannot s y n th e s i z e  DNA 
th rough th e  a l t e r n a t i v e  pathway in  HAT s e l e c t i o n  medium. Although 
lymphocytes can u t i l i z e  both pathways o f  n u c l e o t id e  s y n t h e s i s ,  they  
cannot  su rv iv e  in  v i t r o  f o r  a long p e r io d  o f  t ime due to  t h e i r  f i n i t e
l i f e  span in  c u l t u r e .  However, th e  hyb r id s  between lymphocytes and
myeloma c e l l s  w i l l  grow in  HAT s e l e c t i o n  medium because o f  the  
a v a i l a b i l i t y  o f  th e  key enzymes from the  lymphocytes and th e
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c o n t r i b u t i o n  o f  im m o r ta l i ty  from myeloma c e l l s .
S ince MCAbs r e a c t  w i th  only a s i n g l e  a n t i g e n i c  de te rm inan t  they  
have proved t o  be remarkably  s p e c i f i c  b io l o g i c a l  
probes f o r  the  a n a l y s i s  o f  p r o t e i n  polymorphism, as well  as 
d i s c e r n in g  th e  s t r u c t u r a l  and f u n c t io n a l  p r o p e r t i e s  o f  va r io u s  v i r a l  
p r o t e i n s .  To d a t e ,  the  emphasis o f  t h e s e  s t u d i e s  were on the  
c h a r a c t e r i z a t i o n  and d e te rm in a t io n  o f  v i r a l  p r o t e i n s  t h a t  s e rv e  as 
t a r g e t s  f o r  v i r u s - n e u t r a l i z i n g  a n t i b o d i e s .
Antigens  d isp la y ed  on the  s u r f a c e  o f  v i r i o n s  o r  v i r u s  i n f e c t e d  
c e l l s  a re  th e  o b j e c t  o f  i n t e n s i v e  i n v e s t i g a t i o n s  as they  media te  
i n f e c t i o n  of  h o s t  c e l l s  and se rve  as pr imary  t a r g e t s  f o r  h o s t  immune 
responses  (9 9 ) .  Monoclonal a n t ib o d ie s  have been in v a lu a b le  f o r  the  
unde rs tand ing  o f  s t r u c t u r a l  and f u n c t io n a l  f e a t u r e s  of  t h e se  v i r a l  
p r o t e i n s .  Epi topes  recognized  by s p e c i f i c  MCAbs d e f in e  s t r u c t u r a l  
and immunological domains of  p r o t e i n s .  Functiona l maps o f  p r o t e i n s  
can be i n f e r r e d  when an t ibody  b ind ing  r e s u l t s  in  a l t e r e d  p r o t e i n  
a c t i v i t y .  In t h e  a rea  o f  vacc ine  development such f u n c t io n a l  maps 
can provide  v a lu ab le  c lu e s  in choosing s y n t h e t i c  p e p t id e  a n t ig e n s  t o  
be t e s t e d  as p r o t e c t i v e  immunogens.
Immunity to  v i r a l  i n f e c t i o n s  in  l a r g e  p a r t  depends on the  
development o f  immune responses  to  a n t ig e n s  d i s p la y e d  on th e  s u r f a c e  
o f  v i r i o n s  o r  v i r u s  i n f e c t e d  c e l l s .  I d e n t i f i c a t i o n  o f  t h e se  
impor tan t  s u r f a c e  g l y c o p r o t e in s  o r  p r o t e i n s  which e l i c i t  p r o t e c t i v e  
immunity, r e f e r r e d  to  as p r o t e c t i v e  a n t i g e n s ,  r e p r e s e n t s  an impor tan t  
s t e p  in th e  development o f  e f f e c t i v e  v i r a l  v a c c in e s .  Polyclonal se ra  
a g a i n s t  p u r i f i e d  g ly c o p r o t e in s  o f  many v i r u s e s  were found to  
n e u t r a l i z e  v i r u s  i n f e c t i v i t y .  A good example in  r e t r o v i r u s e s  i s  the
70,000 d a l to n  g ly c o p r o t e in  (gp70) of  murine leukemia v i r u s  (MLV). 
This gp70 i s  th e  major s u r f a c e  component o f  t h i s  v i r u s ,  and c a r r i e s  
de te rm inan ts  a g a i n s t  which n e u t r a l i z i n g  a n t i b o d i e s  a r e  d i r e c t e d  
(53,  56,  63,  135). The envelope  g ly c o p r o t e in s  o f  MLV a re  b e l ie v ed  to  
c o n s i s t  o f  two d i s t i n c t  domains ( 9 ) ,  the  amino te rm ina l  domain, which 
i s  min imally  conserved between MLV s t r a i n s  and i s  though t  to  be 
involved  in  h o s t  c e l l  r e c e p t o r  b inding  and t y p e - s p e c i f i c i t y ,  and the  
carboxy te rm ina l  domain which i s  h igh ly  conserved and i s  b e l ie v ed  to  
se rve  a more s t r u c t u r a l  r o l e .  S i m i l a r l y ,  an im por tan t  de te rm inan t  of 
v i r u s  n e u t r a l i z a t i o n  on f e l i n e  leukemia v i r u s  (FeLV) was a l so
lo c a l i z e d  on th e  major s u r f a c e  g ly c o p r o t e in  o f  70,000 d a l t o n .  
I n t e r e s t i n g l y  the  MCAbs used to  d e f in e  t h i s  de te rm inan t  was found to  
be b road ly  r e a c t i v e ,  i . e . ,  most FeLV i s o l a t e s  t e s t e d  from FeLV
subgroups A, B, and C, were n e u t r a l i z e d  (114) .
P r o t e c t i v e  s u r f a c e  a n t ig e n s  have been i d e n t i f i e d  f o r  many 
v i r u s e s  and o f t e n  more than  one s u r f a c e  g ly c o p r o t e in  i s  im por tan t  in 
immunity to  such v i r u s e s .  The hemagglu t in in  (HA) of
or thromyxoviruses  i s  r e q u i r e d  f o r  a t tachm ent  o f  v i r u s  to  h o s t - c e l l  
r e c e p to r s  and f o r  fu s io n  with  i n t r a c e l l u l a r  membranes. This  s u r f a ce  
an t ig e n  s t i m u l a t e s  n e u t r a l i z i n g  a n t i b o d i e s ,  w h i le  neuramin idase  (NA), 
the  o t h e r  s u r f a c e  g l y c o p r o t e i n ,  i s  r e q u i r e d  f o r  r e l e a s e  o f  v i r u s  from 
i n f e c t e d  c e l l s ,  and i t  s t i m u l a t e s  a n t ib o d ie s  t h a t  impede r e l e a s e  of  
v i r u s  from i n f e c t e d  c e l l s  and hence reduce th e  q u a n t i t y  o f  v i ru s  
produced dur ing  i n f e c t i o n  (3 ,  75,  77 ) .  Monoclonal a n t ib o d ie s
d i r e c t e d  a g a i n s t  th e  s u r f a c e  HA and NA o f  i n f lu en z a  v i r u s  p r o t e c t  
mice a g a i n s t  ch a l l en g e  with  v i r u l e n t  w i ld - ty p e  v i r u s ,  whereas o th e r  
monoclonals d i r e c t e d  a g a i n s t  i n t e r n a l  n u c le o p r o te in s  o r  m a t r ix
14
p r o t e i n s  do not a l t e r  th e  course  o f  th e  d i s e a s e  (3 ) .
I t  should  be n o ted ,  however, t h a t  immune responses  to  c e r t a i n  
i n t e r n a l  v i r a l  p r o t e i n s  may p lay  a c o o p e r a t iv e  r o l e  in the  
development o f  e f f e c t i v e  immunity.  A l a r g e  body of  in fo rm at ion  i s  
accumula ting on th e  i n t e r a c t i o n  o f  t h e se  i n t e r n a l  v i r a l  p r o t e i n s  a n d  
c e l l  membranes. Lamb e t  a l .  (80) s tu d i e d  the  M2  p r o t e i n  o f  in f lu en z a  
A v i r u s .  This p r o t e i n  i s  t r a n s l a t e d  from a s p l i c e d  mRNA sequence 
t r a n s c r i b e d  from genome segment 7,  and i s  a 97 amino ac id  
n o n -g ly co sy la ted  p r o t e i n  with  a s i n g l e  hydrophobic reg ion  between 
r e s id u e s  25 and 43. Lamb e t  a l .  (80) showed t h a t  i s  p r e s e n t  in 
th e  i n f e c t e d  c e l l  and i s  i n s e r t e d  i n t o  th e  plasma membrane, w ith  i t s  
N-terminus e x t e r n a l  to  t h e  c e l l .  They sugges ted  t h a t  t h i s  p r o t e i n  
could be an im por tan t  t a r g e t  in  n a tu ra l  i n f e c t i o n  s in ce  they  were 
ab le  to  demonst ra te  t h a t  a n t i - p e p t i d e  a n t ib o d ie s  could  recogn ize  the  
e x t e r n a l  p o r t i o n  o f  t h i s  p r o t e i n .  In p a r t i c u l a r ,  they s p ec u la ted  
t h a t  M2  could  be a major  v i r a l  p r o t e i n  d i sp la y ed  on i n f e c t e d  c e l l  
membranes which a re  recogn ized  by c y to to x ic  T - c e l l s .
The major p r o t e c t i v e  an t ig e n s  o f  naked v i r u s e s  a re  a l s o  lo c a ted  
on t h e i r  s u r f a c e s .  One example would be f o o t  and mouth d i s e a s e  v i ru s  
(FMDV) which c o n s i s t s  o f  8kb s i n g l e  s t r an d ed  RNA surrounded by 60 
cop ie s  o f  fo u r  s t r u c t u r a l  p o ly p ep t id e s  (7 8 ) .  Only VP1 has been 
a s s o c i a t e d  with a b i l i t y  t o  induce v i r u s  n e t u r a l i z i n g  a n t ib o d ie s  (4 ) .  
However, r e c e n t  r e p o r t s  on p o l io  v i r u s  in d i c a t e d  t h a t  e p i to p e s  
lo c a ted  on VP2 and VP3 in  a d d i t i o n  to  those  c l u s t e r e d  on VP1 can 
induce n e u t r a l i z i n g  a n t i b o d i e s  (3 2 ) .  S tud ies  with po lyc lona l  and 
MCAbs to  p o l i o v i r u s  type  1 caps id  p r o t e i n  VP1 confirmed t h a t  th e  
v i ru s  underwent conformat iona l  changes dur ing  n e u t r a l i z a t i o n  (36,
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8 9 ) .  P o l io v i r u s  assumes two i s o e l e c t r i c  forms with  p i s  of  about 7 
and 4 ,  o f  which only  th e  former i s  i n f e c t i o u s .  When v i ru s  i s  
n e u t r a l i z e d ,  th e  pi i s  s h i f t e d  and f rozen  a t  4.  The n e u t r a l i z a t i o n  
and pi s h i f t  occur  only  i f  an t ibody  molecules  bind b i v a l e n t l y  to  the  
v i r i o n .  An average  of fo u r  bound a n t i b o d i e s  pe r  v i r i o n  a r e  r e q u i r e d  
to  n e u t r a l i z e  the  v i r u s  (5 5 ) .
Monoclonal a n t i b o d i e s  have proved t o  be very  im por tan t  r e a g en ts  
t o  d i s c e r n  t h e  fu n c t io n a l  and s t r u c t u r a l  p r o p e r t i e s  o f  v i r a l  
p r o t e i n s .  The number and l o c a t i o n  o f  an t ibody  b inding  s i t e s  on the  HA 
and NA o f  i n f lu en z a  v i ru s e s  were de termined us ing  MCAbs in s e l e c t i n g  
v a r i a n t s  and in  co m p e t i t iv e  b ind ing  a ssays  which demonst ra ted  the  
presence  of  t h r e e  o r  fou r  nonoverlapping an t ibody  b inding  s i t e s  (10,  
144, 148).
The s p e c i f i c i t y  o f  th e  r e a c t i o n  o f  MCAbs p rov ide  the  b a s i s  f o r  
th e  d e t e c t i o n  of s u b t l e  d i f f e r e n c e s  between the  gene products  of  
r e l a t e d  v i r u s e s  and thus  th e  d i f f e r e n t i a t i o n  o f  one v i r u s  from 
an o th e r .  Indeed t h i s  approach g r e a t l y  exceeds convent ional  se ro logy  
in s p e c i f i t y ,  and has l ead  to  the  r e c o g n i t i o n  o f  d i f f e r e n c e s  between 
v i ru s e s  p re v io u s ly  thought  i d e n t i c a l .  Human c o n v a le sce n t  serum f o r  
example,  f a i l e d  to  d e t e c t  s e r o l o g i c a l  d i f f e r e n c e s  between human 
r e s p i r a t o r y  s y n c y t i a l  v i r u s  (RSV) i s o l a t e s .  However, MCAbs were 
capable  o f  d i s t i n g u i s h i n g  between d i f f e r e n t  human RSV i s o l a t e s  and 
t h e r e f o r e  d i f f e r e n t  types  o f  human RSV were sugges ted  to  e x i s t  (4 5 ) .  
S i m i l a r l y ,  a wide a n t i g e n i c  v a r i a t i o n  was sugges ted  to  occur 
n a t u r a l l y  among f i e l d  s t r a i n s  of  coxsack ie  B v i r u s  type 4 (CBV-4). 
Cao e t  a l .  (14) were a b l e  to  i d e n t i f y  f i v e  d i f f e r e n t  a n t i g e n i c  
v a r i a n t s  among nine  v i r u s  s t r a i n s  by us ing  a panel o f  n ine
n e u t r a l i z i n g  MCAbs to  CBV-4. Comparing n ine  t r a n s m i s s i b l e  
g a s t r o e n t e r i t i s  v i r u s  (TGEV) s t r a i n s  by us ing  a panel o f  MCAbs, Laude 
e t  a l .  (81) confirmed th e  e x i s t e n c e  o f  a c lo s e  a n t i g e n i c  r e l a t i o n s h i p  
between th e se  s t r a i n s  bu t  re v e a le d  a l s o  th e  occu r rence  o f  d i s t i n c t  
a n t i g e n i c  d i f f e r e n c e s  a t  t h e  same t im e .  Thus,  t h e  s i t u a t i o n  with 
TGEV seems to  d i f f e r  from th e  murine c o ro n av i ru s  (MHV-4) where each 
i s o l a t e  was re p o r te d  to  have a unique p a t t e r n  o f  r e a c t i v i t y  to  a s e t  
of a n t i - g l y c o p r o t e i n  MCAbs (39, 81 ) .  The l a b o r a t o r y  s t r a i n s  o f  
r a b i e s  v i r u s  were found t o  be d i f f e r e n t  from each o t h e r  as well  as 
from r a b i e s - r e l a t e d  v i r u s e s  (38) .  These d i f f e r e n c e s  were a t t r i b u t e d  
to  d i f f e r e n t  a n t i g e n i c  d e te rm in an ts  on th e  g ly c o p r o t e i n s  o f  t h e se  
v i r u s e s .
The d i s c r i m i n a t o r y  power o f  MCAbs make them id e a l  r e a g e n t s  f o r  
i n v e s t i g a t i o n  o f  a n t i g e n i c  r e l a t e d n e s s  between v i r a l  p r o t e i n s .  They 
a re  in v a lu a b le  r e a g en t s  in  dem ons t ra t ing  minor a n t i g e n i c  d i f f e r e n c e s  
between c l o s e l y  r e l a t e d  p r o t e i n s .  This i s  well i l l u s t r a t e d  by r e c e n t  
work with  r a b i e s  and p o l i o  v i r u s e s ,  where a n t i g e n i c  d i f f e r e n c e s  
between c l o s e l y  r e l a t e d  p r o t e i n s  could  be d e l i n e a t e d  between 
r e s p e c t i v e  f i e l d  and vacc ine  s t r a i n s  p r e v io u s ly  co n s id e re d  to  be 
a n t i g e n i c a l l y  i n d i s t i n g u i s h a b l e  (38 ,  8 7 ) .  This f i n d i n g  i s  of
p a r t i c u l a r  importance and may e x p la in  why vacc ines  o c c a s i o n a l l y  f a i l  
t o  p r o t e c t  a g a i n s t  i n f e c t i o n  by f i e l d  s t r a i n s .  The appearance  o f  
a n t i g e n i c a l l y  v a r i a n t  p o l i o v i r u s  type  3 s t r a i n s  in  a v a cc in a ted  
p o p u la t io n  in Fin land  document t h e s e  f a c t s  (8 7 ) .  In f a c t ,  th e  p o l io  
v i r u s e s  i s o l a t e d  dur ing  th e  ou tbreak  were a n t i g e n i c a l l y  he terogeneous  
when examined f o r  n e u t r a l i z a t i o n  by a l a r g e  panel o f  MCAbs. Most o f  
th e  s t r a i n s  were unusual a n t i g e n i c a l l y  in  t h a t  they  were not
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n e u t r a l i z e d  by th e  m a j o r i t y  o f  t h e  a n t ib o d ie s  t e s t e d  and the  
a n t i g e n i c  p r o p e r t i e s  were c o n s i s t e n t  w i th  th e  v a r i a t i o n  found in the  
sequence o f  th e  immunodominant a n t i g e n i c  s i t e  involved  in  the  
n e u t r a l i z a t i o n  of  t h e  v i r u s .  I t  i s ,  however, no t  c l e a r  why the  
h e t e r o g e n e i t y  a r o s e ,  as t h i s  s i t e  i s  g e n e r a l l y  well  conserved among 
u n r e l a t e d  type  3 p o l io  v i r u s e s  (87) .
I .A .3 .C .  An t igen ic  v a r i a t i o n
The s u rv iv a l  and c i r c u l a t i o n  o f  many pathogens in  n a tu re  
d e s p i t e  the  in d u c t io n  o f  a r ig o ro u s  immune response  in  th e  i n f e c t e d  
h o s t  depend on th e  i n h e r e n t  c a p a b i l i t i e s  of  t h e se  pathogens t o  change 
th e  a n t i g e n i c  d e te rm in a n ts  o f  t h e i r  s u r f a c e  p r o t e i n s  dur ing  the  
cou rse  o f  an i n f e c t i o n .  Ant igen ic  v a r i a t i o n  o f  v a r ious  pa thogens ,  
i n c lu d in g  p a r a s i t e s ,  b a c t e r i a  and v i r u s e s ,  i s  now well documented and 
p a r t i a l l y  unders tood  a t  th e  m olecu la r  l e v e l .  This p ro p e r ty  has been 
an im por tan t  f a c t o r  c o n t r i b u t i n g  to  f a i l u r e s  in the  c o n t ro l  o f  th e se  
pathogens by conven t iona l  v a c c i n a t i o n .  A prime example o f  a n t i g e n i c  
v a r i a t i o n  has been observed in  A fr ican  trypanosomes which evade the  
immune responses  o f  t h e i r  mammalian h o s t  by s e q u e n t i a l l y  e x p re s s in g  a 
s e r i e s  o f  v a r i a b l e  s u r f a c e  g ly c o p r o t e in s  (VSGs) from a l i b r a r y  of  
VSGs genes (3 4 ) .  This enab le s  c e r t a i n  p o p u la t io n s  o f  trypanosomes of 
an i n f e c t e d  animal t o  keep "one s t e p  ahead" o f  th e  a n t i b o d i e s  r a i s e d  
a g a i n s t  t h e i r  VSGs. Under most c o n d i t i o n s  each trypanosome exp re sses
one,  and only  one ,  VSG on i t s  s u r f a c e  a t  a g iven i n s t a n t  (11 ,  30) .
A n t igen ic  v a r i a t i o n  r e p r e s e n t s  a p o t e n t  s u rv iv a l  s t r a t e g y  whereby
v i r u s e s  can e lude  th e  a n t i v i r a l  immune response  by emergence of
a n t i g e n i c a l l y  new v i r u s  s t r a i n s .  These a re  due to  m uta t iona l  changes 
o f  th e  v i r a l  genome. Once th e se  changes a re  m an ife s ted  in the
a n t i g e n i c i t y  o f  the  v i r u s ,  the  v i r u s  can p e r s i s t  and c i r c u l a t e  in the  
p o p u la t io n  r a t h e r  f r e e l y .  An e x c e l l e n t  example o f  a n t i g e n i c  
v a r i a t i o n  i s  in type  A human in f lu en z a  v i r u s e s  (119, 149).  The 
v a r i a b i l i t y  of in f lu e n z a  v i r u s e s  appears  to  invo lve  seve ra l  
mechanisms, o f  which r e a s s o r tm e n t ,  p o i n t  m u ta t io n ,  a d d i t i o n  or  
d e l e t i o n  in genes coding f o r  both s u r f a c e  g l y c o p r o t e i n s ,  HA and NA, 
have been d e s c r ib e d .  Of t h e s e  mechanisms, r e a s so r tm e n t  in genes 
coding f o r  both s u r f a c e  g l y c o p ro t e in s  induces  major a l t e r a t i o n s  in 
th e  v i r u s  a n t i g e n i c i t y ,  which i s  recognized  as " a n t i g e n i c  s h i f t . "  On 
th e  o t h e r  hand, minor m uta t ions  in th e  genome, le ad in g  to  one o r  more 
amino a c id  sequence changes may a l t e r  th e  a n t i g e n i c  s i t e s  in  such a 
way t h a t  they  a re  no longe r  recognized  by th e  h o s t ' s  immune system, 
i . e . ,  " a n t i g e n i c  d r i f t "  (149) .  However, in  an i n f e c t e d  h o s t ,  
a l t e r a t i o n  of  the  a n t i g e n i c  s t r u c t u r e  o f  th e  i n f e c t i n g  v i r u s  a llows 
th e  a n t i g e n i c  v a r i a n t  to  escape  from n e u t r a l i z a t i o n  by a n t i b o d i e s ,  
th us  p e rp e tu a t i n g  th e  i n f e c t i o n  in an o th e rw ise  immunologically  
competent h o s t .
A n t igen ic  v a r i a t i o n s  were a l s o  demonstra ted  in  in d iv id u a l  
animals  i n f e c t e d  with  th e  l e n t i v i r u s ,  v i s n a .  However, v i r u s e s  
recovered  from sheep p e r ip h e r a l  blood leukocy tes  p r i o r  to  and severa l  
months a f t e r  development o f  a n t i b o d ie s  were a n t i g e n i c a l l y  i d e n t i c a l  
t o  th e  p a re n ta l  s t r a i n  used f o r  i n o c u l a t i o n .  Longi tud ina l  s t u d i e s  of  
v isna  v i r u s e s  c o l l e c t e d  from two i n f e c t e d  sheep were i n t e r e s t i n g  in 
t h a t  they  showed t h a t  more than one s t r a i n  o f  v i r u s  could  c o - e x i s t  in 
th e  animal (108, 109, 110, 111).  The s e l e c t i o n  o f  a n t i g e n i c  v a r i a n t s  
under an t ibody  p re s su re  was s u b s t a n t i a t e d  by exper iments  done in 
v i t r o  us ing  sheep c e l l  c u l t u r e s  t h a t  were i n o c u la te d  with
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p la q u e - p u r i f i e d  v isna  v i r u s  and main ta ined  with  an t ibody  in the  
medium (111) .  This a n t i g e n i c  v a r i a t i o n  o f  v isna  v i r u s  has been 
c o r r e l a t e d  with p o in t  m u ta t io n s  c l u s t e r e d  in  th e  3 '  te rm ina l  reg ion  
o f  th e  v i r a l  RNA (2 2 ) .  The same workers f u r t h e r  found t h a t  th e se
changes were c l u s t e r e d  in  a s i n g l e  reg ion  of  th e  v i r a l  genomes of
seven a n t i g e n i c  v a r i a n t s  and sugges ted  t h a t  t h e se  genomic changes a re  
l in k ed  to  th e  a n t i g e n i c  phenotype of  th e se  v a r i a n t s  (23) .
Equine i n f e c t i o u s  anemia i s  a unique r e t r o v i r u s  i n f e c t i o n  in 
t h a t  t h e  c l i n i c a l  d i s e a s e  i s  c h a r a c t e r i z e d  by b u r s t s  o f  v iremia  which 
occur in  s e q u e n t i a l  ep isodes  s e p a ra te d  by s ev e ra l  weeks o r  months 
(29 ,  60,  6 8 ) .  Kono (68) and Kono e t  a l . (69,  72) have sugges ted  t h a t  
a n t i g e n i c  v a r i a t i o n  i s  l i k e l y  t o  be th e  mechanism ope rab le  in  EIAV to  
e x p la in  v i r a l  p e r s i s t e n c e  and th e  r e c u r r in g  ep i sodes  o f  c l i n i c a l
i l l n e s s  in EIAV. These workers  r e p o r t e d  t h a t  s e r a  taken a t  va r io u s
times from an i n f e c t e d  animal were a b le  to  n e u t r a l i z e  v i r u s  i s o l a t e s  
from prev ious  c l i n i c a l  e p i s o d e s ,  bu t  d id  not e f f e c t i v e l y  n e u t r a l i z e  
subsequent v i r u s  i s o l a t e s .  They f u r t h e r  confirmed th e  a n t i g e n i c  
d r i f t  o f  EIAV in i n f e c t e d  horses  by us ing  a n t ib o d ie s  r a i s e d  in 
r a b b i t s  a g a i n s t  t h e se  v i r u s e s  (69 ,  72 ) .  R ecen t ly ,  a l t e r a t i o n s  were 
observed in  the  RNA genome o f  s ev e ra l  EIAV i s o l a t e s  by us ing 
o l i g o n u c l e o t i d e  f i n g e r p r i n t i n g  techn ique  (121) .  At th e  same t im e ,  
s t r u c t u r a l  a l t e r a t i o n s  o f  the  s u r f a c e  g ly c o p r o t e in s  o f  EIAV were 
demonst ra ted  dur ing  p e r s i s t e n t  i n f e c t i o n s  (102, 129).  They were 
e v id e n t  in  p e p t id e  and g ly c o p ep t id e  maps with  s ev e ra l  p e p t id e  
a d d i t i o n s  an d /o r  d e l e t i o n s  o ccu r r in g  between each i s o l a t e  and i t s  
p r e d e c e s s o r .  These genotyp ic  and phenotypic  changes demonst ra te  t h a t  
EIAV i s  a h ig h ly  mutable  v i r u s  and sugges t  t h a t  p o in t  m uta t ions  occur
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f r e q u e n t l y  in  genes coding f o r  v i r a l  g ly c o p ro te in s  (102, 121,
129).  I t  i s  probable  t h a t  th e  emergence o f  novel a n t i g e n i c  s t r a i n s  
o f  EIAV i s  a m a n i f e s t a t i o n  of  t h e se  a l t e r a t i o n s .
Genomic h e t e r o g e n e i t y  has a l s o  been f i r m ly  e s t a b l i s h e d  as a 
prominent c h a r a c t e r i s t i c  of  th e  AIDS v i r u s ,  HIV (6 ,  152) .  In
a d d i t i o n ,  t h e  envelope gene o f  t h i s  v i r u s  i s  r e l a t i v e l y  h y p e rv a r i a b le  
in  comparison with th e  remainder o f  the  v i r a l  genome. R ecen t ly ,  Hann 
e t  a l .  (49) r e p o r t e d  t h a t  AIDS v i r u s e s  i s o l a t e d  s e q u e n t i a l y  from 
p e r s i s t e n t l y  i n f e c t e d  i n d i v i d u a l s  appear  t o  have evolved in  p a r a l l e l  
from a common p r o g e n i to r  v i r u s ,  as examined by Southern b l o t  genomic 
a n a l y s i s ,  m o lecu la r  c lo n in g ,  and n u c l e o t id e  sequencing . The same 
workers f u r t h e r  confirmed t h a t  v i r u s  i s o l a t e s  from any one p a t i e n t  
were a l l  much more r e l a t e d  to  each o t h e r  than to  v i r u s e s  from o th e r  
i n d i v i d u a l s .  The v a r i a t i o n  in th e  envelope p r o t e i n s  o f  EIAV and v isna  
as well  as the  g e n e t i c  v a r i a t i o n  in  HIV may g ive  r i s e  to  v i r u s e s  with 
a l t e r e d  a n t i g e n i c i t y / i m m u n o g e n i c i t y , v i r u l e n c e ,  t i s s u e  t ro p i sm ,  or  
drug s e n s i t i v i t y .  These in  t u r n  may a f f e c t  v i r a l  pa thogenes is  and 
allow th e  v i r u s  to  escape  th e  h o s t ' s  immune d e fe n se s .
I . A . 4.  Vira l  i n f e c t e d  c e l l  membrane a n t ig e n s
Many p r o t e i n s  d e s t i n e d  to  become i n t e g r a t e d  i n t o  c e l l u l a r  
membrane ( in c lu d in g  a l l  th e  v i r a l  g ly c o p ro te in s )  a r e  sy n th es iz ed  on 
membrane bound polyribosomes (7 6 ) .  All th e se  p r o t e i n s  a re  
sy n th es iz ed  with an amino- te rmina l p e p t id e  ex ten s io n  termed a " s igna l  
pep t ide"  o r  " l e a d e r "  sequence.  These v i r a l  g l y c o p ro t e in s  a re  
a t t a c h e d  to  the  l i p i d  b i l a y e r  by a s i n g l e  transmembrane anchor ing 
p e p t i d e ,  the  bulk o f  t h e i r  s t r u c t u r e  being on th e  e x te r n a l  s i d e  of  
the  membrane with a small domain on th e  cy top lasmic  s i d e .  C e l l s
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i n f e c t e d  with r e t r o v i r u s e s  express  a number of p r o t e i n s  on the  c e l l  
s u r f a c e ,  e . g . ,  gp70 o f  murine leukemia v i r u s  (2 4 ) .
S p e c i f i c  EIAV a n t ig e n  was demonstra ted  on th e  s u r f a c e  of 
p e r s i s t e n t l y  i n f e c t e d  f i b r o b l a s t s  us ing  both a radioimmune binding  
t e s t  (94) and lymphocyte c y t o t o x i c i t y .  Antibody a g a i n s t  t h i s  an t ig en  
appeared w i th in  one month a f t e r  i n f e c t i o n  and p e r s i s t e d  a t  l e a s t  fo u r  
y e a r s .  However, j_n v i t r o  k i l l i n g  of  c e l l s  i n f e c t e d  with  EIAV by 
an t ibody-dependen t  c e l l - m e d ia t e d  c y t o t o x i c i t y  has been d i f f i c u l t  to  
demonst ra te  (4 1 ) .  This was a t t r i b u t e d  to  low an t ig e n  d e n s i t y  
expressed  on the  c e l l  s u r f a c e .  In a d d i t i o n ,  low leve l  j j i  v i t r o  
k i l l i n g  o f  EIAV i n f e c t e d  c e l l s  by lymphocytes from i n f e c t e d  horses  
was a l s o  demonstra ted  (4 1 ) .  The a n t ig e n  type  expressed  on EIAV 
i n f e c t e d  c e l l s  i s  not known; however,  the  p resence  o f  t h e se  s u r f a c e  
an t ig e n s  prov ides  s ev e ra l  p o t e n t i a l  mechanisms f o r  d e s t r u c t i o n  o f  
i n f e c t e d  c e l l s  in v i v o .
I -B- RESEARCH OBJECTIVES 
The main t h r u s t  of  the  p r e s e n t  r e s e a rc h  i s  t o  g e t  a b e t t e r  
unders tand ing  o f  EIAV a n t i g e n i c  v a r i a t i o n  as  a mechanism f o r  v i r a l  
p e r s i s t e n c e  and to  d e f in e  d e t e r m in a n t ( s )  capab le  of  s t im u la t in g  
n e u t r a l i z i n g  an t ib o d y .  The s p e c i f i c  o b j e c t i v e s  a r e  l i s t e d  below 
along with t h e i r  r e l a t i v e  s i g n i f i c a n c e .
1) To g e n e r a te  a d i v e r s e  panel o f  monoclonal a n t i b o d ie s  
to  th e  s u r f a c e  g l y c o p r o t e in s  (gp90 and gp45) o f  th e  p ro to ty p e  s t r a i n  
o f  EIAV. These monoclonal a n t i b o d i e s  w i l l  be used to  i d e n t i f y  and 
d i s s e c t  the  a n t i g e n i c  s i t e s  o f  th e  EIAV g l y c o p r o t e i n s .
2) To d e f in e  the  p a t t e r n  and e x t e n t  o f  s e r o l o g i c a l  
c r o s s - r e a c t i o n s  o f  EIAV i s o l a t e s .  The s e r o l o g i c a l  r e a c t i v i t i e s  of
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t h e  EIAV i s o l a t e s  w i l l  be dete rmined with MCAbs in  Western b l o t  and 
ELISA. These s t u d i e s  w i l l  a l low us to  compare th e  g ly c o p ro te in s  
(gp90 and gp45) o f  d i f f e r e n t  EIAV i s o l a t e s  with  MCAbs.
3) To s tudy  a n t i g e n i c  v a r i a t i o n  o f  EIAV and d e l i n e a t e  the  
changes in  th e  v i r i o n  s u r f a c e  g l y c o p r o t e i n s .  Using a d i v e r s e  panel 
o f  MCAbs, i t  i s  p o s s i b l e  to  d i s s e c t  o r  map ou t  th e  a l t e r e d  
a n t i g e n i c i t y  o f  the  s u r f a c e  g l y c o p r o t e in s  p r e s e n t  in  i s o l a t e s  from 
ponies  with  ch ron ic  EIA. A d e t a i l e d  s e r o l o g i c a l  comparison o f  v i r a l  
g l y c o p r o t e i n s  o f  d i f f e r e n t  EIAV i s o l a t e s  recovered  from animals  
i n f e c t e d  in  p a r a l l e l  w i th  th e  same inoculum might he lp  in  d e f in in g  
th e  e x t e n t  and p a t t e r n  o f  th e  e v o lu t io n  o f  EIAV v a r i a n t s .  I t  may 
he lp  de te rm ine  th e  number of  EIAV s e r o ty p es  t h a t  may e x i s t  and w i l l  
a s s i s t  in  c a t a lo g in g  EIAV i n t o  s e r o l o g i c a l  groups .
4) To de te rm ine  which v i r u s  component(s)  a r e  invo lved  in  
th e  a n t i g e n i c  changes observed  in EIAV v a r i a n t s .  Using th e  d iv e r s e  
panel o f  MCAbs we w i l l  see  i f  a n t i g e n i c  v a r i a t i o n  i s  l i m i t e d  to  gp90 
o r  gp45 o r  whether  both components c o n t r i b u t e  s i g n i f i c a n t l y  t o  the  
observed  a l t e r e d  a n t i g e n i c i t y  o f  EIAV v a r i a n t s .
5) To d e f in e  th e  d e t e r m in a n t ( s )  invo lved  in  s t i m u l a t i n g  
n e u t r a l i z i n g  a n t i b o d i e s  t o  EIAV. The i d e n t i f i c a t i o n  o f  unique  a n d /o r  
conserved e p i t o p e ( s )  which a re  necessa ry  t a r g e t s  f o r  n e u t r a l i z i n g  
a n t i b o d i e s  may r e p r e s e n t  an e s s e n t i a l  f i r s t  s t e p  f o r  d e s ign ing  a 
s y n t h e t i c  v a cc in e .  I f  conserved o r  g r o u p - s p e c i f i c  e p i to p e s  can be 
i d e n t i f i e d  which possess  p r o t e c t i v e  immunogenic ity , then the  
g e n e r a t io n  o f  an e f f e c t i v e  g r o u p - s p e c i f i c  immunogen would be 
f e a s i b l e .
CHAPTER I I
GENERATION OF MONOCLONAL ANTIBODIES: PRODUCTION AND CHARACTERIZATION
I I . A .  INTRODUCTION 
Equine i n f e c t i o u s  anemia v i r u s ,  a r e t r o v i r u s  in t h e  subfamily  
L e n t i v i r i n a e ,  causes  a n a t u r a l l y  o c cu r r in g  d i s e a s e  in  a l l  members o f  
t h e  horse  f a m i ly .  The d i s e a s e  has a worldwide d i s t r i b u t i o n  and i s  
o f  g r e a t  economic importance  to  th e  horse  i n d u s t r y .  The unique 
f e a t u r e  o f  EIA i s  t h e  p e r s i s t e n t  n a tu re  o f  th e  i n f e c t i o n  which 
invo lves  b u r s t s  o f  v i rem ia  a s s o c i a t e d  w i th  r e c u r r i n g  c l i n i c a l  
symptoms, i . e . ,  th e  c h ro n ic  form o f  th e  d i s e a s e  (29,  60,  72 ) .  Within 
th e  l e n t i v i r u s e s , EIAV i s  c l o s e l y  r e l a t e d  t o ,  and sh a re s  a d d i t i o n a l  
f e a t u r e s  with  th e  human immunodeficiency v i r u s  (98,  137).
Equine i n f e c t i o u s  anemia v i r u s  has been found to  c o n ta in  two 
main s u r f a c e  g ly c o p r o t e i n s  (gp90 and gp45) and fo u r  major  
n ong lycosy la ted  i n t e r n a l  p r o t e i n s  d e s ig n a te d  p26, p l 5 ,  p l l ,  and p9 
(100, 120).  The major g l y c o p r o t e in s  o f  the  r e f e r e n c e  Wyoming s t r a i n  
o f  EIAV were found to  have d i f f e r e n t  e l e c t r o p h o r e t i c  m o b i l i t i e s  from 
th o se  o f  a n t i g e n i c  v a r i a n t s ,  w h i le  th e  major  core  p r o t e i n s  were 
i d e n t i c a l .  Research t o  d a t e  has shown t h a t  EIAV v a r i a n t s  c o n ta in  
s t r u c t u r a l  a l t e r a t i o n s  conf ined  to  th e  envelope g l y c o p r o t e in s  and 
t h a t  t h e s e  changes a re  p a r a l l e l e d  by changes in v i r a l  RNA (102, 121, 
129).  I f  t h e s e  g eno typ ic  and phenotypic  changes a r e  m ir ro red  
a n t i g e n i c a l l y ,  EIAV w i l l  possess  an e s s e n t i a l  mechanism f o r  
p e r s i s t e n c e  and sp re ad .
A more comprehensive  u n de rs tand ing  o f  t h e  m o lecu la r  b a s i s  o f  the  
a l t e r e d  a n t i g e n i c i t y  and immunogenicity i s  needed in o rd e r  to  produce 
a vacc ine  f o r  EIA. To o b t a in  knowledge about  th e  a n t i g e n i c
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a l t e r a t i o n s ,  MCAbs were produced a g a i n s t  a n t i g e n i c  de te rm inan ts  on 
the  s u r f a c e  g l y c o p r o t e in s  o f  EIAV. S e ro lo g i ca l  r e a c t i v i t i e s  o f  a 
panel o f  MCAbs were monitored  in  enzyme-l inked  immunosorbent a s s a y ,  
Western b l o t  immunoassay and n e u t r a l i z a t i o n  a s s a y s .  Since r e s u l t s  
have shown t h a t  s e q u e n t i a l  i s o l a t e s  o b ta in e d  from p e r s i s t e n t l y  
i n f e c t e d  ponies  d i f f e r  in  t h e i r  s u r f a c e  p r o t e i n s ,  our aim was to  use 
t h e se  g ly c o p r o t e in  s p e c i f i c  MCAbs to  i d e n t i f y  and d i s s e c t  the  
a n t i g e n i c  s i t e s  on EIAV i s o l a t e s  o b ta in ed  from p e r s i s t e n t l y  i n f e c t e d  
p o n ie s .  This w i l l  he lp  in  mapping ou t  t h e  a l t e r e d  a n t i g e n i c i t y  of  
the  s u r f a c e  g ly c o p r o t e in s  which may be o f  r e lev an ce  to  the  observed 
r e c u r r e n t  c l i n i c a l  d i s e a s e .
I I .B  MATERIALS AND METHODS 
I I . B . l .  Cell C u l tu re
Feta l  equine kidney (FEK) c e l l s  and f e t a l  donkey dermal (FDD) 
c e l l s  used f o r  v i r u s  p roduc t ion  and n e u t r a l i z a t i o n  a ssay  were 
p repared  in  the  l a b o r a t o r y ,  main ta ined  in  E a g le ' s  minimal e s s e n t i a l  
medium (GIBCO L a b o r a t o r i e s ,  Grand I s l a n d ,  NY), and supplemented with 
5 t o  10% s t e r i l e  f e t a l  c a l f  serum (GIBCO), 25 mM HEPES 
( N -2 -h y d ro x y e th y lp ip e raz in e -N 1- 2 - e t h a n e s u l f o n i c  a c id )  b u f f e r ,  10 mM 
sodium b i c a r b o n a t e ,  150 U of  p e n i c i l l i n  G per  ml ,  and 150 ug o f  
s t rep tom yc in  s u l f a t e  per  ml.  P e r s i s t e n t l y  i n f e c t e d  c u l t u r e s  were
p
main ta ined  in  r o l l e r  b o t t l e  c u l t u r e s  (850 cm growth a re a )  c o n ta in in g  
50 ml o f  medium.
I I . B . 2. Virus p ropaga t ion  and p u r i f i c a t i o n
The c e l l - a d a p t e d  Wyoming s t r a i n  of EIAV (88) was propaga ted  in  
primary FEK c e l l  c u l t u r e s .  The procedure  f o r  v i r u s  p u r i f i c a t i o n  has 
been d e sc r ib e d  in d e t a i l  (100) .  B r i e f l y ,  t h e  v i r u s  was propagated  in
primary FEK c e l l s  which remain p e r s i s t e n t l y  i n f e c t e d .  The c u l t u r e s  
were m ain ta ined  in  r o l l e r  b o t t l e s  and s u p e r n a t a n t  f l u i d  was h a rv e s te d  
every  3 to  4 days ,  c l a r i f i e d  by c e n t r i f u g a t i o n  a t  10,000 xg f o r  30 
min in  a Sorva l l  GSA r o t o r ,  and c o n ce n t ra t e d  about 10 to  40 f o ld  by 
us ing  a p e l l  icon membrane f i l t e r  (nominal e x c l u s i o n ,  10® d a l to n  
m olecu la r  w e ig h t ,  M i l l i p o r e  C o rp . ,  Bedford ,  Mass).  The c o n c e n t r a t e  
was c e n t r i f u g e d  through an u n d e r layered  10 ml cushion o f  10% sucrose  
and p e l l e t e d  by c e n t r i f u g a t i o n  in  a type  19 r o t o r  (Beckman 
In s t ru m e n t s ,  I n c . ,  F u l l e r t o n ,  C a l i f . )  a t  19,000 rpm (50,000 xg) f o r  2 
h.  P e l l e t e d  v i ru s  was resuspended  in 0.01 M phosphate  b u f f e r  (pH 
7 .2 )  and sedimented t o  i t s  e q u i l i b r iu m  d e n s i t y  (1 .18  g/ml) on a 3 ml 
20 to  80% (V0L/V0L) g ly c e ro l  g r a d i e n t  (100, 102, 120) in  a Beckman 
SW-28 r o t o r  c e n t r i f u g e d  a t  28,000 rpm (130,000 xg) f o r  4 h.  The 
v i r u s  band was c o l l e c t e d ,  d i l u t e d  in  sodium phosphate  b u f f e r  t o  a 
f i n a l  g ly ce ro l  c o n c e n t r a t i o n  o f  approx im ate ly  10% and p e l l e t e d  by 
c e n t r i f u g a t i o n  in  a Beckman SW-28 r o t o r  a t  28,000 rpm (130,000 xg) 
f o r  90 min. The f i n a l  v i r u s  p e l l e t  was suspended in 0.01 M sodium 
phosphate  b u f f e r  and s t o r e d  a t  -70°C in small  a l i q u o t s .  All 
procedures  were c a r r i e d  ou t  a t  4°C.
I I . B . 3.  G lycopro te in  p u r i f i c a t i o n
The g l y c o p ro t e in s  of  EIAV were p u r i f i e d  by a f f i n i t y  
chromatography over  a column o f  l e n t i l  l e c t i n  bound to  Sepharose  in 
th e  p resence  o f  d e t e r g e n t  as d e s c r ib e d  p r e v io u s ly  (101, 102).
B r i e f l y ,  20 mg o f  p u r i f i e d  EIAV was t r e a t e d  with  10 volumes o f  cold  
ace tone  to  remove excess  l i p i d s  and to  p r e c i p i t a t e  th e  p r o t e i n s  of  
the  v i r u s .  The p r o t e i n s  were c o l l e c t e d  by c e n t r i f u g a t i o n  a t  10,000 
xg f o r  10 min a t  4°C and the  p e l l e t  was s o l u b i l i z e d  by in c u b a t io n  f o r
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15 min in b u f f e r  A (T r i s  [0 .02  M], Nacl [0 .1  M], pH 8 .3 )  co n ta in in g  
0.5% sodium deoxycho la te  (Sigma Chemical Co.,  S t .  Lou is ,  MO). 
In s o lu b le  m a te r ia l  was removed by c e n t r i f u g a t i o n  a t  10,000 xg f o r  10 
min. S o lu b i l i z e d  p r o t e i n s  were then s ep a ra te d  by a f f i n i t y  
chromatography over  a column o f  l e n t i l  l e c t i n - S e p h a r o s e  (Pharmacia 
Chemicals ,  P isca taway ,  NJ) p r e - e q u i l i b r a t e d  with b u f f e r  A c o n ta in in g  
0.1% sodium deoxycho la te .  The sample was allowed to  adsorb f o r  4 h 
a t  room te m p e ra tu re ;  unbound m a te r i a l  was washed through wi th  the  
same b u f f e r .  Bound g ly c o p r o t e in s  were e l u t e d  w i th  0 .2  M 
m ethy lg lucos ide  in b u f f e r  A c o n ta in in g  0.1% sodium deoxychola te  and 
d i a ly z ed  f o r  36 h a g a i n s t  0 .1  M ammonium b i c a r b o n a t e ,  pH 8 .0  and 12 h 
a g a i n s t  0.05 M ammonium b i c a r b o n a t e ,  pH 8 . 0 .  The p r o t e i n s  were then 
ly o p h i l i z e d  to  d ry n e s s ,  resuspended  in 0.01 M phosphate b u f f e r ,  pH 
7 . 2 ,  and the  p r o t e in  c o n te n t  was analyzed by th e  Lowry techn ique  and 
polyacry lamide  gel e l e c t r o p h o r e s i s  (85,  100).
I I . B . 4.  Immunization o f  Mice
Two month o ld  female BALB/c mice were i n j e c t e d  subcutaneously  
(sc )  and i n t r a p e r i t o n e a l l y  ( i p )  with e i t h e r  100 yg o f  p u r i f i e d  
g ly c o p ro te in s  o f  EIAV o r  200 yg o f  i n t a c t  v i r u s  or  deoxychola te  
d i s r u p te d  v i ru s  in F reund 's  complete a d ju v an t  (FCA). The mice were 
i n j e c t e d  on day 14 and 28 w i th  th e  a n t ig e n  p e r p a r a t i o n s  (same 
c o n c e n t r a t i o n  and same r o u te  as  above) in  Freund 's  incomplete  
a d ju v a n t .  The f i n a l  i n j e c t i o n  was given on day 88 with  an t ig en  in 
0 .01 M phosphate  b u f f e r ,  e i t h e r  i n t r a p e r i t o n e a l l y  o r  i n t r a v e n o u s l y  
( i v ) 4 days p r i o r  to  f u s i o n .  Four types  o f  an t ig e n  p r e p a r a t io n  were 
used as the  immunizing a n t ig e n :  1 . )  l e n t i l  l e c t i n  p u r i f i e d
g l y c o p r o t e i n s ,  2 . )  i n t a c t  whole v i r u s ,  3 . )  i n t a c t  whole v i r u s  given
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i v ,  and 4 . )  EIAV d i s s o c i a t e d  with deoxycho la te .
I I . B . 5. P r e p a ra t io n  of  c e l l s  
I I . B . 5 . a .  Myeloma c e l l s  SP2/0-Agl4
This sp e c ia l  c e l l  l i n e  i s  c h a r a c t e r i z e d  as a non-immunoglobulin 
s e c r e t i n g  myeloma c e l l .  These c e l l s  lack  th e  enzyme 
hypoxanth ine-guan ine  phosphoribose  t r a n s f e r a s e  (HGPRT) which makes 
them unable  to  s y n th e s i z e  p u r in e s  by th e  sa lvage  pathway. They a re  
s u s c e p t i b l e  to  t h e  f o l i c  a c id  a n t a g o n i s t  aminop te r in  which blocks  de 
novo b i o s y n t h e s i s  o f  p u r in e s  and p y r im id in es .  Aminopterin  b locks  th e  
d i h y d r o f o l a t e  r e d u c ta s e  enzyme and leaves  the  c e l l  unable  t o  produce 
pu r in e s  v ia  de novo pathway s y n t h e s i s .  This c l a s s i c a l  biochemical 
s e l e c t i o n  p ro ced u re ,  in t ro d u ced  by L i t t l e f i e l d  ( 8 4 ) ,  i s  wide ly  
a p p l i e d  and i s  based on th e  use o f  e i t h e r  HGPRT-negative o r  thymidine  
k i n a s e - n e g a t iv e  tumor c e l l s .  Thus,  an HGPRT-deficient c e l l  in  media 
c o n ta i n in g  am inop te r in  cannot  s y n th e s i z e  o r  sa lvage  p u r in e s  and 
r a p i d l y  d i e s .  The use of  8-azaguanine  r e s i s t a n t  myeloma l i n e s  a llows 
th e  s e l e c t i v e  d e s t r u c t i o n  o f  unfused myeloma c e l l s  and myeloma c e l l
t o  myeloma c e l l  fu s io n  p r o d u c t s .  The sp leen  c e l l s  which have
h y b r id ize d  to  myeloma c e l l s  c an ,  however, s u rv iv e  in  t h e  p resence  of 
aminop te r in  due to  th e  p resence  o f  HGPRT a c t i v i t y  from th e  sp leen  
c e l l s .  In a d d i t i o n ,  SP2/0-Agl4 (S P2 /0 ) ,  i s  a t o t a l  nonproducer  
v a r i a n t  from a hybridoma in v o lv in g  fu s io n  o f  MOPC-21 and BALB/c
sp leen  c e l l s .  As a r o u t i n e  p r a c t i c e  in our l a b o r a t o r y ,  t h e se  c e l l s
were passaged in  medium c o n ta i n in g  8-azaguan ine  (20 yg/ml) to  p rev en t  
them from r e v e r t i n g  back to  p roduc t ion  of  th e  HGPRT enzyme. A f t e r  
p a s sag e ,  th e  c e l l s  were main ta ined  in  growth medium f r e e  o f  
8 -azaguan ine .
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SF2/0 c e l l s  were seeded 3 to  4 days p r i o r  t o  a n t i c i p a t e d  use in
5 5a fu s io n  u s u a l l y  a t  a range o f  1 X 10 to  7 X 10 per ml. The day 
be fo re  t h e  f u s i o n ,  immunized mice were checked f o r  an t ibody  
p roduc t ion  a g a i n s t  EIAV a n t ig e n s  us ing  an ELISA and th o se  mice with 
h ig h e s t  an t ibody  t i t e r s  were s e l e c t e d  f o r  sp leen  donors .
I I . B . 5 . b .  Feeder l a y e r :
Thymocytes were found to  be ex trem ely  u se fu l  as a f e e d e r  l a y e r ,  
which may provide  undef ined  f a c t o r s  f o r  con t inuous  growth of 
hybridoma l i n e s .  The use o f  a f e e d e r  l a y e r  i s  p a r t i c u l a r l y  c r i t i c a l  
dur ing  c lo n in g  procedures  (83 ,  115).  Mice were k i l l e d  and t h e i r  
thymuses were c o l l e c t e d ,  minced and washed 3X in  calc ium and 
magnesium f r e e  Hanks' ba lanced  s a l t  s o l u t i o n  (CMF Hanks'  BSS) 
c o n ta in in g  100 U o f  p e n i c i l l i n  6 ,  and 100 yg of  s t rep tom yc in  s u l f a t e  
per  m l . The thymocytes were then suspended a t  3 X 10® t o  5 X 10® 
c e l l s  pe r  ml and 0 .1  ml added to  each well where a p p r o p r i a t e .  
I I . B . 5 . C .  Sp len ic  lymphocytes
Spleens  o f  immunized mice were c o l l e c t e d  a s e p t i c a l l y  in  50 ml 
c e n t r i f u g e  tu b e s .  All procedures  beyond t h i s  p o i n t  were c a r r i e d  out 
in  a lam inar  flow hood. Each sp leen  was washed wi th  s ev e ra l  changes 
o f  CMF Hanks' BSS and then  t r a n s f e r r e d  to  a small p e t r i  d i s h ,  r i n s e d ,  
and excess  omentum removed. The sp leen  was then  t r a n s f e r r e d  to  a 
second p e t r i  d i sh  and reduced t o  a s i n g l e  c e l l  suspension  v ia  mincing 
by s c i s s o r s  and th e  "blow out"  t e c h n iq u e .  The "blow-out"  te chn ique  
invo lves  th e  use o f  a 3 ml p l a s t i c  s y r in g e  f i l l e d  with  CMF Hanks' BSS 
and f i t t e d  with  a 25-gauge n e ed le .  The need le  i s  i n s e r t e d  i n t o  the  
sp leen  c ap su le  and th e  medium s lowly  i n j e c t e d .  M u l t ip le  p e r f o r a t i o n s  
and s imul taneous  i n j e c t i o n s  of  CMF Hanks'  BSS he lp  t o  exp ress  most o f
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the  lymphocytes ou t  o f  t h e  s p le e n .  The r e s u l t i n g  c e l l  suspens ion  was 
t r a n s f e r r e d  to  a c e n t r i f u g e  tube  and allowed to  s tand  b r i e f l y  to  
a llow l a r g e  d e b r i s  t o  s e t t l e .  A f te r  t h i s ,  th e  c e l l  suspension  was 
decanted c a r e f u l l y  to  a second c e n t r i f u g e  tu b e ,  washed tw ice  in CMF 
Hanks' BSS (200 xg f o r  5 m in ) ,  and resuspended in  se rum -f ree  RPMI 
(Roswell Park Memorial I n s t i t u t e  1640) medium. Total  c e l l  count and 
v i a b i l i t y  ( t ry p an  b lue  e x c lu s io n )  were done s im u l tan eo u s ly  us ing  a 
modif ied  Neubauer hemacytometer chamber.
I I . B . 6.  H y b r id iz a t io n
V i a b i l i t y  o f  both lymphocyte and myeloma c e l l s  p r e p a r a t io n s  used 
f o r  t h e  fu s io n  was more than  90%. The sp leen  c e l l s  and myeloma c e l l s  
(SP2/0) were washed a t  l e a s t  tw ice  in CMF Hanks' BSS and resuspended 
in RPMI, and then mixed a t  a r a t i o  o f  1 SP2/0 c e l l  t o  4 sp leen  c e l l s .  
The r e s u l t i n g  m ix ture  was washed and p e l l e t e d  f o r  5 min a t  200 xg in 
a 50 ml c e n t r i f u g e  tu b e .  Most o f  the  s u p e r n a ta n t  medium was removed 
by a s p i r a t i o n ,  th e  p e l l e t  was broken with g e n t l e  e x t e r n a l  mixing and 
the  tube  was p laced  in a 37°C w ater  b a th .
The fu s io n  p ro toco l  was de r ived  and modif ied  from t h a t  of  G a l f re  
and M i l s t e in  (42) and Shulman e t  a l .  (134) .  B a s i c a l l y  po lye thy lene  
g lycol (PEG) was added to  th e  c e l l  m ix ture  dropwise with  g e n t l e  
s t i r r i n g  over  a pe r iod  o f  1 min. The mix tu re  was f u r t h e r  s t i r r e d  
g e n t ly  f o r  a n o th e r  min u s ing  the  same p i p e t t e .  To g ra d u a l ly  d i l u t e  
th e  PEG, 2 ml o f  growth medium were added dropwise whi le  s t i r r i n g  
over a p e r io d  o f  2 min.  An a d d i t i o n a l  3 ml o f  growth medium fo llowed 
by 5 ml o f  growth medium were added in th e  same manner as d e sc r ib e d  
above over a pe r iod  o f  1 min each .  Using th e  above d e sc r ib e d  p ro toco l
O
we were ab le  to  fuse  as many as 4 .0  X 10 sp leen  c e l l s / t u b e  us ing  1
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ml o f  PEG f o r  every  1.6  X10 sp leen  c e l l s  and 10 ml o f  growth medium 
to  d i l u t e  t h e  PEG. The suspens ion  was c e n t r i f u g e d  a t  200 xg f o r  5 
min and the  media removed by a s p i r a t i o n .  The remaining c e l l  p e l l e t  
was g e n t ly  broken,  th e  c e l l s  were resuspended a t  7 .3  X 106 sp leen  
c e l l s  pe r  ml in  growth medium and d ispensed  from a 5 ml p i p e t t e  a t  2 
drops  pe r  well o f  a 96 well  f l a t - b o t to m e d  m i c r o t i t e r  p l a t e .
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Thymocytes were added as a f e e d e r  l a y e r  a t  3 X 10 c e l l s  pe r  well in 
100 yl a l i q u o t .
I I . B . 7. Maintenance and s p e c i f i c i t y  t e s t i n g  o f  hybridomas 
I I . B . 7 . a .  Care and s e l e c t i o n  o f  hybridomas
C u l tu re s  were b r i e f l y  in sp ec te d  d a i l y  under th e  microscope to  
m oni to r  t h e i r  p r o g r e s s .  The fu s io n  o f  c e l l s  by PEG i s  e s s e n t i a l l y  a 
random and i n e f f i c i e n t  p r o c e s s ,  t h u s ,  c e l l u l a r  h y b r i d i z a t i o n  occurs  
in  a low pe rcen tage  o f  c e l l s .  Consequent ly ,  th e  s e l e c t i o n  of  hybrid  
c e l l s  from re s id u a l  p a r e n t a l  c e l l s  was i n i t i a t e d  1 day p o s t  fu s io n  by 
th e  a d d i t i o n  o f  100 yl growth medium c o n ta in in g  hypoxanth ine ,  
am in o p te r in ,  and thymid ine  (HAT) d a i l y  f o r  fo u r  days p o s t  fu s io n  and 
by removing one h a l f  o f  th e  spen t  medium and r e p l a c in g  i t  with f r e s h  
medium. The media was a llowed to  t r i c k l e  down th e  s id e  o f  th e  well 
so t h a t  the  c e l l s  were no t  d i s p e r s e d  and c lones  were co u n tab l e .  
C e l l s  were fed medium c o n ta i n in g  hypoxanthine and thymidine  (HT) on 
day 5,  6 ,  and 7 p o s t  f u s i o n .  Screening  f o r  an t ibody  produc t ion  us ing  
enzyme-l inked immunosorbent a ssay  (see  below) s t a r t e d  when 10% o f  the  
w e l l s  tu rned  a c i d i c  o r  when c o lo n ie s  a t t a i n e d  a s i z e  o f  1 t o  2 mm in 
d ia m e te r .  C e l l s  g e n e r a l l y  reached t h i s  s a t u r a t i o n  d e n s i t y  a t  10 to  
12 days p o s t  f u s i o n .  Hybn'doma c lones  o f  t h i s  s i z e  u s u a l l y  produce 
immunoglobulins a t  d e t e c t a b l e  l e v e l s  and the  pe rcen tage  o f  f a l s e
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neg a t iv e  r e s u l t s  d e c r e a s e s .
I I . B . 7 . b .  Cloning by l i m i t i n g  d i l u t i o n
A f te r  a hybridoma s e c r e t i n g  a use fu l  an t ibody  was d e t e c t e d ,  
c e l l s  from th e  a p p r o p r i a t e  well were immedia tely c loned .  This  i s  a 
nece ssa ry  s t e p  f o r  th e  fo l low ing  r e a so n s .  F i r s t ,  the  hybridoma may 
be u n s t a b l e  and a v a r i a n t ,  non-immunoglobulin s e c r e t i n g  hybridoma may 
overgrow the  hybridoma producing u se fu l  a n t i b o d i e s .  There may a l s o  
be more than one c lone  o f  hybridoma in th e  o r i g i n a l  w e l l ,  and c lon ing  
w i l l  s e p a r a t e  th e  d e s i r e d  hybridoma l i n e  from i r r e l e v e n t  c e l l s .  
Cloning by l i m i t i n g  d i l u t i o n  in l i q u i d  medium i s  a well accep ted  
method (115) .  A f t e r  a p o s i t i v e  p a re n t  well  was s e l e c t e d ,  i t  was 
cloned by l i m i t i n g  d i l u t i o n  in  which l im i t e d  numbers o f  c e l l s  were 
added to  96 well m i c r o t i t e r  p l a t e s .  T h e o r e t i c a l l y ,  th e  number o f  
c e l l s  in th e  o r i g i n a l  well  was counted and d i l u t e d  a p p r o p r i a t e l y  so 
t h a t  every  2 rows o f  a 96 well  m i c r o t i t e r  p l a t e  co n ta in  4 hybridoma 
c e l l s / w e l l ,  2 c e l l s / w e l l ,  1 c e l l / w e l l  and 50% o f  t h e  w e l l s  in the  
l a s t  2 rows c o n ta in  1 c e l l  each.
The number o f  c o lo n ie s  pe r  well was determined a t  approximate ly  
day 7 t o  10 and s i n g l e  c lone  w e l l s  were s e l e c t e d  f o r  t e s t i n g .  S ing le  
p o s i t i v e  c lones  were rec loned  a second t im e .  The s i n g l e  c lones  from 
the  second l i m i t i n g  d i l u t i o n  were assayed  f o r  an t ibody  p roduc t ion  and 
i f  a l l  th e  c lones  were p o s i t i v e ,  th e  c lone  was cons ide red  to  be
s t a b l e .  C e l l s  were then expanded from 96-well  p l a t e s  to  24 well  
t i s s u e  c u l t u r e  c l u s t e r s  and f i n a l l y  t r a n s f e r r e d  to  f l a s k s  f o r
u l t i m a t e  c ry o p r e s e r v a t io n  and a s c i t i c  f l u i d  p ro d u c t io n .
I I . B . 7 . C .  C ry o p re se rv a t io n  and thawing o f  c lones
Hybridoma c e l l s  were grown to  high d e n s i t i e s ,  resuspended a t  5 X
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10 c e l l  pe r  ml in cold growth medium, supplemented with 20% f e t a l  
c a l f  serum and 10% dimethyl s u l f o x id e  (DMSO), and p laced  in  g l a s s  
ampules.  The ampules were s ea le d  and p laced  immediately i n to  a
c oo l ing  chamber where th e  r a t e  o f  coo l ing  was approx im ate ly  1°C per 
min. Once f rozen  to  -80°C, they  were t r a n s f e r r e d  d i r e c t l y  i n to  
l i q u i d  n i t r o g e n .
Careful handl ing  of  th e  hybridoma c e l l s  du r ing  thawing i s  very 
c r i t i c a l  to  a s s u r e  good v i a b i l i t y .  The ampules were r e t r i e v e d  from 
the  l i q u i d  n i t r o g e n  tank and immediately placed  in  a 37°C w a te r  bath 
where they  were r a p i d l y  thawed. When thawed, th e  ampule was placed 
in  a laminar  f low hood, swabbed with  70% a lcoho l  and th e  co n ten t s  
were t r a n s f e r r e d  to  a 15 ml c e n t r i f u g a t i o n  tu b e .  Cold HT medium (10 
ml) was added s lowly  to  the  c e l l  suspension  over  about 2 min to  
g r a d u a l ly  d i l u t e  the  c e l l s  and p r e s e r v a t i v e .  This was necessa ry
because sudden d i l u t i o n  in  the  p r e s e r v a t i v e  DMSO has been r e p o r t e d  to  
cause seve re  osmotic  damage to  th e  c e l l s .  The c e l l s  were then 
p e l l e t e d  by c e n t r i f u g a t i o n  a t  200 xg f o r  5 min,  and resuspended in 
f r e s h  HT medium f o r  c u l t u r e .
I I . B . 8.  P r e p a ra t io n  o f  a s c i t i c  f l u i d
Hybridoma c e l l s  grown in  th e  p e r i t o n e a l  c a v i t y  produce as much 
as 20 mg of  immunoglobulin pe r  m i l l i l i t e r  o f  a s c i t i c  f l u i d  (113) .
There fo re  BALB/c mice ( p r e f e r a b l y  male 12 t o  20 weeks o ld )  were
primed i n t r a p e r i t o n e a l l y  with  0 .5  ml p r i s t a n e  (2 ,  6 ,  10,
1 4 - t e t r a m e th y lp e n tad e c an c e ,  A ld r ich  Chemical Company, Milwaukee, WI). 
This i s  very  impor tan t  as the  success  r a t e  o f  tumor development and 
th e  p r o b a b i l i t y  o f  a s c i t e s  fo rmat ion  i s  h ig h ly  in c re a se d  when mice 
a re  p r e i n j e c t e d  w i th  p r i s t a n e  (12) .  One to  fou r  weeks a f t e r  priming
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with p r i s t a n e ,  mice were i n j e c t e d  i n t r a p e r i t o n e a l l y  with  cloned  
hybridoma c e l l s  (1 X 10^ to  2 X 10^ c e l l s  per mouse).  At 10 to  14 
days a f t e r  i n j e c t i o n ,  th e  a s c i t i c  f l u i d  was a s e p t i c a l l y  c o l l e c t e d  and 
c l a r i f i e d  a t  1000 xg f o r  10 min,  and s t o r e d  a t  -20°C.
I I . B . 9. D e term ina t ion  o f  immunoglobulin c l a s s
F lu id s  from c u l t u r e d  hybridomas u s u a l l y  c o n ta in  small amounts of  
an t ibody  and i t  was n eces sa ry  t o  c o n c e n t r a t e  t h e  f l u i d s  by ammonium 
s u l f a t e  p r e c i p i t a t i o n  (50% s a t u r a t i o n )  to  d e t e c t  immunoglobulins in 
immunodiffusion t e s t s .  The immunoglobulin i so ty p e  was determined by 
immunodiffusion us ing  commercia lly  a v a i l a b l e  a n t i s e r a :  goa t
an t i -mouse  IgGl,  IgG2a, IgG2b, IgM, IgA (Meloy L a b o r a to r i e s )  and
r a b b i t  an t i -mouse  IgG3 (Miles L a b o r a t o r i e s ,  I n c . ) .  Immunodiffusion 
t e s t s  were performed in  1% Noble agar  p l a t e s  (b o r a t e  b u f f e r  0 .15  M, 
pH 8 . 4 ) .  About 40 pi o f  c o n ce n t r a te d  s u p e r n a t a n t  were a r ranged  
r a d i a l l y  in in d iv id u a l  p e r ip h e r a l  w e l l s  and 40 pi o f  1:4 d i l u t i o n  of  
a n t i  s e r a  were p laced  in t h e  c e n t r a l  w e l l .  P l a t e s  were incubated  
o v e rn ig h t  and p r e c i p i t i n  l i n e s  were developed between the  monoclonal 
immunoglobulin and th e  a p p r o p r i a t e  i s o t y p e - s p e c i f i c  an t ibody .
I I . B . 1 0 .  Screening  o f  hybridomas
To dec rea se  the  p o s s i b i l i t y  of  f a l s e  n e g a t i v e s ,  hybridomas were 
screened  when th e  c e l l s  reached maximum d e n s i t y  o r  th e  c lone  s i z e
ranged from 1 to  2 mm. This u s u a l l y  occur red  from 10 to  28 days
a f t e r  fu s io n .  A s e n s i t i v e ,  s imple  and r a p id  enzyme-l inked 
immunosorbent a ssay  (ELISA) was developed so t h a t  an immediate 
d e c i s io n  about c lo n in g  t h e  hybridoma could  e a s i l y  be reached .  A 
s o l i d  phase enzyme irranunoassay was modif ied  from t h a t  d e sc r ib e d  by 
V o l le r  e t  a l .  (146) and O 'S u l l iv a n  e t  a l .  (118) .  P u r i f i e d  v i r i o n s
were d i s r u p t e d  with 0.5% deoxychola te  in  T r i s - s a l i n e  b u f f e r  
(0 .02  M/0.1 M) and m a in ta ined  a t  200 yg/ml c o n c e n t r a t i o n .  They were 
d i l u t e d  in  c o a t in g  b u f f e r  TEN ( T r i s  [0 .0 5  M], EDTA [0 .001 M], NaCl 
[0 .1 5  M]) to  a c o n c e n t r a t i o n  of 20 yg p ro te in /m l  and d ispensed  a t  1 
yg/well  and al lowed to  adsorb  onto  each well o f  a 96-well  f l a t  bottom
m i c r o t i t e r  p l a t e  (Dynatech Immulon 1) f o r  16 to  20 h a t  37°C
in c u b a t io n .  The an t ig e n  was f ix e d  with paraformaldehyde  (4% Wt/Vol9 
pH 7 .2 )  f o r  5 min and nonadsorbed an t ig e n  was washed away w i th  TEN 
b u f f e r .  The w e l l s  were blocked f o r  n o n s p e c i f i c  b ind ing  by in cu b a t io n  
with  5% bovine  serum albumin in  p h o sp h a te -b u f fe red  s a l i n e  (PBS) f o r  2 
h a t  room te m p e ra tu re .  The t i s s u e  c u l t u r e  s u p e r n a t a n t  o r  a s c i t i c  
f l u i d  to  be t e s t e d  f o r  an t ib o d y  was added (50 y l / w e l l )  and allowed to  
r e a c t  f o r  1 h a t  room te m p e ra tu re .  The p l a t e s  were washed 3 t imes
with  TEN and 50 yl o f  p e r o x id a s e - l a b e l e d  goa t  an ti -mouse
immunoglobulins (1:1000 d i l u t i o n  in TEN, Cappe l , C o c h r a n v i l l e ,  PA) 
was added and incuba ted  f o r  45 to  60 min a t  room t e m p e ra tu re .  The 
p l a t e s  were washed as b e fo re  and developed us ing  th e  s u b s t r a t e  ABTS 
(2 ,  2 ' - a z i n o - b i s ( 3 - e t h y l b e n z - t h i a z o l i n e - 6 - s u l f o n i c  a c i d ) ,  diammonium 
s a l t  (Sigma).  The r e a c t i o n  was con t inued  f o r  10 to  20 min and the  
o p t i c a l  d e n s i t y  a t  490 nm was recorded  with  a spec t ropho tom ete r  
(Dynatech Lab. VA).
P o s i t i v e  hybridomas were a l s o  t e s t e d  f o r  a b i l i t y  to  bind p r o t e i n  
A. The same procedure  was used as above excep t  t h a t  p r o t e i n  A 
p e ro x id a se  co n ju g a te  was used a t  a 1:500 d i l u t i o n ,  and th e  con juga te  
and washing b u f f e r s  co n ta in ed  0.1% Tween 20.
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I I . B . l l .  I d e n t i f i c a t i o n  o f  v i r a l  p r o t e i n s  by the  p r o t e i n  b l o t  
immunoassay "Western b l o t "
Unlabeled p u r i f i e d  EIAV p r o t e i n s  were s e p a r a t e d  by sodium 
dodecyl s u l f a t e - p o l y a c r y l a m i d e  gel e l e c t r o p h o r e s i s  (SDS-PAGE), and 
the  s e p a r a t e d  p r o t e i n s  were e l e c t r o p h o r e t i c a l l y  t r a n s f e r r e d  to  
n i t r o c e l l u l o s e  membranes (13 ,  143).  The n i t r o c e l l u l o s e  membrane was 
then s a t u r a t e d  with  3% bovine  serum albumin (BSA) in T r i s  b u f f e r  
s a l i n e  (TBS) f o r  30 min,  incuba ted  with  th e  MCAb o r  serum from 
immunized mice f o r  90 min a t  room te m p e r a t u r e ,  and washed in  a t  l e a s t  
t h r e e  changes o f  T r i s - s a l i n e  c o n ta i n in g  0.05% Nonidet P-40 (NP-40, 
P a r t i c l e  Data L a b o r a t o r i e s ,  E lm hurs t ,  IL ) .  The n i t r o c e l l u l o s e  
membrane was then  incuba ted  f o r  1 h in  T r i s - s a l i n e  c o n ta i n in g  a 
1:1000 d i l u t i o n  o f  p e rox idase  con jugated  goa t  an t i -mouse  
immunoglobulins.  A f t e r  in c u b a t io n  w i th  th e  second a n t ib o d y ,  the  
membrane was washed as above and incuba ted  with  th e  c o l o r  development 
s o l u t i o n .  This s o l u t i o n  was p repa red  by d i s s o l v i n g  60 mg of 
4 - c h l o r o - l - n a p h t h o l  (Sigma, Chemical Co. S t .  Lou is ,  M0) in  20 ml of 
i c e - c o l d  methanol and then  mixing i t  with  100 ml T r i s - s a l i n e  p lus  60 
yl 30% (Wt/Vol) hydrogen p e ro x id e .  The immunoreactive p r o t e i n s  
s t a i n e d  p u rp le  with  t h i s  r e a g e n t .
I I . B . 1 2 .  P r e p a r a t io n  o f  r e a g e n t s  
I I . B . 12 .a .  Growth media
Growth media (RPMI 1640, GIBC0 L a b o r a t o r i e s ,  Grand I s l a n d ,  NY) 
was prepared  from powdered medium supplemented with  24 mM sodium 
b i c a r b o n a t e ,  15% f e t a l  c a l f  serum, 1% 200 mM L -g lu tam ine ,  1% 
n o n - e s s e n t i a l  amino a c i d s ,  50 U of p e n i c i l l i n  G per  ml,  and 50 yg of  
s t rep tom yc in  s u l f a t e  pe r  ml.
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I I . B . 1 2 . b .  Po lye thy lene  glycol  (PEG)
The PEG (MW 1450, Kodak Labora tory  Chemicals ,  R oches te r ,  NY) was
au toc laved  a t  15 PSI,  f o r  15 min and kept in a 56°C w a te r  b a th .  One
ml o f  RPMI was added per  gram PEG. The pH was a d ju s t e d  t o  7 .2  under
s t e r i l e  c o n d i t i o n s  with  0 .1  N sodium hydroxide  o r  0 .1  N h y d ro c h lo r i c
ac id  as r e q u i r e d .  The PEG medium was d ispensed  in small q u a n t i t i e s
and s t o r e d  a t  -20°C.
I I .B .1 2 .C .  Hypoxanthine-Thymidine (HT)
A 100 X s tock  s o l u t i o n  (hypoxanth ine  1.0  X 10"^ M, thymidine 1.6 
- 3X 10" M) was p repared  by d i s s o l v i n g  136.1 mg o f  hypoxanthine (Sigma, 
S t .  L o u i s ,  M0), and 38.75 mg o f  thymid ine  (Sigma) in 100 ml o f  
d i s t i l l e d  w a ter  warmed to  60-70°C. The HT medium was f i l t e r  
s t e r i l i z e d  (0 .45  pm) and s to r e d  in  a l i q u o t s  a t  -20°C.
I I . B . 1 2 . d .  Ami n o p te r in
A 100 X s tock  s o l u t i o n  (4 .0  X 10”5 M) was prepared  by suspending
I .7 6  mg o f  ami n o p te r in  (Sigma) in  50 ml o f  d i s t i l l e d  w a te r ,  
d i s s o l v i n g  i t  by th e  dropwise a d d i t i o n  o f  0 .1  N sodium hydrox ide ,  and 
a d j u s t i n g  the  volume to  100 ml with d i s t i l l e d  w a te r .  The medium was 
f i l t e r  s t e r i l i z e d  (0 .45  pm), a l i q u o t e d  in  small volumes and s to r e d  a t  
-20°C.
I I . B . 1 2 . e .  8-Azaguanine (250 X Stock)
A s to ck  o f  8-Azaguanine (Sigma) was prepared  to  a f i n a l  
c o n c e n t r a t i o n  o f  5 mg/ml in d i s t i l l e d  w a te r .  The 8-Azaguanine was 
brought  i n t o  s o l u t i o n  by th e  dropwise a d d i t i o n  o f  0 .1  N sodium 
hydroxide .  The medium was f i l t e r  s t e r i l i z e d  (0 .45  pm), and a l i q u o t s  
were s t o r e d  a t  -20°C.
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I I .  C. RESULTS
I I .  C . l .  Enzyme-linked immunosorbent assay
Optimal c o n d i t io n s  f o r  ELISA were determined by performing 
checkerboard t i t r a t i o n s .  D is rup ted  EIAV was d i l u t e d  in  TEN b u f f e r  so 
as to  c o n ta in  1000 ng, 750 ng,  500 ng, 300 ng, 250 ng, 200 ng, and 
150 ng per  50 yl r e s p e c t i v e l y .  A 50 yl sample of  each v i r u s  d i l u t i o n s  
was added to  each well  in  a row ac ro ss  th e  ELISA p l a t e .  Bound 
an t ig e n  was d e t e c t e d  us ing  a two f o ld  d i l u t i o n  s e r i e s  o f  po lyc lona l  
immune mouse serum t h a t  formed th e  second dimension o f  the
checkerboard  t i t r a t i o n s .  An optimal a n t ig e n  c o n c e n t r a t i o n  of  1 
ug/well  of  d i s s o c i a t e d  v i r u s  gave th e  h ig h e s t  r e s u l t s  a t  50% maximum 
o p t i c a l  read ings  as shown in Figure  I I . 1. This c o n c e n t r a t i o n  of 
an t ig e n  was used to  maximize s e n s i t i v i t y  to  small q u a n t i t i e s  of  
immunoglobulins t h a t  r e s u l t  from small colony s i z e  hybridomas and to  
i n c r e a s e  t h e  chance of  d e t e c t i n g  hybridomas s p e c i f i c  t o  EIAV
g l y c o p r o t e i n s .  T h e o r e t i c a l l y ,  ELISA p l a t e s  were coated  with  about 
100 ng/well  o f  t h e se  g ly c o p r o t e in s  s in ce  10% o f  p u r i f i e d  v i ru s  i s  
composed o f  g ly c o p r o t e in s  (120) .
I I . C . 2. I s o l a t i o n  o f  hybr id  c e l l s  producing anti-EIAV a n t ib o d ie s
Hybridomas which r e s u l t e d  from fu s in g  SP2/0 myeloma c e l l s  and 
B-lymphocyte c e l l s  were s e l e c t i v e l y  i s o l a t e d  from the  p a re n ta l  c e l l s  
by growth in  HAT medium in  t h e  w e l l s  o f  the  m i c r o t i t e r  p l a t e s .
Hybrid c e l l s  grew in each well t h a t  was seeded and c u l t u r e  f l u i d s
from approx im ate ly  4800 w e l l s  were examined f o r  an t ibody  a c t i v i t y  
a g a i n s t  EIAV p r o t e i n s  us ing ELISA. A minimum o f  one hybr id  was 
scored  in each o f  t h e  o r i g i n a l  w e l l s  (F ig .  I I . 2 ) .  C e l l s  from 
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FIGURE I I . 1. T i t r a t i o n s  in  ELISA o f  immune mouse serum a g a i n s t  
d i f f e r e n t  c o n c e n t r a t i o n s  o f  EIAV a n t ig e n .
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FIGURE I I . 2. Ea r ly  outgrowth o f  a hybridoma colony as a focus of  
r e l a t i v e l y  l a r g e ,  lymphoid c e l l s  in  a background o f  thymocyte f e e d e r  
c e l l s ,  d e b r i s ,  and dying unfused lymphocytes ( 350X).
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ELISA (15 t o  20% o f  w e l l s  produced a n t i v i r a l  a n t i b o d i e s )  were cloned  
tw ice  by l i m i t i n g  d i l u t i o n  and again  r e t e s t e d  f o r  an t ib o d y  a c t i v i t y  
u n t i l  they  had ach ieved  phenotypic  s t a b i l i t y .  From th e  12 
independent  fu s io n s  150 hybridomas were o b ta in ed  and a s c i t i c  f l u i d  
was produced.  The s e r o l o g i c a l  r e a c t i v i t y  o f  t h e s e  hybridomas was 
moni tored  by enzyme immunoassay (ELISA and Western b l o t  immunoassay) 
and n e u t r a l i z a t i o n  t e s t .
I I . C . 3.  P r o t e i n s  recogn ized  by se ra  from immunized mice
Serum ob ta ined  from immunized mice was t e s t e d  in  Western b l o t  
immunoassay with the  p r o t e i n s  o f  EIAV re so lv ed  by SDS-PAGE (F ig .
I I . 3 ) .  Serum o b ta in ed  from mice immunized with  g ly c o p r o t e in  
p r e p a r a t i o n s  had most o f  i t s  a c t i v i t y  a g a i n s t  gp90, gp45, and p l 5 ,  
w h i le  r e a c t i n g  weakly w i th  p26. While serum from mice immunized with 
d i s s o c i a t e d  v i r u s  p lus  a d ju v an t  was mos t ly  a c t i v e  a g a i n s t  gp90, p26, 
and p l 5 ,  i t  r e a c te d  f a i n t l y  with gp45. In f a c t  t h e  r e a c t i o n  with  
gp90 was as s t ro n g  as th e  serum ob ta ined  from g ly c o p r o t e in  in o c u la te d  
mice .  In c o n t r a s t ,  serum o f  mice i n o c u la te d  with  whole v i r u s  p lus  
a d ju v a n t  r e a c te d  weakly w i th  gp90 and gp45 but very  s t r o n g l y  with  p26 
and p l5 .  The same r e s u l t s  were o b ta in ed  u s ing  serum from mice 
immunized with whole v i r u s  given i n t r a v e n o u s l y  excep t  t h a t  r e a c t i o n s  
to  p l5  were weaker in  t h e s e  mice.  S u r p r i s i n g l y ,  serum from mice 
immunized with  whole v i r u s  (2 i n o c u l a t i o n s )  with  no i n t r a p e r i t o n e a l  
i n o c u l a t i o n  re a c te d  s t r o n g l y  with  p26 o n ly .
I I . C . 4.  I d e n t i f i c a t i o n  o f  v i r a l  p r o t e i n s  d e t e c t e d  by monoclonal 
a n t i b o d i e s
Monoclonal a n t i b o d i e s  were examined by Western b l o t  immunoassay 
with  t h e  p ro to ty p e  EIAV t o  check f o r  t h e i r  s p e c i f i c i t y .  A t o t a l  of






FIGURE I I . 3.  Western b l o t  a n a l y s i s  o f  serum samples from mice 
immunized with  EIAV. Po ly p ep t id e s  of  EIAV were s e p a ra te d  on SDS-PAGE, 
t r a n s f e r r e d  to  n i t r o c e l l u l o s e  membranes,  and immunoblotted with  immune 
mouse serum. Lanes a ,  b and c a r e  n e g a t iv e  c o n t r o l s ,  (a)  v i r u s  on ly ;  
(b) co n ju g a te  on ly ;  and (c )  normal mouse serum; (d) serum from mice 
immunized w i th  g l y c o p r o t e i n ;  (e and f )  serum from mice immunized with  
d i s s o c i a t e d  EIAV; (g and h) serum from mice immunized with  whole EIAV; 
( i  and j )  serum from mice immunized i n t r a v e n o u s l y  with whole EIAV; and 
(k and 1) serum from mice immunized w i th  whole EIAV w ith  no 
i n t r a p e r i t o n e a l  i n o c u l a t i o n .
42
23 independent c loned hybr id  c e l l  l i n e s  t h a t  produced an t ibody  
a g a i n s t  EIAV p r o t e i n s  were i s o l a t e d  and s e l e c t e d  ou t  o f  th e  150 
hybridomas in  Western b l o t  immunoassay (Table I I . 1) .  Ten o f  th e se  
MCAbs were s p e c i f i c  f o r  gp90, 8 f o r  gp45, and 5 f o r  p26. MCAbs 
86-1E3, 71-1A9, 95-1G8, 85-1E11, 87-1E7, 115-3D7, 98-101,  82-1C2,
114-3A7, and 128-2B9 were s p e c i f i c  f o r  gp90 in Western b l o t  
immunoassay (F ig .  I I . 4 ) .  MCAbs 75-1F2, 101-2F10, 92-1E6, 105-3C8, 
90-1C1, 117-1C5, 109-1A6, and 120-1H9 were s p e c i f i c  f o r  gp45 (F ig .
1 1 .5 ) .  The MCAbs 141-4D5, 140-1C3, 149-4E3, 135-4E5, and 131-2D6 
re a c t e d  with  th e  group s p e c i f i c  a n t i g e n ,  p26 (F ig .  I I . 6 ) .  These 
monoclonals showed r e a c t i v i t y  in  Western b l o t  immunoassay with  
a n o th e r  p r o t e i n  o f  an a p p a ren t  m olecu la r  w e igh t  o f  about 55,000 (F ig .
11 . 6) .
I I . C . 5. C h a r a c t e r i z a t i o n  o f  MCAbs
Immunoglobulins in  t h e  c u l t u r e  f l u i d  from each of  the  hybr id  
c e l l  l i n e s  were c o n ce n t r a te d  by ammonium s u l f a t e  p r e c i p i t a t i o n  (50% 
s a t u r a t i o n )  and t e s t e d  in  immunodiffusion assays  w i th  he te ro logous  
a n t i  s e r a  prepared  a g a i n s t  p u r i f i e d  mouse immunoglobulins.  
Immnoglobulins produced by hybr id s  86-1E3, 95-1G8, 114-3A7, 71-1A9,
85-1E11, 82-1C2, 87-1E7, 98-1D1, 115-307, 75-1F2, 92-1E6, 101-2F10, 
109-1A6, 117-1C5, 120-1H9, 90-1C1, 149-4E3, 141-4D5, 140-1C3, and 
131-2D6 were o f  IgGl s u b c la s s  (F ig .  I I . 7 ) .  Immunoglobulins produced 
by 105-3C8 and 135-4E5 were o f  IgG2b s u b c l a s s ,  and th e  immunoglobulin 
produced by th e  hybr id  128-2B9 was o f  an IgA s u b la s s  (Table  I I . 1) .
I I . C . 6. P r o t e i n  A b inding  assay
P o s i t i v e  hybridomas were a l s o  t e s t e d  f o r  t h e i r  a b i l i t y  t o  bind 
p r o t e i n  A. The r e s u l t s  i n d i c a t e d  t h a t  MCAbs 105-3C8 and 135-4E5,
Table I I . 1. Characterizat ion of monoclonal antibodies to EIAV polypeptides
Clone No. I so type  P r o te in  A binding  Antigen s p e c i f i c i t y
86-1E3 IgGl + gp90
95-1G8 IgGl - gp90
114-3A7 IgGl + gp90
85-1E11 IgGl + gp90
71-1A9 IgGl + gp90
87-1E7 IqGl - gp90
82-1C2 IgGl + gp90
98-1D1 IgGl - gp90
115-3D7 IgGl + gp90
128-2B9 igA - gp90
75-1F2 IgGl + gp45
92-1E6 IgGl + gp45
101-2F10 IqGl + gp45
109-1A6 IgGl + gp45
117-1C5 IgGl + gp45
120-1H9 IgGl + gp45
105-3C8 IgG2b +++ gp45
90-1C1 IgGl + gp45
131-2D6 IgGl + p26, Pr55gag
135-4E5 IgG2b +++ p26, Pr55gag
140-1C3 IgGl + p26, Pr55gag
141-405 IgGl + p26, Pr55gag
149-4E3 IgGl + p26, Pr55gag
+++ denotes  s t ro n g  binding in ELISA ( th r e e  s tanda rd  d e v ia t i o n s  above the  mean) and p o s i t i v e  in p r o t e in  b l o t  
immunoassay using p r o t e i n  A pe rox idase .
+ low a f f i n i t y  in ELISA 




FIGURE I I . 4.  Western b l o t  a n a l y s i s  o f  10 a n t i -g p 9 0  monoclonal 
a n t i b o d i e s .  Immunoblots were performed as  d e sc r ib e d  in  t h e  t e x t .  The 
p o ly p e p t id e s  o f  EIAV were s e p a ra te d  by SDS-PAGE, and t r a n s f e r r e d  to  
n i t r o c e l l u l o s e  membranes. The s t r i p s  were incubated  with  monoclonal 
a n t i b o d i e s  86-1E3, 95-1G8, 114-3A7, 85-1E11, 71-1A9, 87-1E7, 82-1C2, 
98-1D1, 115-3D7 and 128-2B9 in  lane  A through J ,  r e s p e c t i v e l y .  Lane K 
r e p r e s e n t s  immune mouse serum, showing immunoreac t iv i ty  with  gp90 and 
gp45 o f  EIAV.
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FIGURE I I . 5. Western b l o t  a n a l y s i s  o f  8 a n t i -g p 4 5  monoclonal 
a n t i b o d i e s .  Immunoblots were performed as  d e sc r ib e d  in t h e  t e x t .  The 
s t r i p s  were incubated  w i th  monoclonal a n t i b o d i e s  75-1F2, 109-1A6, 
105-3C8, 92-1E6, 90-1C1, 101-2F10, 117-1C5, and 120-1H9 in  lane  A 
through H, r e s p e c t i v e l y .  Lane I r e p r e s e n t s  immune mouse serum, 
showing immunoreac t iv i ty  w i th  gp90 and gp45 o f  EIAV.
4 6






FIGURE I I . 6.  Western b l o t  a n a l y s i s  o f  5 a n t i - p 2 6  monoclonal 
a n t i b o d i e s .  Immunoblots were performed as d e sc r ib e d  in  th e  t e x t .  The 
s t r i p s  were incuba ted  w i th  monoclonal a n t i b o d i e s  131-2D6, 135-4E5, 
140-1C3, 141-4D5, and 149-4E3 in  lane  b through f ,  r e s p e c t i v e l y .  B lo t  
o f  p r o t e i n  s t a n d a rd s  s t a i n e d  with  amido b lack  ( l a n e  a) were inc luded  
as  r e f e r e n c e .  The arrow head shows th e  l o c a t i o n  o f  t h e  55K p r o t e i n .
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FIGURE I I . 7. Immunodiffusion a n a l y s i s .  Immunoglobulin p roduc t  o f  
s e l e c t e d  hybridomas: 86-1E3, 82-1C2, 105-3C8, 98-1D1, 128-2B9, and
115-3D7 were a r ranged  r a d i a l l y  in  i n d iv id u a l  p e r ip h e r a l  w e l l s  1 
through 6 ,  r e s p e c t i v e l y  w hi le  goa t  an t i -mouse  IgGl was p l a t e d  in  the  
c e n t e r  w e l l .  Monoclonal a n t i b o d i e s  in  w e l l s  1, 2 ,  4 and 6 were 
p o s i t i v e  ( IgGl) whi le  MCAbs in  w e l l s  3 and 5 were n e g a t iv e .
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which a re  o f  IgG2b i s o t y p e ,  bind s t r o n g l y  to  p r o t e in  A. On th e  o th e r  
hand, MCAbs 92-1E6, 109-1A6, 90-1C1, 120-1H9, 75-1F2, 101-2F10,
86-1E3, 117-1C5, 149-4E3, 141-4D5, 140-1C3, 131-2D6, 114-3A7,
85-1E11, 115-3D7, 82-1C2, and 71-1A9 e x h ib i t e d  v a r i a b l e  degrees  of  
b inding  to  p r o t e i n  A. The MCAbs 95-1G8, 87-1E7, 98-1D1, and 128-2B9 
were n e g a t iv e  f o r  p r o t e i n  A b inding  (Table I I . 1) .
I I . D .  DISCUSSION
Hybridoma technology has c r e a t e d  a r e v o lu t io n  in  th e  biomedical  
s c i e n c e s  in  genera l  and v i ro l o g y  in  p a r t i c u l a r .  I t  i s  p o s s i b l e  us ing  
MCAb procedures  to  produce l a rg e  q u a n t i t i e s  o f  a n t ib o d ie s  s p e c i f i c  
f o r  a s i n g l e  e p i to p e  on a s i n g l e  v i r a l  po ly p ep t id e  us ing  crude 
a n t ig e n  f o r  immunizat ion.  These MCAbs a re  th e  most s p e c i f i c  
b io l o g i c a l  probes a v a i l a b l e  f o r  the  a n t i g e n i c  a n a l y s i s  o f  p r o t e i n s .  
A l t e r a t i o n s  o f  s u r f a c e  g ly c o p r o t e in s  a re  be l ieved  to  be involved in  
a n t i g e n i c  changes observed in EIAV v a r i a n t s  (129) .  The s e n s i t i v i t y  
and s p e c i f i c i t y  o f  MCAbs can be used to  d e f in e  and map s p e c i f i c  
v i r i o n  changes t h a t  c o n t r i b u t e  to  the  observed a l t e r e d  a n t i g e n i c i t y  
o f  EIAV v a r i a n t s  in  animals  p e r s i s t e n t l y  i n f e c t e d  with  EIAV.
T h e re fo re ,  th e  o b j e c t i v e s  o f  t h e se  s t u d i e s  were to  g e n e ra te  a d i v e r s e  
panel o f  hybridoma a n t ib o d ie s  a g a i n s t  mainly  t h e  s u r f a c e
g ly c o p r o t e in s  o f  EIAV to  compare th e  g ly c o p ro te in s  o f  EIAV i s o l a t e s  
and to  d e f in e  th e  de te rm in an ts  involved in n e u t r a l i z a t i o n .
E lab o ra te  p r o to c o l s  f o r  immunization and c e l l  h y b r i d i z a t i o n  
e x i s t  in  t h e  l i t e r a t u r e ,  but t h e r e  i s  no consensus  on th e  most 
a p p r o p r i a t e  p r o t o c o l .  In dev is in g  an e f f i c i e n t  fu s io n  techn ique
s ev e ra l  v a r i a b l e s  were taken  i n t o  c o n s i d e r a t i o n .  One o f  t h e se  
v a r i a b l e s  i s  th e  immunization schedu le .  The immunization scheme used
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in  t h i s  s tudy has r e s u l t e d  in good immune responses  in  mice (ELISA 
t i t e r  2 640) .  However, th e  most u n i v e r s a l l y  accepted  procedure  in 
the  v a r i e t y  o f  pub l i shed  p r o to c o l s  i s  t h a t  the  f i n a l  immunizat ion,
e i t h e r  in t ravenous  o r  i n t r a p e r i t o n e a l , be given 3 to  4 days be fo re
th e  sp leen  i s  h a rv e s te d  f o r  f u s i o n .  The o t h e r  v a r i a b l e  was the
s e l e c t i o n  o f  PEG, t h e r e f o r e ,  s ev e ra l  ba tches  o f  commercially  
a v a i l a b l e  PEG were t e s t e d ,  as some d i f f e r e n t  ba tches  have been 
r e p o r t e d  to  be t o x i c  to  c e l l s  (48) .  The h y b r i d i z a t i o n  scheme i s
a n o th e r  im por tan t  v a r i a b l e  taken  i n to  accoun t .  T h e r e f o r e ,  an 
a p p r o p r i a t e  h y b r i d i z a t i o n  scheme was s e l e c t e d  and modif ied  to  achieve  
a good f requency of  hybr id  fo rm a t io n .  I t  i s  c l e a r  t h a t  g e n e r a t in g  as 
d i v e r s e  a panel of  MCAbs as p o s s i b l e  w i l l  he lp  in d i s s e c t i n g  the  
a n t i g e n i c  s i t e s  of  th e  s u r f a c e  g l y c o p r o t e i n s .  Severa l  f a c t o r s  must 
be cons ide red  i f  one aims a t  g e n e r a t in g  a d i v e r s e  panel of MCAbs. 
These f a c t o r s  were e v a lu a te d  f o r  a n t i - i n f l u e n z a  v i r u s  hybridomas by 
Yewdell and Gerhard,  (154) and in c lu d e  (1) th e  number o f  in d iv id u a l  
mice used as an t igen -p r im ed  lymphocyte donors (2) th e  immunization 
p r o t o c o l ,  and (3) t h e  organ source  o f  th e  lymphocytes used f o r  
f u s i o n .  Some of t h e se  f a c t o r s  were cons ide red  in  our s t u d i e s  f o r  the  
p roduc t ion  o f  MCAbs s p e c i f i c  f o r  g ly c o p r o t e in s  o f  EIAV. To in c re a s e  
the  chance o f  i s o l a t i n g  hybridomas which produced a n t ib o d ie s  to  th e se  
g l y c o p r o t e i n s ,  we used immunogens en r iched  in  t h e i r  gp90 and gp45 
c o n te n t  fo l lowing  l e n t i l - l e c t i n  column chromatography,  s in c e  p u r i f i e d  
v i r u s  c o n ta in s  only about 10% o f  t h e se  g ly c o p ro te in s  by mass (120) .  
D i f f e r e n t  p re p a ra t io n s  o f  a n t ig e n  were a l s o  i n o c u la te d  i n to  mice with 
the  hope t h a t  a d iv e r s e  panel of  MCAbs would be g e n e ra te d .  I t  i s  
obvious from Western b l o t  immunoassays t h a t  s e r a  from mice immunized
with d i f f e r e n t  p r e p a r a t i o n s  showed d i f f e r e n t  r e a c t i v i t i e s  a g a i n s t  
EIAV p r o t e i n s .  Serum from mice immunized with  e i t h e r  d i s s o c i a t e d  
v i r u s  o r  g ly c o p r o t e in  p r e p a r a t i o n s  had the  s t r o n g e s t  r e a c t i v i t y  
a g a i n s t  gp90 and gp45. In a d d i t i o n ,  serum from mice immunized with 
e i t h e r  whole o r  d i s s o c i a t e d  v i r u s  n e u t r a l i z e d  i n f e c t i v i t y  bu t  with 
va ry ing  p o ten c ie s  ( n e u t r a l i z a t i o n  t i t e r  ranged from 80 to  320, Table 
3 ,  Chapter I I I ) .  Previous  s t u d i e s  (154) i n d i c a t e d  t h a t  i n d iv id u a l  
a n t i s e r a  ob ta ined  a t  d i f f e r e n t  p e r iods  o f  immunization o f t e n  co n ta in  
d i s t i n c t  s p e c t r a  o f  an t ibody  s p e c i f i c i t i e s .  To i n c r e a s e  the  
d i v e r s i t y  o f  EIAV s p e c i f i c  hybridomas we performed s ev e ra l  fu s io n  
exper iments  in  t h i s  s tudy  and modif ied  th e  t ime from i n i t i a l  
immunization to  h a r v e s t  s p l e n i c  c e l l s  to  maximize the  d i v e r s i t y .
The sc ree n in g  o f  hybridomas f o r  an t ibody  produc t ion  i s  one of  
th e  e s s e n t i a l  requ irements  of  the  fu s io n  exper im en ts .  At p r e s e n t ,  
th e  most d i f f i c u l t  a sp e c t  o f  hybridoma technology  i s  to  i d e n t i f y  and 
s e l e c t  hybridomas t h a t  a re  producing an t ibody  o f  t h e  d e s i r e d  
s p e c i f i c i t y .  T h e re fo re ,  an a p p r o p r i a t e l y  designed s e n s i t i v e  
sc r een in g  scheme t h a t  pe rm i ts  e a r l y  d e t e c t i o n  o f  s p e c i f i c  a n t ib o d ie s  
i s  a n e c e s s i t y .  However, the  cho ice  o f  s c r ee n in g  a ssay  f o r  s p e c i f i c  
an t ibody  depends on th e  n a tu re  o f  th e  a n t ig e n  and i t s  a v a i l a b i l i t y  in  
pure  form. A prime c o n s i d e r a t i o n  in  the  cho ice  o f  any a ssay  i s  th e  
e a s e ,  r a p i d i t y ,  and r e p r o d u c i b i l i t y  f o r  hand l ing  l a rg e  numbers of  
samples .  However, th e  b e s t  approach t o  sc reen  hybridomas i s  to  use 
methods t h a t  a l low d e t e c t i o n  o f  th e  type  o f  a n t i b o d i e s  a g a i n s t  
a n t ig e n s  o f  i n t e r e s t .  I f ,  f o r  example,  one wishes  t o  o b ta in  
a n t i b o d i e s  t h a t  can be used to  immunoprec ip i ta te  p r o t e i n  an t ig e n s  
from c e l l  l y s a t e s ,  immunoprec ip i ta t ion  i s  probably  the  b e s t  sc reen ing
assay  to  u se .  I f  one needs a n t ib o d ie s  t h a t  bind an t ig e n  in  Western 
b l o t  immunoassay, or  t h a t  a re  c y to to x ic  in th e  p resence  of  complement 
o r  f u n c t io n  in  c e l l u l a r  c y t o t o x i c i t y  a s s a y s ,  one should  sc reen  f o r  
a n t i b o d i e s  with  j u s t  those  p r o p e r t i e s .  The s t r a t e g i e s  fo llowed f o r  
s c r ee n in g  EIAV s p e c i f i c  hybridomas was d i c t a t e d  by and c o r r e l a t e d  
wi th  the  o b j e c t i v e s  of  developing  MCAbs, i . e . ,  to  g e n e r a te  as  d i v e r s e  
an an t ib o d y  panel as p o s s i b l e .  T h e re fo re ,  a reasonab ly  s e n s i t i v e  
ELISA was developed to  d e t e c t  hybridomas a g a i n s t  EIAV p r o t e i n s .  
However, ELISA was regarded  as a sc reen ing  a s s a y ,  no t as an a b s o lu t e  
d e f i n i t i o n  o f  a n t ig e n - a n t ib o d y  s p e c i f i c i t y .  T h e re fo re ,  u l t i m a t e  
d e te r m in a t io n  o f  MCAbs r e a c t i v i t i e s  to  EIAV inc luded  Western b l o t  
immunoassay and n e u t r a l i z a t i o n  t e s t  (Chapter I I I ) .  The b ind ing  a ssay  
used he re  should n o t ,  t h e r e f o r e ,  be used to  th e  e x c lu s io n  o f  o t h e r  
more in fo rm a t iv e  sc r een in g  a ssays  such as n e u t r a l i z a t i o n  t e s t .
Although MCAbs a re  d i r e c t e d  a t  s p e c i f i c  a n t i g e n i c  d e t e r m in a n t s ,  
i t  i s  o f t e n  o f  i n t e r e s t  t o  unders tand  the  n a t i v e  conformation o f  the  
p r o t e i n  p o s se s s in g  th e se  d e te r m in a n t s .  In t h a t  r e g a rd ,  de te rm inan ts  
a r e  o f t e n  r e f e r r e d  to  as c o n t in u o u s ,  d i s c o n t in u o u s ,  o r  to p o g ra p h ic .  
A con t inuous  d e te rm inan t  i s  de f ined  as a cont inuous  sequence of  
r e s id u e s  exposed a t  the  s u r f a c e  o f  a n a t i v e  p r o t e i n  and p o s se s s in g  
d i s t i n c t i v e  conformat iona l  f e a t u r e s .  A d i s co n t in u o u s  d e te rm inan t  
c o n s i s t  o f  r e s id u e s  t h a t  a r e  not contiguous  in  th e  pr imary s t r u c t u r e  
bu t  a r e  jux taposed  through f o ld in g  and format ion  o f  t h e  secondary  
s t r u c t u r e  o f  th e  p r o t e i n .  However, th e  topograph ic  d e te rm in an t  i s  
d e sc r ib e d  as  an ep i to p e  which ga ins  i t s  s t r u c t u r a l  uniqueness  by 
long - range  i n t e r a c t i o n s  a t  th e  l eve l  o f  secondary  and t e r t i a r y  
s t r u c t u r e .  I t  i s  l i k e l y  t h a t  MCAbs s p e c i f i c  f o r  con t inuous  o r
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d i s co n t in u o u s  e p i to p e s  on EIAV g l y c o p r o t e in s  were d e t e c t e d  by ELISA. 
So lub le  p r o t e i n s  have been shown to  a t t a c h  to  s o l i d  phase by p a ss iv e  
a b s o r p t io n  t o  p l a s t i c  w i th o u t  d e t e c t a b l e  in f l u e n c e s  on t h e i r  
a n t i g e n i c  s t r u c t u r e  (3 5 ) .  However, MCAbs t h a t  recogn ize  
t o p o g r a p h i c a l l y  assembled e p i to p e s  may no t  be recognized  in  ELISA 
t e s t s  us ing  deoxycho la te  d i s r u p t e d  v i r u s  and n e u t r a l i z a t i o n  t e s t s  a re  
o f t e n  more r e l e v a n t  in  t h i s  r e g a r d .  U n fo r tu n a te ly  such a
n e u t r a l i z a t i o n  a ssay  which a f f o r d s  e a r l y  s c r een in g  f o r  d e t e c t i o n  o f  
n e u t r a l i z i n g  a n t i b o d i e s  does no t  e x i s t  f o r  EIAV a t  th e  moment.
The i d e n t i f i c a t i o n  o f  v i r a l  p r o t e i n s  d e t e c t e d  by MCAbs was 
de termined by Western b l o t  immunoassay. Western b l o t  immunoassay 
combines t h e  high r e s o l v i n g  power o f  SDS-PAGE and th e  high 
s e n s i t i v i t y  o f  the  ELISA t o  produce an ex trem ely  powerful q u a l i t a t i v e  
too l  f o r  de te rm in ing  th e  s p e c i f i c i t y  o f  a n t i b o d i e s  a g a i n s t  th e  
spectrum o f  EIAV p o ly p e p t id e s .  The f a c t  t h a t  th e  a n t ig e n s  in  Western 
b l o t  immunoassay a r e  a l l  t r e a t e d  w i th  SDS, b r in g s  f o r t h  the
t h e o r e t i c a l  c o n s i d e r a t i o n  of  l o s s  o f  n a t i v e  c o n f i g u r a t i o n a l  i n t e g r i t y  
o f  th e  p o t e n t i a l  a n t i g e n i c  e p i t o p e s .  There i s  th e  danger  t h a t  not 
a l l  th e  a n t i g e n i c  s i t e s  can r e t a i n  th e  n a t i v e  c o n f i g u r a t i o n  a f t e r  SDS 
t r e a tm e n t  to  a l low  r e c o g n i t i o n  by t h e  a p p r o p r i a t e  an t ib o d y .  However, 
exper iments  with  IgG, BSA, and o t h e r  d e f in ed  a n t i g e n s ,  would tend  to  
nega te  t h i s  argument ,  s i n c e  t r a n s f e r  o f  p o ly p e p t id e s  onto 
n i t r o c e l l u l o s e  membranes a llows p o ly p e p t id e s  to  l o s e  t h e i r  SDS 
c o a t in g  and may a l low  s u f f i c i e n t  r e f o l d i n g  o f  p r o t e i n s  i n t o  t h e i r  
n a t i v e  conformat ion  t o  a l low  an t ib o d y  r e c o g n i t i o n  (142) .  Only 
f u r t h e r  i n v e s t i g a t i o n s  can f u l l y  answer t h e se  q u e s t i o n s .  Western
b l o t  immunoassay proved t o  be r a p id  and e f f i c i e n t  in  s c r ee n in g  of
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t h e se  MCAbs. Numerous a p p l i c a t i o n s  o f  MCAbs in  b a s ic  r e s e a rc h  
r e q u i r e  p u r i f i c a t i o n  o f  MCAbs from th e  r e s t  o f  th e  p r o t e i n s  in 
a s c i t i c  f l u i d s .  The most conven t iona l  method to  p u r i f y  MCAbs i s  to  
use p r o t e i n  A chromatography. The re fo re  p r o t e i n  A b ind ing  assays  
w i l l  be h e lp fu l  to  i d e n t i f y  MCAbs t h a t  bind p r o t e i n  A. The v a r i a t i o n  
e x h i b i t e d  by some EIAV s p e c i f i c  MCAbs in  p r o t e i n  A b ind ing  a ssay  may 
be simply a t t r i b u t e d  to  v a r i a t i o n  in  an t ig e n  c o n c e n t r a t i o n  o f  
d i f f e r e n t  EIAV p o ly p e p t id e s  or  the  pH may not be optimal f o r  the  
t h e i r  b in d in g .  I t  i s  known t h a t  th e  a s s o c i a t i o n  c o n s t a n t  f o r  b ind ing  
o f  IgGl immunoglubulins t o  p r o t e i n  A i s  ex t rem ely  pH dependent (3 7 ) .
S e ro lo g i c a l  r e a c t i v i t i e s  o f  EIAV s p e c i f i c  MCAbs as monitored by 
Western b l o t  immunoassay i n d i c a t e d  t h a t  10 MCAbs were s p e c i f i c  f o r  
gp90, 8 f o r  gp45, and 5 f o r  p26. Monoclonal a n t i b o d i e s  which r e a c t e d  
with  p26, a l s o  r e a c t e d  with  a n o th e r  p r o t e i n  o f  an a p p a ren t  MW of  
55 ,000. The p resence  of  m u l t i p l e  bands on th e  p r o t e i n  b l o t  r e f l e c t  
a n t i g e n i c  r e l a t e d n e s s .  This p r o t e i n  i s  most l i k e l y  t o  be th e  gag 
p r e c u r s o r  o f  EIAV ( r e f e r r e d  to  as Pr55gag) . Previous  s t u d i e s  
dem onst ra ted  th e  u n r e l a t e d n e s s  of  t h e  fo u r  major n ong lycosy la ted  
i n t e r n a l  ( gag ) p r o t e i n s  o f  EIAV (p26, p l 5 ,  p l l ,  and p9) by p e p t id e  
mapping and se ro lo g y  (100) .  In a d d i t i o n  the  agg rega te  c o l l e c t i v e  
m olecu la r  w e igh t  o f  t h e  gag p r o t e i n s  i s  e q u i v a l e n t  t o  61K, which 
approxim ates  t h a t  o f  t h e i r  p u t a t i v e  gag p re c u r s o r  (55K).  These 
o b s e r v a t io n s  along with the  c ro s s  r e a c t i v i t y  noted between p26 and 
th e  55K p r o t e i n  su g g es t  t h a t  t h e se  p r o t e i n s  (p26, p l 5 ,  p l l ,  and p9) 
a r e  c leavage  p roduc ts  o f  the  55K p r o t e i n  (P r55gag) . However, t h e  
e p i to p e  recognized  by t h e s e  MCAbs must be l o c a t e d  on th e  group 
s p e c i f i c  a n t ig e n  (p26) s in c e  t h e se  MCAbs showed r e a c t i v i t y  w i th  both
th e  55K p r e c u r so r  p r o t e i n  and i t s  c leavage  p ro d u c t ,  p26. On the  
o t h e r  hand, a l l  the  g ly c o p ro te in  s p e c i f i c  MCAbs were h ig h ly  s p e c i f i c  
in  t h e i r  r e a c t i v i t y  with  e i t h e r  gp90 or  gp45. A d d i t i o n a l l y ,  no 
p r o t e i n  o f  m olecu lar  weight h ighe r  than gp90 could  be d e t e c t e d  by 
our  panel o f  MCAbs and no c ro s s  r e a c t i v i t y  was observed between gp90 
and gp45. Both o f  t h e se  o b s e r v a t io n s  argue a g a i n s t  the  e x i s t e n c e  of  
a h ig h e r  m olecu lar  weight  p r o t e in  t h a t  might be a common p re c u r s o r  of  
th e  envelope  g l y c o p r o t e i n s .  These o b s e r v a t io n s  demonst ra ted  the  
u n re l a t e d n e s s  o f  t h e se  s u r f a c e  g ly c o p ro te in s  and proved t h a t  they  a re  
d i s t i n c t .
The b a t t e r y  o f  MCAbs genera ted  f o r  t h e  s u r f a c e  g l y c o p ro t e in s  
(gp90 o r  gp45) o f  EIAV r e p r e s e n t  v a luab le  r e a g e n t s  which may have 
tremendious b e n e f i t  in  th e  i d e n t i f i c a t i o n  o f  e p i to p e s  n eces sa ry  f o r  
p r o t e c t i v e  immunogenicity.
CHAPTER II I
ANTIGENIC ANALYSIS OF EQUINE INFECTIOUS ANEMIA VIRUS VARIANTS BY 
USING MONOCLONAL ANTIBODIES: EPITOPES OF GLYCOPROTEIN 90 (GP90) OF
EIAV STIMULATE NEUTRALIZING ANTIBODIES
I I I . A .  INTRODUCTION 
Equine i n f e c t i o u s  anemia v i r u s ,  a l e n t i v i r u s ,  causes  an 
im por tan t  d i s e a s e  in  a l l  members o f  th e  horse  f a m i ly .  The d i s e a s e  
EIA i s  c h a r a c t e r i z e d  by v i r a l  p e r s i s t e n c e ,  immunologically  media ted 
l e s i o n s ,  and a v a r i a b l e  c l i n i c a l  course  (29,  60) .  B iochem ica l ly ,  the  
v i r u s  c o n ta in s  two main s u r f a c e  g ly c o p ro te in s  (gp90 and gp45) and 
f o u r  major  n ong lycosy la ted  i n t e r n a l  p r o t e i n s  (100, 120).  One
p o s s i b l e  mechanism f o r  v i r a l  p e r s i s t e n c e  with EIAV invo lves  the  
e v o lu t io n  o f  a n t i g e n i c  v a r i a n t s  which a llow the  v i r u s  to  t e m p o r a r i l y  
e lude  e s t a b l i s h e d  h o s t  immune d e fe n se s .  Ant igen ic  v a r i a t i o n  in EIAV 
i s  thought  to  involve  f r e q u e n t  p o in t  m uta t ions  o f  th e  v i r a l  g e n e t i c  
m a te r i a l  in  th o se  s p e c i f i c  a re a s  coding f o r  the  v i r a l  s u r f a c e  
p r o t e i n s .  In an i n f e c t e d  an im al ,  such an a l t e r a t i o n  o f  the  v i r u s  
a n t i g e n i c  s t r u c t u r e  would a llow th e  emerging v a r i a n t  to  escape  from 
n e u t r a l i z a t i o n  by p r e e x i s t i n g  a n t ib o d y ,  t h u s ,  p e r p e tu a t i n g  th e  v i r u s  
i n f e c t i o n  in  an immunologica lly  competent h o s t .  The e v o lu t io n  of 
th e se  a n t i g e n i c  v a r i a n t s  which a re  not s u s c e p t i b l e  to  p r e v io u s ly  
formed an t ibody  may e x p la in  th e  p e r io d i c  f e b r i l e  r e l a p s e s  and the  
p e r s i s t e n c e  o f  v iremia  in horses  i n f e c t e d  with  EIAV.
Antigens  d i sp la y ed  on th e  s u r f a c e  o f  th e  v i r i o n  s e rv e  as 
p o t e n t i a l  t a r g e t s  f o r  n e u t r a l i z i n g  a n t i b o d i e s  (99,  130) .  V a r ia n t s  o f  
th e  l e n t i v i r u s e s  EIAV and v isna  v i r u s  co n ta in  a l t e r a t i o n s  conf ined  to  
the  envelope g l y c o p r o t e in s  (22 ,  102, 129, 132). In t h i s  i n s t a n c e ,
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the  emerging mutant v i r u s e s  have a l t e r e d  envelope g l y c o p r o t e i n s ,  and 
th e se  a l t e r a t i o n s  a re  p u r p o r te d ly  s u f f i c i e n t  to  a l low th e  v i r u s  to  
t e m p o ra r i ly  escape  immunological i n a c t i v a t i o n .  Although i t  would be 
premature  to  p r e d i c t  t h e  r o l e  o f  a n t i g e n i c  v a r i a t i o n  in  human 
immunodeficiency v i r u s  (HIV), i s o l a t e s  of  t h i s  v i r u s  from d i f f e r e n t  
i n d i v i d u a l s  d i f f e r  g e n o t y p i c a l l y ,  and t h i s  genomic h e t e r o g e n e i ty  i s  
g r e a t e s t  in  the  reg ion  o f  th e  env gene (6 ,  125, 152).  R ecen t ly ,  Hahn 
e t  a l . (49) sugges ted  t h a t  human immunodeficiency v i r u s e s  i s o l a t e d  
s e q u e n t i a l l y  from p e r s i s t e n t l y  in f e c t e d  i n d i v i d u a l s  have evolved in 
p a r a l l e l  from a common p r o g e n i to r  v i r u s .  This type  o f  v a r i a t i o n  may 
be common to  a l l  members o f  the  subfamily  L e n t i v i r i n a e .  I f  t h e se  
geno typ ic  and phenotypic  changes a re  m i r ro red  a n t i g e n i c a l l y ,  they  
w i l l  undoubtedly  pose s e r i o u s  problems f o r  vacc ine  development and 
p rovide  an e s s e n t i a l  mechanism f o r  t h e se  v i r u s e s  to  p e r s i s t  and 
spread  in  i n d i v i d u a l s  and p o p u la t i o n s .
Monoclonal a n t ib o d ie s  have proven to  be in v a lu a b le  in s tudy ing  
a n t i g e n i c  v a r i a t i o n  o f  in f lu en z a  v i r u s e s  as well as many o th e r  
v i r u s e s .  The number and l o c a t i o n  of an t ibody  binding  s i t e s  on the  
hemagglu t in in  (HA) and neuramin idase  (NA) were dete rmined us ing  MCAbs 
in  s e l e c t i n g  v a r i a n t s  and in  c o m p e t i t iv e  b inding  assays  which 
demonstra ted  the  p resence  of  t h r e e  o r  fo u r  nonoverlapping an t ibody  
b inding  s i t e s  (10,  144, 148).
In a d d i t i o n ,  the  use o f  MCAbs f o r  ana ly z in g  th e  e p i to p e s  on 
v i r a l  p r o t e i n s  r e p r e s e n t s  a very  im por tan t  new too l  f o r  i d e n t i f y i n g  
c r i t i c a l  s i t e ( s )  involved  in v i r u s  n e u t r a l i z a t i o n .  The 
d i s c r i m i n a t o r y  power o f  MCAbs make them idea l  r e a g en t s  f o r  
i n v e s t i g a t i o n  of  a n t i g e n i c  r e l a t e d n e s s  between v i r a l  p r o t e i n s .  The
a l t e r a t i o n s  o f  v i r u s  a n t i g e n i c i t y ,  d e t e c t a b l e  only  by MCAbs, seem to  
be o f  major  re levance  in v i r u s  h o s t  i n t e r a c t i o n s .  Coxsack iev i rus  
Type B4 i s  an example where a n t i g e n i c  v a r i a n t s  of  th e  v i r u s  were 
found to  be d i f f e r e n t  from the  p a re n ta l  s t r a i n ,  and from one a n o th e r ,  
in t h e i r  m y o card i t i c  and c a r d i o t r o p i c  p r o p e r t i e s  in  a murine model 
(14) .  T h e re fo re ,  we were committed to  th e  p roduc t ion  o f  MCAbs to  
s tudy a n t i g e n i c  v a r i a t i o n  of  EIAV, and to  d e f in e  e p i to p e s  a l t e r a t i o n  
in v i r i o n  s u r f a c e  g l y c o p r o t e i n s .  Through the  use o f  a d i v e r s e  panel 
o f  MCAbs i t  w i l l  be p o s s i b l e  to  d i s s e c t  o r  map ou t  th e  a l t e r e d  
a n t i g e n i c i t y  o f  the  s u r f a c e  g ly c o p r o t e in s  t h a t  s ig n a l  th e  emergence 
o f  a n t i g e n i c a l l y  d i s t i n c t  v a r i a n t s  capable  o f  e lu d in g  th e  immune 
d e f e n se s .  These da ta  w i l l  p rovide  a d d i t i o n a l  in fo rm at ion  on 
a l t e r a t i o n  o f  a n t i g e n i c i t y  t h a t  may p a r a l l e l  t h e  s t r u c t u r a l  and 
genomic v a r i a t i o n  observed with EIAV v a r i a n t s  (102, 121).  In
a d d i t i o n ,  MCAbs a g a i n s t  the  EIAV s u r f a c e  g l y c o p ro t e in s  w i l l  he lp  to  
i d e n t i f y  a n t i g e n i c  de te rm inan ts  im por tan t  f o r  n e u t r a l i z a t i o n .  The 
s u r f a c e  g l y c o p ro t e in s  o f  s e l e c t e d  EIAV v a r i a n t s  w i l l  be compared 
us ing  a b a t t e r y  o f  n e u t r a l i z i n g  MCAbs to  map ou t  t h e  p r o t e c t i v e  
a n t i g e n i c  d e t e r m i n a n t ( s ) . I t  may help  a l s o  to  i d e n t i f y  de te rm inan ts  
common to  a l l  EIAV v a r i a n t s  t h a t  may a f f o r d  c ro s s  p r o t e c t i o n .
I I I .  B. MATERIALS AND METHODS 
I I I .  B. 1. Virus p r o d u c t io n ,  p ro p a g a t io n ,  and p u r i f i c a t i o n
All v i r u s  i s o l a t e s  used f o r  t h i s  s tudy  were produced by s e r i a l  
passage of  p ro to ty p e  s t r a i n  o f  EIAV in She t land  ponies  (116) .  Virus 
i s o l a t e s  were d e s ig n a te d  by the  l e t t e r  "P" fo llowed by a t h r e e - d i g i t  
number w i th  th e  f i r s t ,  second,  and t h i r d  d i g i t  cor responding  to  the  
passage number, pony number, and i s o l a t e  number, r e s p e c t i v e l y  ( e . g . ,
P I . 1 -1 ) .  The p ro to ty p e  c e l l - a d a p t e d  Wyoming s t r a i n  o f  EIAV (88) and
i s o l a t e s  P 2 .1 - 1 ,  P 2 .1 - 6 ,  P 3 .1 -1 ,  P 3 .1 -2 ,  P 3 .1 -3 ,  P 3 .1 -4 ,  P 3 .2 -1 ,
P 3 .2 - 2 ,  P 3 .2 -3 ,  P 3 .2 -4 ,  P 3 .2 - 5 ,  P 3 .3 - 1 ,  P 3 .3 - 2 S P 3 .3 -3 ,  and P3.3-4
(116, 117, Rwambo e t  a l . ,  subm it ted )  were propagated  in pr imary FEK
c e l l s  and p u r i f i e d  accord ing  to  d e sc r ib e d  procedures  in  c h a p te r  I I .
The v i r u s  i s o l a t e s  o b ta in e d  from plasma c o l l e c t e d  du r ing  the
in d i c a t e d  s e q u e n t i a l  f e b r i l e  ep i sodes  o f  e x p e r im e n ta l ly  i n f e c t e d
She t land  ponies  were p u r i f i e d  by end p o in t  d i l u t i o n  in FEK c e l l s  to
ensu re  i s o l a t i o n  o f  th e  predominant  v i r u s  po p u la t io n  (102) .  I s o l a t e s
P2 .1-1  and P2 .1-6  were o b ta in e d  from an e x p e r im e n ta l ly  i n f e c t e d  pony
dur ing  th e  f i r s t  and s i x t h  f e b r i l e  ep isodes  (F ig .  111. 1 ) .  The
remaining 13 i s o l a t e s  were recovered  from 3 She t land  ponies  i n f e c t e d
w i th  th e  same v i r u s  inoculum (1 ml o f  plasma c o l l e c t e d  from pony #82
dur ing  i t s  f i r s t  f e b r i l e  e p i so d e ,  P 2 .1 -1 ,  w ith  plasma i n f e c t i v i t y  of  
4 510 * 50% t i s s u e  c u l t u r e - i n f e c t i v e  dose [TCIDjjq] pe r  0 .5  m l ) .  These
i s o l a t e s  a r e  i d e n t i f i e d  as  fo l l o w s :  4 c o n se c u t iv e  i s o l a t e s  (P3 .1 -1  
through P3.1-4)  from the  t h i r d  passage  animal #127 wi th  each f e b r i l e  
ep i so d e  s e p a ra te d  by on ly  4 to  8 weeks; 5 c o n se c u t iv e  i s o l a t e s  
(P3 .2-1  through P3 .2-5)  from th e  t h i r d  passage  animal #91; and 4 
c o n se c u t iv e  i s o l a t e s  (P3 .3 -1  through P3.3-4)  from th e  t h i r d  passage 
animal #F135, r e p r e s e n t i n g  c o n se c u t iv e  f e b r i l e  ep isodes  s e p a ra te d  by 
only  2 weeks t o  4 months.
I I I .  B. 2. Enzyme-linked immunosorbent a ssay  (ELISA)
The procedure  used as a s c r ee n in g  assay  was as  d e sc r ib e d  in  
Chapter I I .  A s c i t i c  f l u i d s  were produced f o r  p o s i t i v e  s e l e c t e d  
c lones  and were s e r i a l l y  d i l u t e d  in  TEN b u f f e r  to  de termine  t h e i r  




F i r s t  passage :
Second passage :
P I . 1-1 (pony #47)
I
P2.1-1  ....................... P2.1-6  (pony #82)
\
P3 .1 -1 ,  P 3 .1 -2 ,  P 3 .1 - 3 ,  P3.1 -4  (pony #127)
Third  passage :  /  y
P 3 .2 - 1 ,  P 3 .2 -2 ,  P 3 .2 -3 ,  P 3 .2 - 4 ,  P3 .2-5  (pony #91)
P 3 .3 - 1 ,  P 3 .3 -2 ,  P3 .3 -3 ,  P3 .3-4  (pony #F135)
FIGURE 111.1 .  In o c u la t i o n  scheme followed f o r  t h e  p roduc t ion  o f  EIAV 
i s o l a t e s  in  e x p e r im e n ta l ly  i n f e c t e d  She t land  p o n ie s .  Each o f  th e  t h r e e  
ponies  (#127, #91, and #F135) r ece iv ed  1 ml o f  plasma c o l l e c t e d  from 
pony #82 dur ing  i t s  f i r s t  f e b r i l e  e p i so d e .  Plasma i n f e c t i v i t y  was 10 * 
TCIDjjq/ 0 .5  m l .
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I I I .  B. 3.  Sodium dodecyl s u l f a t e - p o ly a c r y l a m id e  gel e l e c t r o p h o r e s i s
( SDS-PAGE)
Sodium dodecyl s u l f a t e - p o l y a r y l a m i d e  gel e l e c t r o p h o r e s i s  was 
performed in s l a b  g e l s  o f  18 cm X 32 cm X 1.5 mm accord ing  to  Laemmli 
procedure  (7 9 ) .  Gels used were 10% polyacry lamide  c o n ta i n in g  0.2% 
b i s - a c r y l a m i d e ,  0.1% SDS, 0.1% TEMED (N, N, N ' t N ' -  
T e t ra m e th y le th y le n e d ia m in e ) , 1 M u r e a ,  and 100 mM sodium phosphate  
b u f f e r ,  pH 7 .2 .  Gels were polymerized by th e  a d d i t i o n  o f  4 ml o f  1% 
ammonium p e r s u l f a t e  pe r  76 ml o f  acry lamide  monomer. E l e c t r o p h o r e s i s  
b u f f e r  c o n s i s t e d  o f  100 mM sodium phosphate ,  pH 7 . 2 ,  with  0.1% SDS 
and 10 mM 3-m ercap toprop ion ic  a c i d .  All g e l s  underwent 
e l e c t r o p h o r e s i s  f o r  a t  l e a s t  1 h a t  normal running c o n d i t io n s  p r i o r  
to  a p p l i c a t i o n  o f  samples in o rd e r  t o  e l i m i n a t e  any perox ides  formed 
dur ing  the  po lym er iza t ion  r e a c t i o n .  The procedures  used f o r  sample 
p r e p a r a t io n  and SDS-PAGE in  con t inous  sodium phosphate b u f f e r  f o r  
EIAV have been p r e v io u s ly  d e sc r ib e d  (100) .  B r i e f l y ,  aqueous samples 
of  un labe led  EIAV (60 yg) were brought to  a volume o f  90 yl with 10 
mM sodium phosphate  b u f f e r ,  pH 7 .2 .  Sodium dodecyl s u l f a t e  and 
2-mercaptoethanol were added to  ach ieve  a 1% c o n c e n t r a t i o n  f o r  each 
in  th e  sample,  and heated  f o r  3 min in  a b o i l i n g  w ater  b a th .  Sucrose 
was added to  g ive  a f i n a l  c o n c e n t r a t i o n  o f  20 to  30%, and 1 yl o f  
0.5% bromophenol b lue  in  0 .02  N sodium hydroxide  was added to  each 
sample as a t r a c k i n g  dye .  Samples were l ayered  onto th e  gel fol lowed 
by e l e c t r o p h o r e s i s  a t  50 mA per s l a b  gel f o r  20 to  24 h r .  B uffe r  was 
c i r c u l a t e d  between th e  upper and lower chambers to  p reven t  l a rg e  pH 
d i f f e r e n c e s  from develop ing  dur ing  e l e c t r o p h o r e s i s .  A f t e r  s e p a r a t i o n  
by SDS-PAGE, p r o t e i n s  were e i t h e r  v i s u a l i z e d  in s l a b  gel by s t a i n i n g
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in  0.25% coomassie b r i l l i a n t  b lue  in a c e t i c  a c id :m e th an o l rw a te r  
(46 :227 :227 ,  V/V/V) f o r  1 h with cont inuous  a g i t a t i o n ,  fo llowed by
d e s t a i n i n g  in a c e t i c  a c id :m e th a n o l :w a te r  ( 3 :1 0 :2 7 ,  V/V/V), or
t r a n s f e r r e d  to  n i t r o c e l l u l o s e  membrane.
I I I . B . 4 .  Western b l o t  immunoassay ( Immunoblotting)
The e l e c t r o p h o r e t i c  t r a n s f e r  o f  p r o t e i n s  a f t e r  s e p a r a t i o n  by 
SDS-PAGE to  n i t r o c e l l u l o s e  membranes was adapted from th e  method of 
Burne t te  (13) and Towbin and Gordon (143) .  B r i e f l y ,  f i l t e r  p a p e r s ,  
sponge pads and n i t r o c e l l u l o s e  membranes (Bio-Rad L a b o r a t o r i e s ,  
Richmond, C a l i f o r n i a )  were soaked f o r  10 min in a t r a n s f e r  b u f f e r  
c o n s i s t i n g  o f  25 mM T r i s ,  192 mM g l y c i n e ,  and 20% methanol ,  pH 8 .3 .  
The SDS gel c o n ta in in g  s e p a ra te d  p r o t e i n s  was washed immediate ly  
a f t e r  e l e c t r o p h o r e s i s  with  t r a n s f e r  b u f f e r ,  then  e q u i l i b r a t e d  in  the  
same b u f f e r  f o r  30 min. The gel was p laced  in d i r e c t  c o n t a c t  with
th e  n i t r o c e l l u l o s e  membrane and sandwiched between two p iece s  of
Whatman 3 mm f i l t e r  papers  and the  po lye thy lene  s h e e t s  o f  the  
c a s s e t t e .  The c a s s e t t e  was placed  in  an e l e c t r o b l o t  u n i t  (Bio-Rad 
L a b o r a t o r i e s ) ,  w ith  th e  n i t r o c e l l u l o s e  o r i e n t e d  toward th e  anode. 
The u n i t  was f i l l e d  w i th  co ld  t r a n s f e r  b u f f e r .  E l e c t r o p h o r e t i c  
t r a n s f e r  was performed a t  15°C f o r  18 t o  20 h a t  a c o n s t a n t  c u r r e n t  
o f  0.25 A. The n i t r o c e l l u l o s e  membrane with  t r a n s f e r r e d  p r o t e i n s  was 
d r i e d  f o r  1 h a t  37°C be fo re  being used f o r  immunoblott ing.  
Immunoreactive components were i d e n t i f i e d  by Western b l o t  immunoassay 
accord ing  to  th e  procedures  o f  Towbin and Gordon (143) and Hawkes 
(5 0 ) .  The n i t r o c e l l u l o s e  membranes were immersed in  3% bovine serum 
albumin (Sigma Chemical Co. ,  S t .  Lou is ,  M0) in  10 mM T r i s  
hyd ro ch lo r id e  (pH 7 .4 )  with  150 mM sodium c h l o r i d e  f o r  30 min a t  room
t em pera tu re  with  continuous  a g i t a t i o n .  The membrane was incubated  
f o r  90 min w i th  g e n t l e  shaking a t  room tem pera tu re  in  a 1:100 
d i l u t i o n  of a s c i t i c  f l u i d  o r  a r e f e r e n c e  an t ise rum  from a n a t u r a l l y  
i n f e c t e d  ho rse .  The n i t r o c e l l u l o s e  membranes were washed f o r  10 min 
in  T r i s - s a l i n e  followed by two 10 min washes in  T r i s - s a l i n e  
c o n ta in in g  0.05% NP-40, with  g e n t l e  a g i t a t i o n .  The n i t r o c e l l u l o s e  
membrane was then incuba ted  f o r  1 h in  T r i s - s a l i n e  c o n ta in in g  a 
1:1000 d i l u t i o n  o f  pe rox idase  con juga ted  goa t  an ti -mouse  
immunoglobulins.  The n i t r o c e l l u l o s e  membrane was washed as de sc r ib ed  
above,  and c o l o r  developed by in c u b a t in g  f o r  a few minutes  a t  room 
tem pera tu re  with th e  c o l o r  development s o l u t i o n  ( 4 - c h l o r o - l - n a p h t h o l ; 
c h a p te r  I I ) .  The development was stopped  by immmersing th e  membrane 
in  d i s t i l l e d  w a te r  f o r  10 min.
I I I . B . 5 .  N e u t r a l i z a t i o n  o f  v i r a l  i n f e c t i v i t y  with monoclonal
a n t ib o d ie s  (Beta Procedure)
Monoclonal a n t i b o d i e s  and immune mice se ra  were e v a lu a te d  f o r
t h e i r  a b i l i t y  t o  n e u t r a l i z e  th e  c y to p a t h i c  a c t i v i t y  of  EIAV. Samples
t o  be used in n e u t r a l i z a t i o n  assays  were f i l t e r e d  (0 .45  yin) and
heated  a t  56°C f o r  30 min be fo re  mixing with the  v i r u s .  S e r i a l
tw o-fo ld  d i l u t i o n s  o f  a s c i t i c  f l u i d s  were mixed with  an equal volume
(50 y l )  of  v i r u s  suspension  (100 TCID^q) in  MEM and incubated  f o r  1 h
a t  37°C. C e l l s  de r ived  from f e t a l  donkey dermal c u l t u r e s
(1 0 ,0 0 0 /w e l l )  were added in  100 yl volume to  each well  as i n d i c a t o r s
f o r  EIAV i n f e c t i v i t y .  Incuba t ion  was c a r r i e d  ou t  f o r  7 to  12 days ,
and c e l l s  were observed f o r  c y to p a t h i c  e f f e c t  (CPE). The
n e u t r a l i z a t i o n  t i t e r  was expressed  as th e  r e c ip r o c a l  of  the  h ig h e s t
d i l u t i o n  which i n h i b i t e d  the  c y to p a t h i c  e f f e c t  o f  100 TCIDcr, of  theou
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EIAV in  f e t a l  donkey dermal c e l l  c u l t u r e s .
I I I . B . 6 .  N e u t r a l i z a t i o n  a c t i v i t y  (Alpha Procedure)
The n e u t r a l i z a t i o n  a c t i v i t y  o f  a n t i -g p 9 0  monoclonal a n t i b o d i e s  
was ev a lu a te d  in  a n e u t r a l i z a t i o n  index a s sa y  us ing  a c o n s t a n t  
serum-vary ing v i r u s  a s s a y .  Sera and a s c i t i c  f l u i d s  to  be t e s t e d  f o r  
an t ibody  c o n te n t  were h e a t  i n a c t i v a t e d  a t  56°C f o r  30 min be fo re
mixing with  the  v i r u s  d i l u t i o n .  A c o n s t a n t  volume o f  MCAb o r  serum 
was re a c te d  with equal volumes o f  va ry ing  v i r u s  d i l u t i o n s  (10 * to  
10”^) o f  EIAV f o r  1 h a t  37°C. Next,  0 .5  ml o f  each m ix ture  was 
adsorbed to  FEK monolayer c e l l  c u l t u r e s  (grown in  25 cm t i s s u e
c u l t u r e  f l a s k s )  f o r  1 h a t  37°C. A f t e r  th e  i n c u b a t io n  p e r i o d ,  each 
f l a s k  was r i n s e d  with PBS and r e f e d  5 ml o f  maintenance medium (MEM 
with  3% FCS) and incuba ted  f u r t h e r  a t  37°C f o r  2 to  3 weeks.  Virus
t i t r a t i o n s  were done s im u l ta n eo u s ly  and a l l  a s says  were done in
d u p l i c a t e .  When th e  n e u t r a l i z a t i o n  a ssay  was performed with 
complement,  th e  same procedure  was used as o u t l i n e d  above ex ce p t  t h a t  
the  mix ture  was incuba ted  f o r  30 min a t  37°C i n s t e a d  of  1 h.  A f t e r  
t h i s ,  50 yl o f  guinea p ig  complement (pooled guinea p ig  serum from 
Miles L a b o r a t o r i e s ,  I n c . )  was added and th e  v i r u s - a n t i s e r u m  or  
a s c i t i c  f l u i d  complement m ix tu res  were incubated  f o r  an a d d i t i o n a l  30 
min a t  37°C. The inoculum was then adsorbed t o  FEK monolayer f o r  1 h 
a t  37°C and the  above d e sc r ib e d  procedure  was aga in  fo l low ed .  Virus 
n e u t r a l i z a t i o n  was e v a lu a te d  by d e t e c t i n g  th e  p re sence  of  p26 a n t ig e n  
in  th e  s u p e r n a t a n t  f l u i d  in  agar  gel immunodiffusion a ssay  s in c e  EIAV 
does not produce CPE in  t h e s e  c u l t u r e s  ( 1 ) .  The n e u t r a l i z i n g  
a c t i v i t y  o f  the  serum o r  a s c i t i c  f l u i d  was expressed  as a log^g 
n e u t r a l i z i n g  index ,  c a l c u l a t e d  as the  d i f f e r e n c e  in log^Q o f  the
t i t e r  o f  the  v i r u s  samples with  o r  w i th o u t  t e s t  serum. A 
n e u t r a l i z i n g  index o f  £ 1.7 was regarded  as p o s i t i v e ,  i . e . ,
n e u t r a l i z a t i o n .
I I I . C .  RESULTS
I I I . C . l .  Western b l o t  a n a l y s i s
Western b l o t  a n a l y s i s  o f  7 EIAV i s o l a t e s  us ing  our r e f e r e n c e  
immune serum was performed simply to  i d e n t i f y  t h e i r  p o ly p e p t id e s  as 
fo u r  of  t h e s e  s e q u e n t i a l  v i r u s  i s o l a t e s  (P 3 .1 - 1 ,  P 3 .1 - 2 ,  P 3 .1 - 3 ,  and 
P3.1 -4)  have proven to  be a n t i g e n i c a l l y  d i s t i n c t  (Table 111.1)  by 
c r o s s - n e u t r a l i z a t i o n  s t u d i e s  (117) .  The p o ly p e p t id e s  o f  t h e s e  
i s o l a t e s  and th e  p ro to ty p e  s t r a i n ,  were r e so lv ed  by SDS-PAGE in  10% 
g e l s  (F ig .  I I I . 2 ) .  Although th e  two major s u r f a c e  g ly c o p r o t e i n s  
cannot  be e a s i l y  lo c a t e d  in t h i s  e l e c t ro p h e ro g ram ,  th e  
nong lycosy la ted  i n t e r n a l  p r o t e i n s  (p26,  p l 5 ,  p l l ,  and p9) can be 
i d e n t i f i e d  in  a l l  seven i s o l a t e s .  The re so lv ed  p r o t e i n s  of  EIAV on 
SDS-PAGE were e l e c t r o p h o r e t i c a l l y  t r a n s f e r r e d  t o  n i t r o c e l l u l o s e  
membrane and immunoblotted with r e f e r e n c e  horse  immune serum. 
P r o t e i n  s t a n d a rd s  as well  as p ro to ty p e  EIAV p r o t e i n s  bound to  
n i t r o c e l l u l o s e  membranes were s t a i n e d  w i th  ami do b lack  to  m oni to r  
t h e i r  e l e c t r o p h o r e t i c  m ig ra t io n  and t r a n s f e r .  The immunoblot (F ig .
111.3) demonstrated  t h a t  both gp90 and gp45 of  the  p ro to ty p e  EIAV 
were i n t e n s e l y  recognized  by th e  r e f e r e n c e  a n t i  serum, however, l e s s  
r e a c t i v i t y  a g a i n s t  p26 was observed even though p26 i s  p r e s e n t  in 
much h ig h e r  q u a n t i t i e s  than  the  g l y c o p r o t e in s  (about 5 f o l d ) .  When
t h e  r e f e r e n c e  immune serum was r e a c t e d  w i th  th e  g l y c o p r o t e in s  o f
seven i s o l a t e s  v a r i a t i o n  in the  im m unoreac t iv i ty  was observed .  The
serum re a c t e d  weakly w i th  gp45 o f  i s o l a t e s  P 2 .1 -6 ,  P 3 .1 - 2 ,  and
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TABLE I I I .1 .  Serum n e u t r a l i z a t i o n  in d ic e s  o f  t h r e e  se ra  c o l l e c t e d  from 
pony #127 a t  d i f f e r e n t  t imes a f t e r  i n o c u l a t i o n .  Each serum was r e a c te d  
with s e q u e n t i a l  v i r u s  i s o l a t e s  from the  same pony.
Virus i s o l a t e Day P I 1
2
N e u t r a l i z a t i o n  index o f  serum c o l l e c t e d  
on the  fo l lowing  day p o s t i n o c u l a t i o n
31 125 158
P3.1-1 13 1.5 3 .0 3 .0
P3.1-2 41 0 .5 3 .0 2 .5
P3.1-3 99 1.5 2 .0 2 .5
P3.1 -4 137 1.0 1.0 1 .0
Days p o s t i n o c u l a t i o n  when plasma was c o l l e c t e d .
2
Log^Q s e r u m - n e u t r a l i z a t i o n  index i s  the  d i f f e r e n c e  in Log^g of  the  
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FIGURE I I I , ,2 .  A na lys is  o f  EIAV p o ly p e p t id e s .  SDS-PAGE s e p a r a t io n  of  
v i r i o n  p r o t e i n s  ( v i s u a l i z e d  by coomassie b lue  s t a i n i n g )  of 
g r a d i e n t - p u r i f i e d  EIAV i s o l a t e s :  p ro to ty p e  ( a ) ,  p 2 . 1 - l ( b ) ,  p 2 . 1 - 6 ( c ) ,  
p 3 . 1 - l ( d ) ,  p 3 . 1 - 2 ( e ) ,  p 3 . 1 - 3 ( f ) ,  p 3 . 1 - 4 ( g ) ,  and p r o t e i n  s t an d a rd s  ( h ) .
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FIGURE I I I . 3.  Western b l o t  a n a l y s i s  o f  r e f e r e n c e  horse  immune serum 
with  seven EIAV i s o l a t e s .  P o lypep t ides  o f  p ro to ty p e  ( a ) ,  P2 .1-1  ( b ) ,  
P2.1 -6  ( c ) ,  P3.1-1  ( d ) ,  P3.1 -2  ( e ) ,  P3.1 -3  ( f ) ,  P3.1 -4  (g) were 
s e p a ra te d  on SDS-PAGE ( s i m i l a r  t o  F ig .  1 ) ,  t r a n s f e r r e d  to  
n i t r o c e l l u l o s e  membrane, and immunoblotted with r e f e r e n c e  an t i s e rum .  
Equal amounts (60 yg) o f  each v i r u s  i s o l a t e  a re  p r e s e n t  in each lan e .  
P ro to type  EIAV (h) and p r o t e i n  s t an d a rd s  ( i )  were inc luded  as 
r e f e r e n c e s  and s t a i n e d  w i th  ami do b lack .
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P 3 .1 -4 ,  whereas i t  r e a c t e d  s t r o n g l y  w i th  gp45 o f  a l l  o t h e r  i s o l a t e s .  
In a d d i t i o n ,  v a r i a t i o n  in  e l e c t r o p h o r e t i c  m o b i l i t y  o f  both 
gp90 and gp45 from a l l  seven i s o l a t e s  was e v id e n t  sugges t ing  
s t r u c t u r a l  a l t e r a t i o n s  might have occur red  in t h e s e  two 
g l y c o p r o t e i n s .  To i d e n t i f y  th e  c o n t r i b u t i o n s  o f  both gp90 and gp45 to  
th e  a n t i g e n i c  v a r i a t i o n ,  t h e se  i s o l a t e s  as well  as o t h e r  s e t s  o f  
i s o l a t e s  ob ta ined  from a p a r a l l e l  i n f e c t i o n  were s u b jec te d  to  
a n t i g e n i c  a n a l y s i s  us ing  a panel o f  18 monoclonal a n t i b o d i e s .
I I I . C . 2 .  R e a c t i v i t y  of  monoclonal a n t i b o d i e s  with th e  homologous 
v i r u s  s t r a i n
The c e l l - a d a p t e d  Wyoming s t r a i n  o f  EIAV was used t o  i n o c u l a t e  
mice f o r  th e  p roduc t ion  o f  MCAbs as d e sc r ib e d  in  d e t a i l  in Chapter
I I .  Monoclonal a n t ib o d ie s  produced us ing  d i f f e r e n t  immunizing 
schemes were compared (Table I I I . 2 ) .  Of th e  150 hybridomas producing 
MCAbs produced to  EIAV, 18 r e a c te d  with th e  g ly c o p r o t e in s  o f  the  
p ro to ty p e  EIAV by Western b l o t  immunoassay. Four o f  th e  18 MCAbs had 
n e u t r a l i z i n g  a c t i v i t y  with  t i t e r s  ranging  from 64 to  128. I n d i r e c t  
ELISA t i t e r  of a s c i t i c  f l u i d s  ranged from 1 X 10^ '^  t o  1 X 10^*®. 
The most f r e q u e n t  i so ty p e  was IgGl fo llowed by IgG2b and IgA (Table
I I I . 2 ) .
I I I . C . 3 .  Reac tions  o f  monoclonal a n t i b o d i e s  with  a panel o f  EIAV 
v a r i a n t s
A t o t a l  o f  18 independent s t a b l e  hybridomas r e a c t i n g  to  EIAV 
g ly c o p ro te in s  (gp90 o r  gp45) were s e l e c t e d  f o r  t h i s  s tu d y .  Each of  
th e se  MCAbs was t e s t e d  in  Western b l o t  immunoassay a g a i n s t  a panel o f  
16 EIAV v a r i a n t s .  All v i r u s  v a r i a n t s  ob ta ined  dur ing  th e  i n d i c a t e d  
f e b r i l e  ep isodes  were p u r i f i e d  by end p o in t  d i l u t i o n  in  FEK c e l l s  to
Table I I I . 2. Characterizat ion of anti-EIAV Monoclonal antibodies
Clone No.
MONOCLONAL ANTIBODY REACTIVITY TO EIAV
N e u t r a l i z a t i o n
( t i t e r )
Iso type Immunizing an t igen Viral  p r o t e i n  
immunoblotted
ELISA
t i t e r  ( l o g 1Q)
86-1E3 IgGl Dis rupted  v i ru s gp90 3 .9
95-168 IgGl Dis rupted  v i ru s gp90 4 .2 -
114-3A7 IgGl Disrup ted  v i ru s gp90 3 .9 -
85-1E11 IgGl Dis rupted  v i r u s gp90 3 .6 -
71-1A9 IgGl Glycopro te ins gp90 3 .3 -
87-1E7 IgGl Disrup ted  v i ru s gp90 3 .3 -
82-1C2 IgGl Dis rupted  v i ru s gp90 3 .6 +(128)
98-1D1 IgGl Disrup ted  v i r u s gp90 3.3 + 64)
115-3D7 IgGl Disrup ted  v i ru s gp90 3.6 +(128)
128-2B9 igA Whole v i ru s gp90 3.6 +(128)
75-1F2 IgGl Glycopro te ins gp45 3 .6 -
92-1E6 IgGl Disrup ted  v i ru s gp45 4 .5 -
101-2F10 IgGl Disrup ted  v i r u s gp45 4 .5 -
109-1A6 IgGl Dis rupted  v i ru s gp45 4 .8 -
117-1C5 IgGl Whole v i ru s gp45 3.9 -
120-1H9 IgGl Whole v i ru s gp45 4 .8 -
105-3C8 IgG2b Dis rupted  v i ru s gp45 4 .5 -
90-1C1 IgGl Disrup ted  v i ru s gp45 4 .5 -
131-2D6 IgGl Whole v i r u s p26 3 .6 -
135-4E5 IgG2b Whole v i r u s p26 3 .0 -
140-1C3 IgGl Whole v i ru s p26 4 .8 -
141-4D5 IgGl Whole v i ru s p26 3 .6 -
149-4E3 IgGl Whole v i ru s p26 4 .2 _
^■Reciprocal o f  h ig h e s t  d i l u t i o n  o f  a s c i t i c  f l u i d  t h a t  i n h i b i t e d  th e  c y t o p a t h e t i c  e f f e c t  o f  100 TCID™ of  
EIAV inoculum in  f e t a l  donkey dermal c e l l  c u l t u r e s .  < 1:4 d i l u t i o n s  of  a s c i t i c  f l u i d .
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i n s u r e  i s o l a t i o n  o f  th e  predominant  v i r u s  p o p u la t io n  (F ig  1 I I . 1 ) .  
E igh t  p a t t e r n s  of  im m unoreac t iv i ty  were o bse rved ,  s i x  f o r  gp90 and 
two f o r  gp45. Each of  t h e s e  im m unoreac t iv i ty  p a t t e r n s  was a ss igned  
t o  r e a c t  w ith  a p u t a t i v e  e p i to p e  ( e p i to p e s  90-A, 90-B, 90-C, 90-D, 
90-E, and 90-F f o r  g p 9 0 - s p e c i f i c  MCAb). S i m i l a r l y  e p i to p e s  45-A and 
45-B were a ss ig n ed  f o r  g p 4 5 - s p e c i f i c  MCAbs. These r e s u l t s  can be 
summarized as fo l l o w s .
A n t ibod ies  from h ybr id s  86-1E3, 95-1G8, and 114-3A7 had a common 
p a t t e r n  o f  r e a c t i o n  and r e a c t e d  with  a l l  i s o l a t e s  t e s t e d  (F ig  I I I . 4 ) .
A n t ibod ies  from hybrid  87-1E7 had a unique  p a t t e r n  o f  r e a c t i o n .  
This  an t ibody  r e a c t e d  with  t h e  p ro to ty p e  EIAV, v a r i a n t s  P 2 .1 -1 ,  
P 3 .1 - 1 ,  P 3 .1 - 2 ,  P 3 .1 - 3 ,  P 3 .2 - 2 ,  P 3 .2 - 3 ,  P3.3-2  and P3 .3-3  and
com ple te ly  f a i l e d  to  r e a c t  w ith  v a r i a n t s  P 2 .1 - 6 ,  P 3 .1 -4 ,  P3 .2 -1 ,  
P 3 .2 - 4 ,  P 3 .2 -5 ,  P 3 .3 - 1 ,  and P3 .3-4  (F ig .  I I I . 5 ) .
A n t ibod ies  from h ybr id s  82-1C2 and 98-1D1 ( n e u t r a l i z i n g  
monoclonals)  r e a c t e d  w i th  the  p ro to ty p e  EIAV, P 2 .1 - 1 ,  P 3 .1 -1 ,  P3 .1 -2 ,  
P 3 .2 - 2 ,  P 3 .2 -3 ,  P 3 .3 - 1 ,  P 3 .3 - 2 ,  and P3.3-3  bu t  com ple te ly  f a i l e d  to  
recogn ize  P 2 .1 - 6 ,  P 3 .1 - 3 ,  P 3 .1 -4 ,  P 3 .2 -1 ,  P 3 .2 -4 ,  P 3 .2 -5 ,  and P3 .3-4  
(F ig .  I I I . 6 ) .
A n t ibod ies  from hybr id  115-3D7 ( n e u t r a l i z i n g  monoclonal)  r e a c te d  
with  t h e  p r o to ty p e  EIAV, P 2 .1 - 1 ,  P 3 .1 - 1 ,  P 3 .1 -2 ,  P 3 .2 -1 ,  P 3 .2 -2 ,  
P 3 .2 -3 ,  P 3 .3 -1 ,  P 3 .3 -2 ,  and P3.3-3  and f a i l e d  t o  r e a c t  w ith  P2 .1 -6 ,  
P 3 .1 - 3 ,  P 3 .1 - 4 ,  P 3 .2 - 4 ,  P3 .2-5  and P3 .3-4  (F ig .  I I I . 7 ) .
A n t ibod ies  from hybr id  128-2B9 ( n e u t r a l i z i n g  monoclonal)  r e a c te d  
with  t h e  p ro to ty p e  EIAV, P2-1,  P 3 .1 -2 ,  P 3 .1 - 4 ,  P3 .2-4  and P3 .2-5  and 
f a i l e d  to  recogn ize  P 2 .1 - 6 ,  P 3 .1 - 1 ,  P 3 .1 -3 ,  P 3 .2 -1 ,  P 3 .2 -2 ,  P 3 .2 -3 ,  
P 3 .3 - 1 ,  P 3 .3 - 2 ,  P3.3-3  and P3.3 -4  (F ig .  I I I . 8 ) .
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FIGURE I I I . 4.  Western b l o t  a n a l y s i s  o f  gp90 s p e c i f i c  monoclonal 
a n t ib o d ie s  with  p o ly p e p t id e s  o f  s i x t e e n  EIAV i s o l a t e s .  P o lypep t ides  
o f  p ro to ty p e  ( a ) ,  P 2 . l - l ( b ) , P 2 . 1 - 6 ( c ) ,  P3. 1 - 1 ( d ) , P 3 . 1 - 2 ( e ) ,
P 3 . 1 - 3 ( f ) ,  P 3 . 1 - 4 ( g ) ,  P3. 2 - 1 ( h ) , P 3 . 2 - 2 ( i ) ,  P 3 . 2 - 3 ( j ) ,  P 3 .2 - 4 ( k ) ,  
P 3 .2 - 5 ( 1 ) ,  P 3 .3 - l ( m ) ,  P 3 . 3 - 2 ( n ) ,  P 3 .3 - 3 ( o ) ,  and P3 .3 -4 (p )  v i r u s e s  were 
s e p a ra te d  on SDS-PAGE, t r a n s f e r r e d  to  n i t r o c e l l u l o s e  membrane and 
immunoblotted w i th  monoclonal an t ibody  86-1E3.
b c d e f g h i j k l m n o p
FIGURE I I I . 5.  Western b l o t  a n a l y s i s  o f  gp90 s p e c i f i c  monoclonal 
an t ibody  with  p o ly p ep t id e s  o f  s i x t e e n  EIAV i s o l a t e s .  Po lypep t ides  
were s ep a ra te d  on SDS-PAGE, t r a n s f e r r e d  to  n i t r o c e l l u l o s e  membrane and 
immunoblotted with  monoclonal an t ibody  87-1E7. EIAV i s o l a t e s  a re  in 
th e  same o rd e r  as  in  FIGURE I I I . 4.
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FIGURE I I I . 6.  Western b l o t  a n a l y s i s  o f  gp90 s p e c i f i c  monoclonal 
a n t i b o d i e s  with p o ly p e p t id e s  o f  s i x t e e n  EIAV i s o l a t e s .  P o lypep t ides  
were s e p a ra te d  on SDS-PAGE, t r a n s f e r r e d  to  n i t r o c e l l u l o s e  membrane and 
immunoblotted with  monoclonal an t ibody  82-1C2. EIAV i s o l a t e s  a r e  in  
th e  same o rd e r  as  in  FIGURE I I I . 4.
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FIGURE I I I . 7.  Western b l o t  a n a l y s i s  o f  gp90 s p e c i f i c  monoclonal 
an t ibody  with  p o ly p e p t id e s  o f  s i x t e e n  EIAV i s o l a t e s .  Po lypep t ides  
were s e p a ra te d  on SDS-PAGE, t r a n s f e r r e d  to  n i t r o c e l l u l o s e  membrane and 
immunoblotted with monoclonal an t ibody  115-3D7. EIAV i s o l a t e s  a re  in 
th e  same o rd e r  as  in  FIGURE I I I . 4.
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FIGURE I I I . 8 .  Western b l o t  a n a l y s i s  o f  gp90 s p e c i f i c  monoclonal 
an t ibody  wi th  p o ly p e p t id e s  o f  s i x t e e n  EIAV i s o l a t e s .  P o lypep t ides  
were s e p a ra te d  on SDS-PAGE, t r a n s f e r r e d  to  n i t r o c e l l u l o s e  membrane and 
immunoblotted with monoclonal an t ibody  128-2B9. EIAV i s o l a t e s  a r e  in  
th e  same o rd e r  as in  FIGURE I I I . 4.
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A ntibodies  from hybr id s  71-1A9 and 85-1E11 re a c te d  s i m i l a r l y .  
These a n t i b o d i e s  r e a c te d  with  th e  p ro to ty p e  EIAV, v a r i a n t s  3 . 1 - 3 ,  
P 3 .2 -3 ,  P3 .3-2  and P3.3-3  but f a i l e d  to  r e a c t  w ith  P 2 .1 -1 ,  P 2 .1 -6 ,  
P 3 .1 -1 ,  P 3 .1 - 2 ,  P 3 .1 -4 ,  P 3 .2 - 1 ,  P 3 .2 - 2 ,  P 3 .2 - 4 ,  P 3 .2 -5 ,  P3 .3-1  and 
P3.3-4  (F ig .  I I I . 9 ) .
A n t ibod ies  from h ybr id s  75-1F2, 92-1E6, 101-2F10, 109-1A6,
117-1C5, 120-1H9, and 105-3C8 r e a c te d  w i th  gp45 o f  a l l  i s o l a t e s  
t e s t e d  (F ig .  I I I . 10) .
Ant ibod ies  from hybrid  90-1C1 r e a c t e d  w i th  gp45 o f  th e  p ro to ty p e  
EIAV, v a r i a n t s  P 2 .1 -1 ,  P 2 .1 -6 ,  P 3 .2 - 1 ,  P 3 .2 - 2 ,  P3 .2 -3 ,  P 3 .2 -4 ,
P3 .2 -5 ,  P 3 .3 - 2 ,  P 3 .3 -3 ,  P3 .3-4  and f a i l e d  to  r e a c t  w ith  v a r i a n t s  
P 3 .1 - 1 ,  P 3 .1 -2 ,  P 3 .1 -3 ,  P 3 .1 -4 ,  and P3 .3-1  (F ig .  I I I . 11).
I I I . C . 4 .  N e u t r a l i z a t i o n  o f  EIAV i n f e c t i v i t y  by monoclonal a n t i b o d i e s
Since we were i n t e r e s t e d  in  deve lop ing  n e u t r a l i z i n g  MCAbs 
a g a i n s t  EIAV we i n j e c t e d  mice with  d i f f e r e n t  p r e p a r a t i o n s  o f  the  
v i r u s .  Immune serum o f  EIAV r e c i p i e n t  mice was e v a lu a te d  f o r  i t s  
n e u t r a l i z a t i o n  c a p a b i l i t y  (Table I I I . 3 ) .  The r e s u l t s  showed t h a t  
both n a t i v e  EIAV and d i s s o c i a t e d  v i r u s  s o l u b i l i z e d  with deoxychola te  
induced high t i t e r  an t ibody  by n e u t r a l i z a t i o n  a s s a y .  T h e re fo re ,  the  
sp leens  o f  t h e se  mice were chosen as th e  doner f o r  B lymphocytes f o r  
fu s io n  with  SP2/0 myeloma c e l l s .  Since th e  g l y c o p r o t e in s  (gp90 and 
gp45) a r e  l o c a t e d  in  t h e  envelope  o f  EIAV and r e p r e s e n t  th e  two main 
s u r f a c e  p r o t e i n s ,  i t  was o f  i n t e r e s t  t o  examine the  MCAbs f o r  
n e u t r a l i z i n g  a c t i v i t y .  Although a l l  18 o f  th e  MCABs bound to  e i t h e r  
gp90 or  gp45 in  Western b l o t s ,  on ly  4 o f  t h e s e  n e u t r a l i z e d  the  
i n f e c t i v i t y  o f  th e  v i r u s  to  an a p p r e c i a b l e  t i t e r  (Table I I I . 3 and 
I I I . 4 ) .  Each was d i r e c t e d  a g a i n s t  an e p i to p e  o f  gp90. The fo u r
FIGURE I I I . 9.  Western b l o t  a n a l y s i s  o f  gp90 s p e c i f i c  monoclonal 
a n t i b o d i e s  with  p o ly p e p t id e s  o f  s i x t e e n  EIAV i s o l a t e s .  P o lypep t ides  
were s e p a r a t e d  on SDS-PAGE, t r a n s f e r r e d  to  n i t r o c e l l u l o s e  membrane and 
immunoblotted w i th  monoclonal an t ibody  85-1E11. EIAV i s o l a t e s  were in 
th e  same o rd e r  as  in FIGURE I I I . 4.
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FIGURE I I I . 10. Western b l o t  a n a l y s i s  o f  gp45 s p e c i f i c  monoclonal 
a n t i b o d i e s  with  p o ly p e p t id e s  o f  s i x t e e n  EIAV i s o l a t e s .  Po lypep t ides  
were s e p a ra te d  on SDS-PAGE, t r a n s f e r r e d  t o  n i t r o c e l l u l o s e  membrane and 
immunoblotted w i th  monoclonal an t ibody  105-3C8. EIAV i s o l a t e s  a r e  in  
th e  same o rd e r  as in  FIGURE I I I . 4.
FIGURE I I I . 11. Western b l o t  a n a l y s i s  o f  gp45 s p e c i f i c  monoclonal 
an t ibody  with  p o ly p e p t id e s  o f  s i x t e e n  EIAV i s o l a t e s .  Po lypep t ides  
were s e p a ra te d  on SDS-PAGE, t r a n s f e r r e d  to  n i t r o c e l l u l o s e  membrane, 
and immunoblotted with  monoclonal an t ibody  90-1C1. EIAV i s o l a t e s  a re  
in  th e  same o rd e r  as in  FIGURE I I I . 4.
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TABLE I I I . 3.  N e u t r a l i z a t i o n  o f  EIAV by monclonal and po lyc lona l  
a n t i b o d i e s .
1 2 Sample t e s t e d  Antigen recognized  N e u t r a l i z a t i o n





Mouse a n t i  serum (D is so c ia te d  v i r u s ) gp90 ,gp45 ,p26 ,p l5 320
Mouse an t i se rum  (Whole v i r u s ) gp90 ,gp45 ,p26 ,p l5 240
Mouse an t i se rum  (Whole v i r u s  I/V) gp90 ,gp45 ,p26 ,p l5 80
■^Immunization schemes used to  o b ta in immune mice se ra  were d esc r ib ed
in  the  t e x t .
2
Antigen r e c o g n i t i o n  was determined by immunoblot ( see  t e x t  f o r  
d e t a i l s ) .
3
Reciprocal of  h ig h e s t  d i l u t i o n  t h a t  i n h i b i t e d  the  c y to p a th ic  e f f e c t  
o f  100 T C I D r n  o f  th e  EI AV inoculum in f e t a l  donkey dermal c e l l  
c u l t u r e s .
81
TABLE I I I . 4. N e u t r a l i z a t i o n  in d i c e s  o f  r e f e r e n c e  p o s i t i v e  horse  serum 
and monoclonal a n t i b o d i e s .
Sample
N e u t r a l i z a t i o n  index o f  sample* 
Without Complement With Complement
Immune horse  serum 2.5 2 .5
82-1C2 2 .0 2 .0
98-1D1 2.5 2 .5
115-3D7 2 .5 2 .5
128-2B9 2 .0 2 .0
^Log^Q N e u t r a l i z a t i o n  index i s  the  d i f f e r e n c e  in  log^Q of  th e  t i t e r  
of  the  v i r u s  with o r  w i th o u t  t e s t  sample.
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MCAbs t h a t  had n e u t r a l i z i n g  a c t i v i t y  (82-1C2, 98-1D1, 115-3D7, and 
128-2B9) r e a c t e d  with  gp90 in t h r e e  d i f f e r e n t  p a t t e r n s .  These da ta  
demonstrated  t h a t  MCAbs were d i r e c t e d  a g a i n s t  d i f f e r e n t  
n e u t r a l i z a t i o n  e p i to p e s  on gp90 (e p i to p e s  90-C, 90-D, and 90-E) .  The 
n e u t r a l i z i n g  a b i l i t y  o f  a s c i t i c  f l u i d s  and se ra  were a l s o  e v a lu a te d  
in  th e  p resence  of  a complement source  to  see whether  complement 
enhanced the  n e u t r a l i z a t i o n  o f  s e n s i t i z e d  v i r u s .  The r e s u l t s  show 
t h a t  th e  a d d i t i o n  o f  complement had no e f f e c t  on th e  n e u t r a l i z a t i o n  
induced by a l l  f o u r  MCAbs o r  by immune horse  serum.
I I I . C . 5 .  Comparison o f  16 EIAV i s o l a t e s
Monoclonal a n t i b o d i e s  r e a c t i n g  to  EIAV gp90 o r  gp45 were t e s t e d  
in  Western b l o t  a ssays  a g a i n s t  a panel of  16 EIAV v a r i a n t s  (F ig .
I I I .1)  to  i d e n t i f y  th e  p a t t e r n  o f  g ly c o p ro te in  a n t i g e n i c  v a r i a t i o n .  
V a r i a t io n  in e l e c t r o p h o r e t i c  m o b i l i t y  o f  both gp90 and gp45 from 
s ev e ra l  i s o l a t e s  was e v id e n t  when immunobloted with a given MCAb 
(F ig .  I I I . 12 ) ,  as r e p o r t e d  p re v io u s ly  (102, 129).  A s e r o l o g i c a l  
comparison o f  th e  v i r a l  g ly c o p ro te in s  o f  a l l  16 EIAV i s o l a t e s  i s  
summarized in  Figure  1 1 1 .13. Six p a t t e r n s  o f  im m unoreac t iv i ty  were 
observed  f o r  gp90 and two f o r  gp45 when a l l  18 MCAbs were t e s t e d  in 
Western b l o t  a s s a y s .  Each o f  th e se  immunoreac t iv i ty  p a t t e r n s  could  
be a ss igned  to  a p o t e n t i a l  e p i to p e  ( e p i to p e s  90-A, 90-B, 90-C, 90-D, 
90-E, and 90-F f o r  g p 9 0 - s p e c i f i c  MCAbs). S i m i l a r l y  e p i to p e s  45-A and 
45-B were a ss igned  f o r  g p 4 5 - s p e c i f i c  MCAbs. Conserved e p i to p e s  were 
i d e n t i f i e d  among a l l  16 v i r u s  i s o l a t e s  ( e p i to p e s  90-A and 45-A).  
Each o f  t h e se  conserved e p i to p e s  was found independen t ly  on gp90 and 
gp45. The MCAbs t h a t  r e a c t e d  with  a l l  EIAV i s o l a t e s  f a i l e d  to  
n e u t r a l i z e  th e  i n f e c t i v i t y  o f  the  p ro to ty p e  s t r a i n .  All MCAbs
p26
p15
FIGURE I I I . 12. Western b l o t  a n a l y s i s  o f  EIAV: p o l y p e p t i d e s  of  
p ro to ty p e  ( l a n e s  a ,  b ,  and d) and i s o l a t e  P2.1-1  ( l a n e s  c and e) 
v i r u s e s  were s e p a ra te d  by SDS-PAGE, t r a n s f e r r e d  to  n i t r o c e l l u l o s e  
membrabe, and immunoblotted w i th  serum from mice immunized with  
d i s r u p t e d  v i r u s  p r e p a r a t i o n s  ( a ) ,  n e u t r a l i z i n g  monoclonal an t ibody  
82-1C2 (b and c ) ,  o r  monoclonal an t ibody  105-3C8 (d and e ) .
m
VIRUSES
EPITOPE n P2.1 P3.1 P3.2 P 3.3r







■ ■ ■  ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■
□ ■ □ ■ □ □ □ n a i i i n n
45-A  ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■
4 5 - B
FIGURE I I I . 13. Immunoreactiv ity  p a t t e r n  o f  gp90- and g p 4 5 - s p e c i f i c  
monoclonal a n t ib o d ie s  w i th  po ly p ep t id e s  o f  16 EIAV i s o l a t e s .  
P o lypep t ides  o f  th e  p ro to ty p e  (P ) ,  P 2 .1 -1 ,  P2 .1 -6 ,  P 3 .1 -1 ,  P 3 .1 -2 ,  
P 3 .1 -3 ,  P 3 .1 -4 ,  P 3 .2 -1 ,  P 3 .2 -2 ,  P 3 .2 -3 ,  P3 .2 -4 ,  P 3 .2 -5 ,  P 3 .3 -1 ,
P 3 .3 - 2 ,  P 3 .3 -3 ,  and P3 .3-4  v i r u s e s  were sep a ra te d  by SDS-PAGE,
t r a n s f e r r e d  to  n i t r o c e l l u l o s e  membranes, and immunoblotted with each 
o f  th e  fo l low ing  MCAbs: 86-1E3, 95-1G8, and 114-3A7 (90-A); 87-1E7 
(9 0 -B ) ; 82-1C2 and 98-1D1 (90-C);  115-3D7 (90-D); 128-289 (90-E) ;  
85-1E11 and 71-1A9 (90 -F ) ;  75-1F2, 92-1E6, 101-2F10, 109-1A6, 117-1C5, 
120-1H9, and 105-3C8 (45-A); and 90-1C1 (45-B).
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s p e c i f i c  f o r  gp90 and gp45 r e a c t e d  s t r o n g l y  with  the  r e s p e c t i v e  
g ly c o p r o t e in s  from the  p ro to ty p e  EIAV, but none o f  the  i s o l a t e s  
r e a c te d  with a l l  th e  MCAbs. The immunoreac t iv i ty  p a t t e r n  e x h ib i t e d  
by p ro to ty p e  EIAV was unique .  Most i s o l a t e s  could  be d i s t i n g u i s h e d  
a n t i g e n i c a l l y  on the  b a s i s  o f  t h e i r  r e a c t i v i t y  with th e  panel of  
g ly c o p ro te in  s p e c i f i c  MCAbs. Only i s o l a t e s  P3 .2-4  and P3 .2-5  and 
i s o l a t e s  P3 .3-2  and P3.3-3  could  no t  be d i f f e r e n t i a t e d .
A c l a s s i f i c a t i o n  scheme f o r  t h e se  EIAV i s o l a t e s  based on t h e i r  
immunoreac t iv i ty  p a t t e r n  was c o n s t r u c t e d  (Table I I I . 5 ) .  Nine 
d i f f e r e n t  groups were noted on th e  b a s i s  o f  r e a c t i o n  with  gp90 
s p e c i f i c  MCAbs. The most common a re  th o se  of  Groups 7 and 2,  which 
a r e  r e p re se n te d  by t h r e e  i s o l a t e s  each .  I s o l a t e s  P3 .2-4  and P3.2-5  
of  Group 7 were recovered from th e  same animal and were i d e n t i c a l  f o r  
both gp90 and gp45 r e a c t i v i t y  with  t h i s  panel o f  MCAbs. They cou ld ,  
however,  be d i s t i n g u i s h e d  from the  o t h e r  member o f  Group 7 (P3 .1-4)  
because o f  s p e c i f i c  changes in  r e a c t i v i t y  o f  gp45. In a d d i t i o n  
v i r u s e s  belong to  Groups 3 and 4 which have s i m i l a r  immunoreactiv ity  
with gp90 s p e c i f i c  MCAbs, d i f f e r  in t h e i r  gp45 r e a c t i v i t y .  In 
c o n t r a s t  Groups 2 and 9 have s i m i l a r  gp90 and gp45 immunoreactiv ity  
p a t t e r n .  Only two immunoreac t iv i ty  p a t t e r n s  were seen f o r  th e  gp45 
s p e c i f i c  MCAbs. The f i r s t  group c o n ta in s  the  m a jo r i t y  of  i s o l a t e s  
(11 ou t  o f  16).  Seven ou t  o f  e i g h t  gp45 s p e c i f i c  MCAbs recognized  a 
h ig h ly  conserved e p i to p e  on a l l  16 EIAV i s o l a t e s  ( e p i to p e  45-A).  A 
second e p i to p e  on gp45 ( e p i to p e  45-B) appeared to  be unique f o r  the  
p ro to ty p e  and some o th e r  v a r i a n t s ,  e . g . ,  f o u r  s eq u e n t ia l  i s o l a t e s  
from pony #127 (P 3 .1 -1 ,  P 3 .1 -2 ,  P 3 .1 -3 ,  and P 3 .1 - 4 ) .  Four o f  the  
f i v e  i s o l a t e s  in Group 2A ( P 3 .1 -1 ,  P 3 .1 -2 ,  P3 .1-3  and P3.1-4)  were
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Table I I I .5. Classification of EIAV isolates by gp90 or gp45 immunoreactivity.
A. Classification by gp90 immunoreactivity pattern
GROUP 1 GROUP 2 GROUP 3 GROUP 4 GROUP 5 GROUP 6 GROUP 7 GROUP 8 GROUP 9
prototype P3.2-3 P2.1-1 P3.1-1 P3.1-3 P3.3-1 P3.1-4 P3.2-1 P2.1-6
P3.3-2 P3.1-2 P3.2-2 P3.2-4 P3.3-4
P3.3-3 P3.2-5
B. Classification by gp45 immunoreactivity pattern












recovered  from th e  same an imal .  T h e i r  gp45 had common changes ,  but 
they  can a l l  be d i f f e r e n t i a t e d  on th e  b a s i s  o f  t h e i r  gp90 r e a c t i v i t y .  
Monoclonal an t ibody  from hybridoma 90-1C1 r e a c te d  with  p r o t o t y p e ,  
P 2 .1 -1 ,  P 2 .1 -6 ,  P3.2-1  through P3.2 -5  and P3 .3-2  through P 3 .3 - 4 ,  but 
no t  i s o l a t e s  P 3 .1 -1 ,  P 3 .1 -2 ,  P 3 .1 -3 ,  P3 .1-4  and P3 .3 -1 .  Only the  
f i r s t  i s o l a t e  P3.3-1  from th e  t h i r d  animal had a l o s s  o f  t h i s  
e p i t o p e .  This e p i to p e  reappeared  in  i s o l a t e s  P 3 .3 -2 ,  P 3 .3 -3 ,  and 
P3 .3 -4 .  I s o l a t e  P3.3-1  was grouped with  i s o l a t e  P3.1 -3  which a l s o  
had s i m i l a r  r e a c t i v i t y  to  gp90 s p e c i f i c  MCAbs. Although v i r u s  
i s o l a t e s  could be d i s t i n g u i s h e d  a n t i g e n i c a l l y  on th e  b a s i s  o f  t h e i r  
immunoreac t iv i ty  p a t t e r n s ,  s i m i l a r  p a t t e r n s  o f  immunoreac t iv i ty  were 
seen in  i s o l a t e s  from animals  i n f e c t e d  in p a r a l l e l .  For example,  
i s o l a t e s  P3 .1-3  and P3.3 -1  recovered  from th e  t h i r d  and f i r s t  f e b r i l e  
ep isodes  o f  two animals  i n f e c t e d  in  p a r a l l e l  e x h ib i t e d  s i m i l a r  
p a t t e r n .  D i s t i n c t  changes were d e t e c t e d  in s p e c i f i c  e p i to p e s  o f  EIAV 
i s o l a t e s  recovered  from a d i s e a s e  ep isode  s e p a ra te d  by only  2 weeks 
in  a s i n g l e  an imal ,  as shown by th e  d i f f e r e n c e s  in immunoreac t iv i ty  
p a t t e r n  o f  i s o l a t e s  P3.2-1  and P3.2 -2  or  P3.3-1  and P3 .3 -2 .  This 
e v o lu t io n  o f  EIAV v a r i a n t s  i s  ve ry  r a p i d .  D e ta i l ed  s e r o l o g i c a l  
comparisons o f  the  v i r a l  g l y c o p r o t e in s  o f  EIAV i s o l a t e s  recovered 
from animals i n f e c t e d  w i th  the  same inoculum (P3.1-1  through P 3 .1 -4 ,  
P3 .2-1  through P 3 .2 -5 ,  and P3.3-1  through P3.3-4)  showed a l s o  t h a t  
they  belong to  d i f f e r e n t  g roups .  Through s e r o l o g i c a l  comparisons we 
were a b le  to  i d e n t i f y  12 d i f f e r e n t  a n t i g e n i c  v a r i a n t s  among 16 v i r u s  
s t r a i n s  (Table I I I . 6 ) .
A l t e r a t i o n s  of  the  g l y c o p r o t e in s  involved both n e u t r a l i z a t i o n  
and n o n - n e u t r a l i z a t i o n  e p i to p e s  du r ing  vivo passage ( e p i to p e s
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Table  I I I . 6.  Se ro typ ing  o f  16 EIAV i s o l a t e s  on the  b a s i s  of  
r e a c t i o n  with  MCAbs t o  gp90 and gp45.
A n t ig en ic  v a r i a n t s  I s o l a t e s  inc luded
Serotype 1 Pro to type
Serotype 2 p 3 .2 - 3 ,  p 3 .3 - 2 ,
Sero type 3 p 2 . 1-1
Serotype 4 p3 .1 -2
Serotype 5 p 3 . 1-1
Sero type 6 p3 .2-2
Serotype 7 p 3 .1-3
Serotype 8 p3.3 -1
Serotype 9 p3 .1 -4
Serotype 10 p 3 .2 - 4 ,  p3 .2 -5
Sero type 11 p 3 . 2 - l
Sero type 12 p 2 .1 - 6 ,  p3 .3 -4
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90-B, 90-C, 90-D, 90-E, and 9 0 -F ) .  Epi topes  90-E and 90-F where 
found only  in  few i s o l a t e s .  In a d d i t i o n  some n e u t r a l i z a t i o n  e p i to p e s  
conserved t h e i r  c o n f i g u r a t i o n a l  i n t e g r i t y  dur ing  in  vivo p a ssag e ,  f o r  
i n s t a n c e  e p i to p e  90-E i s  found on the  p ro to ty p e  and only  i s o l a t e s  
P 2 .1 - 1 ,  P 3 .1 - 2 ,  P 3 .1 -4 ,  P 3 .2 - 4 ,  and P3 .2 -5 .  In a l i m i t e d  s tu d y ,  th e  
fo u r  n e u t r a l i z i n g  MCAbs (82-1C2, 98-1D1, 115-3D7, and 128-2B9) were 
a l s o  t e s t e d  in  n e u t r a l i z a t i o n  assays  a g a i n s t  EIAV i s o l a t e s  P 2 .1 -1 ,  
P 2 .1 - 6 ,  P 3 .1 -1 ,  P 3 .1 - 2 ,  P 3 .1 - 3 ,  and P 3 .1 -4 ,  which d i s p la y e d  d i f f e r e n t  
im m unoreac t iv i ty  p a t t e r n s  with  th e  n e u t r a l i z i n g  MCAbs in  Western b l o t  
a n a l y s i s  (F ig .  I I I . 13).  The v i r u s  d i l u t i o n - c o n s t a n t  a s c i t i c  f l u i d  
method was used s in ce  not a l l  the  i s o l a t e s  r e p ro d u c ib ly  produced CPE 
in c e l l  c u l t u r e  ( I s s e l ,  unpubl ished  r e s u l t s ) .  The r e s u l t s  i n d i c a t e d  
t h a t  MCAbs 82-1C2, 98-1D1, 115-3D7, and 128-2B9 had a n e u t r a l i z a t i o n  
index o f  2 ,  2 . 5 ,  2 . 5 ,  and 2,  r e s p e c t i v e l y ,  a g a i n s t  th e  p ro to ty p e  
EIAV. However, none o f  th e  i s o l a t e s  t e s t e d  were n e u t r a l i z e d  by any 
o f  th e  fo u r  n e u t r a l i z i n g  MCAbs.
I l l . D .  DISCUSSION 
L e n t i v i r u s e s  d e r iv e  t h e i r  name from the  slow time course  o f  th e  
i n f e c t i o n s  they  cause in  humans and an im a ls .  The p e r s i s t e n c e  and 
spread  o f  t h e se  v i r u s e s  d e s p i t e  h o s t  de fenses  and th e  o r i g i n s  and 
slow e v o lu t io n  o f  the  d i s e a s e s  they  cause pose f a s c i n a t i n g  problems 
in  pa th o g en es i s  and vacc ine  development .  R ecen t ly ,  t h e s e  mechanisms 
assumed new s i g n i f i c a n c e  w i th  the  a d d i t i o n  o f  human immunodeficiency 
v i r u s  (HIV),  t h e  c a u s a t i v e  agen t  o f  AIDS, to  th e  l e n t i v i r u s e s .  
Severa l  q u e s t io n s  were add ressed  r e p e a t e d ly  to  answer th e  enigmas o f  
pa thogenes i s  o f  l e n t i v i r u s  induced d i s e a s e s .  These in c lu d e  (1) How 
does a v i r u s  escape  from th e  immunological s u r v e i l l a n c e  mechanisms of
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i t s  h o s t  over a long pe r iod  of  t ime? (2) How i s  a v i ru s  
d is sem ina ted  in the  animal in  the  face  o f  competent immunological 
de fense  mechanisms? (3) How does th e  v i r u s  cause t h e  p a th o lo g ic a l  
l e s i o n s ?  and, (4) Why does the  i n f e c t i o u s  process  evolve  so slowly? 
The emergence o f  mutant v i r u s e s  with a l t e r e d  envelope g l y c o p r o t e i n s ,  
i . e . ,  a n t ig e n ic  v a r i a t i o n ,  i s  the  p o s t u l a t e d  mechanism by which EIAV 
te m p o ra r i ly  escapes  immunological i n a c t i v a t i o n  and p e r s i s t s  in the  
h o r s e .  The p r e s e n t  i n v e s t i g a t i o n  has enabled us t o  dete rmine  th e  
fo l low ing  f a c t o r s  which may a s s i s t  in  unde rs tand ing  a n t ig e n i c  
v a r i a t i o n  o f  EIAV:
1) The i d e n t i f i c a t i o n  and d i s s e c t i o n  o f  a n t i g e n i c  s i t e s  of  the  
two main s u r f a ce  g ly c o p r o t e in s  o f  EIAV.
2) The documentation o f  r ap id  e p i to p e  a l t e r a t i o n s  in th e  v i r i o n  
s u r f a c e  g ly c o p ro te in s  of  EIAV during p e r s i s t e n t  i n f e c t i o n s .
3) The p a t t e r n  and e x t e n t  o f  s e r o l o g i c a l  c r o s s - r e a c t i o n s  of 
EIAV i s o l a t e s ,  and an e s t i m a t i o n  of  the  minimum number o f  p o s s ib l e  
s e r o ty p es  o f  EIAV.
4) The l o c a l i z a t i o n  o f  d e t e r m in a n t ( s )  involved  in s t im u la t in g  
n e u t r a l i z i n g  MCAbs.
The development by Kohler and M i l s t e in  (65,  66) o f  a method f o r  
th e  i s o l a t i o n  of  immunoglobulin producing  hybr id  c e l l s  has proven to  
be u se fu l  t o  analyze  p r o t e i n s .  T h e re fo re ,  we were engaged in  the  
p roduc t ion  o f  MCAbs to  s tudy a n t i g e n i c  v a r i a t i o n  o f  EIAV and 
d e l i n e a t e  the  changes in  th e  v i r i o n  s u r f a c e  g l y c o p r o t e i n s .  We have 
d e sc r ib e d  the  p ro d u c t io n ,  c h a r a c t e r i z a t i o n ,  and use o f  hybridoma 
a n t i b o d i e s  s p e c i f i c  f o r  EIAV g l y c o p ro t e in s  (gp90 and gp45).  Our 
r e s u l t s  showed t h a t  s u b t l e  a n t i g e n i c  d i f f e r e n c e s  among EIAV i s o l a t e s
e x i s t .  These were e v id e n t  by d e f i n i t i v e  a n t i g e n i c  a l t e r a t i o n s  a t  a 
s i n g l e  o r  group of  e p i to p e s  in  th e  s u r f a c e  g ly c o p r o t e in s  of  EIAV in  
p e r s i s t e n t l y  i n f e c t e d  an im a ls .  The m a jo r i t y  o f  i s o l a t e s  t e s t e d  could 
be d i s t i n g u i s h e d  a n t i g e n i c a l l y  on th e  b a s i s  o f  t h e i r  p a t t e r n  o f  
r e a c t i v i t y  w i th  th e  panel o f  MCAbs. This su g g es t s  a high degree  of  
h e t e r o g e n e i ty  o f  t h e s e  i s o l a t e s  a l though a h igh ly  conserved e p i to p e s  
( e p i to p e s  90-A and 45-A) among t h e s e  s t r a i n s  was i d e n t i f i e d .  The 
g e n o ty p ic ,  phenotypic  and a n t i g e n i c  comparisons o f  EIAV i s o l a t e s  
r ev ea led  d i f f e r e n c e s ,  bu t t h e r e  were cases  when two i s o l a t e s  appeared 
i d e n t i c a l  by one method o f  a n a l y s i s  but d i f f e r e d  by o t h e r s .  For 
example,  i s o l a t e s  P3 .2-4  and P3 .2-5  t h a t  appeared to  be c l o s e l y  
r e l a t e d  and could not be d i s t i n g u i s h e d  by our b a t t e r y  o f  MCAbs had 
t o t a l l y  d i f f e r e n t  p a t t e r n s  o f  o l i g o n u c l e o t i d e ,  p e p t i d e ,  and 
g ly co p ep t id e  maps (122, 129).  In c o n t r a s t ,  i s o l a t e s  P3.2-1 and 
P 3 .2 -4 ,  which could  no t  be d i s t i n g u i s h e d  by o l i g o n u c l e o t i d e  o r  
g ly co p ep t id e  mapping o f  gp45, were found to  be d i f f e r e n t  by a t  l e a s t  
one e p i to p e  on gp90 ( e p i to p e  90-E).  This c o r r e l a t e d  with da ta  
documenting d i f f e r e n c e s  in  th e  gp90 p e p t id e  and g ly co p ep t id e  maps of  
t h e s e  same i s o l a t e s  (122) .  I s o l a t e s  P3 .2-2  and P 3 .2 -3 ,  which could 
no t  be d i s t i n g u i s h e d  by p e p t id e  maps, were d i s t i n g u i s h e d  by 
o l i g o n u c l e o t i d e  and g ly c o p ep t id e  maps and by immunoreac t iv i ty  with 
our panel o f  MCAbs. The d i s s i m i l a r i t y  observed f o r  t h e s e  i s o l a t e s  
w ith  r e s p e c t  to  g ly co p ep t id e  and immunoreac t iv i ty  p a t t e r n  may 
i n d i c a t e  th e  importance o f  g ly c o s y l a t i o n  f o r  th e  a n t i g e n i c i t y  o f  t h i s  
p a r t i c u l a r  e p i t o p e .  I s o l a t e s  P 3 .1 - 1 ,  P 3 .1 -2 ,  P 3 .1 -4 ,  P3.1 -3  and 
P3.2 -5  whose g ly co p ep t id e  maps have proven s i m i l a r ,  could  be 
d i s t i n g u i s h e d  by t h e i r  immunoreac t iv i ty  p a t t e r n  with  th e  panel of
MCAbs. This may i n d i c a t e  t h a t  g ly c o s y l a t i o n  may not be im por tan t  f o r  
the  r e a c t i v i t y  o f  t h i s  e p i t o p e .  Previous  s t u d i e s  showed t h a t  
pe p t id e s  number 49 and 52 o f  gp90 (122) were p r e s e n t  in one i s o l a t e ,  
a b se n t  from the  n e x t ,  and subsequen t ly  reappeared  in  l a t e r  i s o l a t e .  
These p ep t id e s  may be c o r r e l a t e d  with  s ev e ra l  gp90 ep i to p e s  d e te c te d  
by our panel o f  MCAbs t h a t  were r e p o r t e d  t o  f l u c t u a t e  among i s o l a t e s  
( e p i to p e s  90-C, 90-D, and 90-E) .  In th e  same s tudy  50% o f  a l l  gp90 
p e p t id e s  were r e p o r t e d  to  be p r e s e n t  in  a l l  i s o l a t e s .  These 
conserved p e p t id e s  may be p r e s e n t  in  e p i to p e  90-A o f  gp90 noted in 
a l l  i s o l a t e s .  These o b s e r v a t io n s  document the  h e t e r o g e n e i ty  o f  a l l  
i s o l a t e s  t e s t e d  and argue  a g a i n s t  th e  e x i s t e n c e  o f  two i d e n t i c a l  
i s o l a t e s .  All 16 i s o l a t e s  used f o r  t h i s  s tudy  could  be d i s t i n g u i s h e d  
by th e  combinat ion o f  o l i g o n u c l e o t i d e ,  p e p t i d e ,  and g ly co p ep t id e  maps 
o r  immunoreac t iv i ty  p a t t e r n  with  MCAbs.
The a v a i l a b i l i t y  of  t h e se  MCAbs and the  use of Western b l o t  
immunoassay have a llowed us t o  s tudy  th e  p a t t e r n  and e x t e n t  of  
s e r o l o g i c a l  c r o s s - r e a c t i o n s  among EIAV i s o l a t e s  s in c e  some o f  th e se  
MCAbs were capable  o f  d i s t i n g u i s h i n g  between d i f f e r e n t  EIAV i s o l a t e s  
and could  d e t e c t  s u b t l e  a n t i g e n i c  d i f f e r e n c e s  among EIAV v a r i a n t s .  I t  
i s  l i k e l y  t h a t  t h i s  panel o f  MCAbs a long with  o th e r s  which a r e  being 
c h a r a c t e r i z e d  could  p rov ide  the  b a s i s  f o r  a method o f  typ ing  EIAV i f  
a l a r g e  number of  i s o l a t e s  a r e  inc luded  in  th e  comparison. Adequate 
c a t a lo g in g  o f  the  p r o t e c t i v e  g ly c o p ro te in s  o f  d i f f e r e n t  EIAV s t r a i n s  
might se rve  as  an im por tan t  means in  the  sea rch  f o r  a p r o t e c t i v e  
v a cc in e .  T h e re fo re ,  we a t tem pted  to  c l a s s i f y  EIAV i s o l a t e s  i n to  
s e r o l o g i c a l l y  d i s t i n c t  groups  based on t h e i r  immunoreac t iv i ty  p a t t e r n  
with  th e  panel o f  MCAbs. Our s t u d i e s  demonstra ted  t h a t  some
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d e te r m in a n t s ,  e . g . ,  e p i to p e s  90-A and 45-A were p re se rved  through the  
p rocess  o f  v a r i a t i o n  of  EIAV in  i n f e c t e d  an im a ls .  In c o n t r a s t ,  o t h e r  
a n t i g e n i c  de te rm in an ts  ( e p i to p e s  90-B, 90-C, 90-D, 90-E, and 90-F) 
were unique f o r  th e  p ro to ty p e  and some v a r i a n t s .
In comparison s t u d i e s  with  our  panel o f  18 MCAbs we observed 
t h a t  both n e u t r a l i z i n g  and n o n - n e u t r a l i z i n g  MCAbs could  d i f f e r e n t i a t e  
between EIAV i s o l a t e s .  Monoclonal a n t i b o d i e s  t h a t  r e a c t e d  w i th  
conserved e p i to p e s  on gp90 and gp45 f a i l e d  to  n e u t r a l i z e  EIAV. On 
th e  o t h e r  hand, th e  v a r i a b l e  reg ions  o f  th e  envelope g ly c o p r o t e in  90 
were o f t e n  a s s o c i a t e d  w i th  n e u t r a l i z i n g  e p i t o p e s .  In some c a s e s ,  th e  
MCAb which could n e u t r a l i z e  p ro to ty p e  d id  no t  bind to  t h e  e p i to p e  o f  
i s o l a t e s  and n e u t r a l i z a t i o n  d id  no t  occu r .  In o t h e r  c a s e s ,  the  MCAb 
could  s t i l l  b ind to  the  v a r i a n t  but d id  no t  d e c rea se  i n f e c t i v i t y .  
Thus,  one could conclude t h a t  an t ibody  b ind ing  to  a p o t e n t i a l  
n e u t r a l i z a t i o n  e p i to p e  and n e u t r a l i z a t i o n  may be u n r e l a t e d  phenomena. 
I d e n t i f i c a t i o n  and i t e m i z a t i o n  o f  d i f f e r e n t  n e u t r a l i z a t i o n  e p i to p e s  
s im u l ta n eo u s ly  p r e s e n t  on the  v i r i o n  i s  o f  p a r t i c u l a r  i n t e r e s t  f o r  
t h e  s tudy  of  the  m o d i f i c a t i o n  o f  n e u t r a l i z a t i o n  p a t t e r n  o f  a l l  
i s o l a t e s  a f t e r  t h e i r  passage  in  p o n ie s .  The p o s s i b l e  c o e x i s t e n c e  o f  
many d i f f e r e n t  e p i to p e s  on a s i n g l e  v i r i o n  was noted f o r  th e  
p ro to ty p e  and o t h e r  i s o l a t e s .  Our p r e s e n t  o b s e r v a t io n s  confirmed th e  
p resence  o f  more than one d i s t i n c t  n e u t r a l i z a t i o n  e p i to p e  on th e  
v i r u s .  With our b a t t e r y  o f  n e u t r a l i z i n g  MCAbs, a minimum o f  t h r e e  
n e u t r a l i z a t i o n  e p i to p e s  s im u l ta n eo u s ly  p r e s e n t  on th e  p ro to ty p e  EIAV 
were d e t e c t e d  (e p i to p e s  90-C, 90-D, and 90-E) .  However, us ing  an 
a d d i t i v e  ELISA our da ta  sugges t  t h a t  a t  l e a s t  2 d i s t i n c t  
n e u t r a l i z a t i o n  e p i to p e s  were l o c a l i z e d  on gp90 ( c h a p te r  IV).
94
Our comparison s tudy  revea led  the  f a t e  o f  the  n e u t r a l i z a t i o n  
e p i to p e s  and demonst ra ted  t h a t  they  may be l o s t  du r ing  m u l t i p l i c a t i o n  
in  v i v o . However, upon in  vivo v i r u s  r e p l i c a t i o n  an e p i to p e  may lo se  
i t s  f u n c t io n  in v i r u s  n e u t r a l i z a t i o n  but may keep i t s  a n t i g e n i c  
conformation  u n a l t e r e d .  For i n s ta n c e  e p i to p e  90-E was found on the  
p r o t o t y p e ,  P 2 .1 -1 ,  P 3 .1 - 2 ,  P 3 .1 -4 ,  P 3 .2 -4 ,  and P3.2-5  bu t  was no t  
d e t e c t e d  on o t h e r  i s o l a t e s  t e s t e d .  S i m i l a r l y ,  e p i to p e s  90-C and 90-D 
were found on some but no t  a l l  v i ru s  i s o l a t e s .  Virus i s o l a t e s  t h a t  
kep t  t h e  a n t i g e n i c  conformation  o f  th e  n e u t r a l i z a t i o n  e p i to p e  
u n a l t e r e d  c a r r y  2 o f  t h e  3 n e u t r a l i z a t i o n  e p i to p e s  found on the  
p r o to t y p e .  However, i s o l a t e s  P2.1-1  and P3.1-2  have a l l  3 e p i to p e s  
(90-C, 90-D, and 90-E).
In th e  unde rs tan d in g  o f  a n t i g e n i c  v a r i a t i o n  o f  EIAV dur ing  
m u l t i p l i c a t i o n  in  v ivo th e  most p e r t i n e n t  f in d i n g  was t h a t  t h e  same 
e p i to p e  can have a l t e r n a t e  f u n c t io n s  in  th e  n e u t r a l i z a t i o n  o f  v i r u s  
i n f e c t i v i t y .  By performing c ro s s  n e u t r a l i z a t i o n  w i th  MCAbs and 
Western b l o t t i n g  with  MCAbs in  p a r a l l e l  we demonstrated  t h a t ,  due to  
m u ta t io n ,  an e p i to p e  can lo s e  i t s  f u n c t io n  in  v i r a l  n e u t r a l i z a t i o n  
w i th o u t  modifying i t s  a n t i g e n i c  s p e c i f i c i t y .  I s o l a t e s  from 
in d iv id u a l  a n im a ls ,  e . g . ,  i s o l a t e s  (P 2 .1 -1 ,  P 2 .1 - 6 ) ,  (P3 .1-1  through 
P3 .1-4)  and (P3 .3-1  through P3.3 -4)  proved to  be d i s t i n c t  by 
c r o s s - n e u t r a l i z a t i o n  s t u d i e s  us ing  homologous serum (117, Rwambo e t  
a l . ,  s u b m i t t e d ) .  Although n e u t r a l i z i n g  e p i to p e s  (90-C and 90-D) were 
p r e s e n t  f o r  example on both i s o l a t e  P3 .1-1  and P3.1-2  which have 
proven to  be unique by a c r o s s - n e u t r a l i z a t i o n  t e s t ,  they  may not 
f u n c t io n  as n e u t r a l i z i n g  e p i to p e s  in t h e s e  i s o l a t e s .  This i s  one 
example where b ind ing  and n e u t r a l i z a t i o n  o f  e p i to p e s  a re  d i s c r e t e
f u n c t i o n s .  However, g ly c o s y l a t i o n  may p lay  a r o l e  in  t h i s  case  by 
masking e p i to p e s  on th e  p r o t e in  backbone t h a t  may o the rw ise  be 
p o t e n t i a l  t a r g e t s  f o r  n e u t r a l i z a t i o n .  A more comprehensive p i c t u r e  
o f  e p i to p e  v a r i a t i o n  was ob ta ined  by ana lyz ing  i s o l a t e s  from animals  
i n f e c t e d  in  p a r a l l e l .  Based on t h e s e  r e s u l t s ,  we concluded t h a t  a 
m uta t ion  can a f f e c t  a n e u t r a l i z a t i o n  s i t e  in  two ways: e i t h e r  by 
modifying i t s  a n t i g e n i c  c o n f i g u r a t i o n  o r  by nega t ing  i t s  fu n c t io n  in  
v i r u s  n e u t r a l i z a t i o n .  I t  seems t h e n ,  t h a t  dur ing  s e l e c t i o n  of  one 
p a r t i c u l a r  i s o l a t e  from i t s  p r o g e n i t o r ,  n e u t r a l i z a t i o n  e p i to p e s  ( f o r  
example e p i to p e  90-E on P3.1-1)  were l o s t  by conformational 
a l t e r a t i o n s .  Other e p i to p e s  r e t a i n e d  t h e i r  conformation ( e p i to p e s  
90-C and 90-D on P3 .1-1)  but l o s t  t h e i r  f u n c t io n  in  v i ru s  
n e u t r a l i z a t i o n .  D esp i te  th e  s i g n i f i c a n t  p ro g res s  made in  the  s tudy 
o f  the  mechanism of  v i r u s  n e u t r a l i z a t i o n ,  no e x p la n a t io n  i s  a v a i l a b l e  
f o r  th e  mechanism by which a v i ru s  e p i to p e  can conserve  i t s  a n t i g e n i c  
c o n f i g u r a t i o n  whi le  l o s in g  i t s  fu n c t io n  in n e u t r a l i z a t i o n .  The high 
degree  o f  v a r i a b i l i t y  i s  well i l l u s t r a t e d  by th e  complete convers ion  
o f  th e  e p i to p e  p a t t e r n  on some i s o l a t e s  ( e p i to p e s  90-C, 90-D, and 
90-E on P3.1 -2)  to  t h a t  o f  th e  p ro to ty p e .  These o b s e r v a t io n s  sugges t  
t h a t  muta t ions  invo lv ing  r e s id u e s  o u t s i d e  th e  a n t i g e n i c  s i t e  would be 
expec ted  to  e x e r t  c o n s id e r a b l e  e f f e c t  and may cause conformat iona l  
r e a d ju s tm en t  o f  th e  whole a n t i g e n .  Recently  however,  a n t ig e n ic  
v a r i a n t s  o f  type 1 p o l i o v i r u s  s e l e c t e d  in  th e  p resence  o f  
n e u t r a l i z i n g  MCAb had m uta t ions  s i t u a t e d  in  VP3, o u t s id e  of  
a n t ib o d y -b in d in g  s i t e  which i s  p r e s e n t  in r e s id u e s  93 through 103 of  
VP1 ( 7 ) .  Genome sequencing o f  such a n t i g e n i c  v a r i a n t s  revea led  
th e  m uta t ion  to  always be lo c a ted  o u t s id e  o f  th e  MCAb b inding  s i t e .
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These o b s e r v a t io n s  may have re levance  to  EIAV i n f e c t i o n s .  Since 
EIAV causes  a p e r s i s t e n t  v iremia  and from our o b se r v a t io n  i t  induces 
t h e  p roduc t ion  o f  n o n - n e u t r a l i z i n g  a n t i b o d i e s ,  then i n f e c t i o u s  
immune complexes may have im por tan t  r o l e  in  th e  pa thogenes is  o f  EIA. 
I n f e c t i o u s  immune complexes have been demonstra ted  in  EIA (9 6 ) .  In 
a d d i t i o n ,  a n t ib o d ie s  may combine with  f r e e  v i r a l  an t ig e n s  
( g l y c o p r o t e i n s ,  p r o t e i n s )  t h a t  may be shed from the  v i r i o n s .  The 
p resence  o f  non -n eu t ra l  ized  v i r i o n s  as well as an t ig en  immune
complexes in  th e  serum may produce immune complex d i s e a s e .  These in 
t u r n  may block immune c y t o l y s i s  o f  v i r u s - i n f e c t e d  t a r g e t  c e l l s  by T 
c e l l s  o r  complement f i x i n g  a n t i b o d i e s .  These n o n - n e u t r a l i z i n g  
a n t ib o d ie s  may fu n c t io n  by s a t u r a t i n g  a l l  p o s s i b l e  a n t i g e n i c
d e te rm inan ts  on EIAV o r  may cause s imple  ag g reg a t io n  of  EIA v i r i o n s  
which may not r e s u l t  in  i n t r i n s i c  n e u t r a l i z a t i o n .  On the  o t h e r  hand, 
they  may combine w i th  EIAV in  l e s s  than  s a t u r a t i o n  c o n c e n t r a t i o n s ,  
y e t  p r o t e c t  th e  v i r u s  a g a i n s t  a d d i t i o n a l  b inding  o f  a n t i b o d i e s .  
This l a s t  a t t r i b u t e  may invo lve  b inding  o f  i n t e r f e r i n g  a n t ib o d ie s  to  
n o n - c r i t i c a l  s i t e s  t h a t  p reven t  b inding  of  p o t e n t i a l  n e u t r a l i z i n g  
a n t i b o d i e s .
I t  i s  i n t e r e s t i n g  to  no te  t h a t  only two immunoreac t iv i ty  p a t t e r n s  
were seen f o r  gp45 s p e c i f i c  MCAbs. Seven g p 4 5 - s p e c i f i c  MCAbs 
recognized  a h igh ly  conserved e p i to p e  ( e p i to p e  45-A) on a l l  16 EIAV 
i s o l a t e s ,  whi le  one g p 4 5 - s p e c i f i c  MCAb recognized  an e p i to p e  ( e p i to p e  
45-B) on s e l e c t e d  i s o l a t e s .  Data provided by a d d i t i v i t y  ELISA 
(Chapter IV) i n d i c a t e d  t h a t  a l l  7 MCAbs may recogn ize  the  same
ep i to p e  on gp45. I t  appears  from our s t u d i e s  t h a t  both gp90 and
gp45 may be involved in  th e  a n t i g e n i c  changes observed in  EIAV
v a r i a n t s .  Although no t  s tu d i e d  h e re ,  no s t r u c t u r a l  v a r i a t i o n s  were 
observed in  the  v i r a l  co re  p r o t e i n s  p9,  p l 5 ,  and p26 o f  s eve ra l  v i r a l  
i s o l a t e s  as t e s t e d  by p e p t id e  mapping (102, 129) .  Both o f  t h e se  
o b s e r v a t io n s  i n d i c a t e  t h a t  a n t i g e n i c  v a r i a t i o n  in  EIAV dur ing  
i n f e c t i o n  may be r e s t r i c t e d  t o  th e  s u r f a c e  po ly p ep t id e s  (gp90 and 
gp45) which a r e  s u b j e c t  t o  hos t  immune s e l e c t i o n  p r e s s u r e .  However, 
our r e s u l t s  showed t h a t  gp90 appears  to  c o n t r i b u t e  more to  t h i s  
v a r i a t i o n  than does gp45. In a d d i t i o n  th e  r e s u l t s  i n d i c a t e  t h a t  
a l though  gp45 i s  s t r o n g l y  recognized  by the  h o s t  (a s  seen from 
Western b l o t  immunoassay us ing  horse  immune serum) i t s  c o n t r i b u t i o n  
t o  the  observed a n t i g e n i c  v a r i a t i o n  in  EIAV appears  to  be l e s s  than 
gp90. H e te rogene i ty  o f  gp90 was documented by i d e n t i f i c a t i o n  o f  nine 
d i f f e r e n t  s e r o l o g i c  g roups .  In c o n t r a s t ,  only  two s e r o l o g i c  groups 
o f  gp45 were i d e n t i f i e d ,  su g g es t in g  a more moderate degree  of 
c o n se r v a t io n .  In some cases  v i r u s e s  having s i m i l a r  immunoreac t iv i ty  
p a t t e r n s  with gp90 s p e c i f i c  MCAbs d i f f e r e d  with  r e s p e c t  to  gp45 
(Groups 3 ,  4 and 7 ) .  Other i s o l a t e s ,  e . g . ,  a l l  those  from P3 .1 ,  had 
i d e n t i c a l  immunoreac t iv i ty  p a t t e r n s  w i th  r e s p e c t  t o  gp45, but 
d i f f e r e d  with r e s p e c t  t o  gp90 im m unoreac t iv i ty .  These observed 
a l t e r a t i o n s  in EIAV g ly c o p r o t e in s  p o in t  ou t  t o  th e  complexity  o f  the  
s i t u a t i o n  f o r  EIAV v a r i a t i o n .  A l t e r a t i o n s  observed in gp45 
a n t i g e n i c i t y  may i n t e r a c t  with gp90 the reby  a f f e c t i n g  o v e ra l l  d i s p l a y  
o f  a n t i g e n i c i t y  o f  very  im por tan t  e p i t o p e s .  I f  t h i s  i s  the  c a s e ,  i t  
r e p r e s e n t s  a complex i n t e r a c t i o n ,  y e t  unique which may r e q u i r e  
f u r t h e r  i n v e s t i g a t i o n .
The r e s u l t s  conf irmed t h a t  a n t i g e n i c  v a r i a t i o n  can occur  in 
EIAV i s o l a t e s  recovered  from d i s e a s e  ep isodes  s ep a ra te d  by only 14 to
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16 days (P3 .2-1  and P3 .2 -2 ;  P3 .3-1  and P 3 .3 - 2 ) .  Thus, th e  t ime 
re q u i r e d  f o r  a p p a ren t  a n t i g e n i c  v a r i a t i o n  in EIAV i s  c o n s id e ra b ly  
s h o r t e r  than t h a t  r e p o r t e d  f o r  v isna  v i r u s ,  which r e q u i r e s  one to  two 
y e a r s  f o r  th e  emergence o f  a n t i g e n i c  v a r i a n t s  in  th e  p e r s i s t e n t l y  
i n f e c t e d  animal (110) .  The spectrum of  EIAV v a r i a n t s  which a ro se  in 
th e  t h r e e  animals  i n f e c t e d  in  p a r a l l e l  were d i s t i n g u i s h e d  
a n t i g e n i c a l l y  on th e  b a s i s  o f  t h e i r  immunoreac t iv i ty  p a t t e r n .  Each 
i s o l a t e  in  th e  same animal i s  d i f f e r e n t  a n t i g e n i c a l l y  from the  
preceed ing  v i r u s .  However, th e  emergence o f  t h e se  v a r i a n t s  appears  
to  be random as no p r e d i c t a b l e  p a t t e r n  o f  immunoreac t iv i ty  was 
observed in  the  t h r e e  animals  i n f e c t e d  in p a r a l l e l  w ith  th e  same
v i r u s  inoculum. These f in d in g s  d i f f e r  from those  with  v isna  v i r u s ,
f o r  which a s i m i l a r  p a t t e r n  o f  v a r i a n t s  evolved in  p a r a l l e l  
p e r s i s t e n t  i n f e c t i o n s  (2 3 ) .  Our f in d in g s  p a r a l l e l e d  those  o f  AIDS 
v i r u s  (HIV), in  which g e n e t i c  v a r i a n t s  appear  t o  have evolved 
randomly (4 9 ) .  In EIAV, a l though v i r u s e s  i s o l a t e d  from a given
animal were d i f f e r e n t  a n t i g e n i c a l l y  from each o t h e r ,  they appeared to  
have s i m i l a r  immunoreac t iv i ty  to  v i r u s e s  i s o l a t e d  from o t h e r  animals  
i n f e c t e d  with  the  same inoculum. This i s  in  c o n t r a s t  to  th e  f in d i n g s  
in HIV where g e n e t i c  v a r i a n t s  from any one p a t i e n t  were observed to  
be more r e l a t e d  t o  each o t h e r  than to  v i r u s e s  from o t h e r  i n d i v i d u a l s  
(49 ) .  However, HIV i s o l a t e s  t h a t  appeared to  be r e l a t e d  t o  each
o t h e r  may a c t u a l l y  r e p r e s e n t  d i s t i n c t  v i r a l  forms t h a t  have p e r s i s t e d  
in  i n d i v i d u a l s  f o r  a long t im e .  These i n d i v i d u a l s  may have been 
exposed to  more than one geno typ ic  form o f  HIV which may account  f o r  
the  d i f f e r e n c e  in t h e se  o b s e r v a t i o n s ,  whi le  ponies  e x p e r im e n ta l ly  
i n f e c t e d  rece ived  th e  same v i r u s  inoculum. Although EIAV has the
p o t e n t i a l  to  change d r a m a t i c a l l y  in each i n f e c t e d  h o r s e ,  our da ta  
sugges t  t h a t  only a f i n i t e  number of  changes a re  p o s s i b l e .  Through 
s e r o l o g i c a l  comparisons  we were a b le  to  i d e n t i f y  12 d i f f e r e n t  
a n t i g e n i c  v a r i a n t s  among 16 v i r u s  s t r a i n s .  A lso ,  t h e  r e s u l t s  have 
shown t h a t  th e  s e q u e n t i a l  i s o l a t e s  d i f f e r  in t h e i r  s u r f a c e  
g l y c o p r o t e i n s ,  and t h a t  t h e s e  s t r u c t u r a l  changes ,  as well as changes 
in  v i r a l  RNA, were p a r a l l e l e d  by changes in  a n t i g e n i c i t y  as monitored  
by n e u t r a l i z a t i o n ,  c r o s s - n e t u r a l i z a t i o n ,  and immunoreac t iv i ty  p a t t e r n  
u s ing  a panel o f  MCAbs. The da ta  su p p o r t  th e  hypo the s i s  o f  a n t i g e n i c  
v a r i a t i o n  which in v o lv es  f r e q u e n t  p o in t  m uta t ions  in  th e  envelope  
gene,  which encodes th e  v i r i o n  envelope  g l y c o p r o t e i n s .  When 
a l t e r a t i o n s  o f  a n t i g e n i c  de te rm in an ts  o f  t h e se  s u r f a c e  p r o t e i n s  
occu r ,  the  emerging v a r i a n t s  a re  not a f f e c t e d  by immune p re s s u r e s  
e f f e c t i v e  a g a i n s t  p rev ious  v a r i a n t s .  This new v a r i a n t  then 
m u l t i p l i e s  in an u n r e s t r i c t e d  fa sh io n  u n t i l  immune responses  to  the  
novel v a r i a n t  e f f e c t i v e l y  check v i r u s  r e p l i c a t i o n .  As t h i s  cy c le  
r e p e a t s  i t s e l f  a t  f r e q u e n t  i n t e r v a l s ,  i t  r e s u l t s  in  th e  ch ron ic  
( c y c l i c )  form o f  c l i n i c a l  d i s e a s e  most recognized  as EIA. I t  i s  
im por tan t  to  mention here  t h a t  the  15 v i r u s  i s o l a t e s  ob ta ined  from 
plasma taken  a t  d i s t i n c t  f e b r i l e  ep isodes  had been p u r i f i e d  by end 
p o in t  d i l u t i o n  b e fo re  expansion  and p ropaga t ion  to  i s o l a t e  th e  
predominant v i r u s  s t r a i n  (100) .  Thus our  documentation Of ra p id  
e p i to p e  a l t e r a t i o n  in  th e  v i r i o n  s u r f a c e  g l y c o p r o t e in s  among 
s e q u e n t i a l  v i r u s  i s o l a t e s  demonst ra ted  t h a t  each d i s e a s e  ep isode  i s  
a s s o c i a t e d  with  a unique v i r u s  s t r a i n .  Thus a n t i g e n i c  v a r i a t i o n  i s  
an im por tan t  mechanism f o r  th e  p e r s i s t e n c e  and d i s se m in a t io n  o f  EIAV 
and seems to  be a more p e r s u as iv e  mechanism than what has been
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r e p o r t e d  f o r  v isna  v i r u s .  In v i s n a ,  v a r i a n t s  do not r e p l a c e  the  
i n f e c t i n g  se ro ty p e  v ia  a n t ib o d y  s e l e c t i o n  mechanisms and,  in  most 
long- te rm  i n f e c t i o n s ,  t h e  i n i t i a l  i n f e c t i n g  v i r u s  s t r a i n  p e r s i s t s  
w i th o u t  t h e  emergence o f  a n t i g e n i c  v a r i a n t s .  These o b s e r v a t io n s  
argue a g a i n s t  th e  r o l e  o f  a n t i g e n i c  v a r i a t i o n  as an im por tan t  means 
o f  d i s s e m in a t io n  o f  v isna  v i r u s  (86 ,  141).
P e r s i s t e n c e  o f  EIAV may a l s o  in vo lve  o t h e r  mechanisms in  
a d d i t i o n  to  a n t i g e n i c  v a r i a t i o n .  This i s  no t  s u r p r i s i n g  in view of  
th e  complex l i f e  c y c le  o f  r e t r o v i r u s e s .  Being a r e t r o v i r u s ,  EIAV i s  
provided  with an i n d e f i n i t e  s u rv iv a l  mechanism because o f  i t s  a b i l i t y  
t o  i n t e g r a t e  p r o v i r a l  DNA i n t o  h o s t  DNA. T h e r e f o r e ,  a l a t e n t  
i n f e c t i o n  may be e s t a b l i s h e d ,  and no mechanisms e x i s t  f o r  the  immune 
system to  e l i m i n a t e  a l a t e n t  v i r a l  genome. The con t inued  presence  of 
EIAV in the  blood s t ream  may invo lve  predom inan t ly ,  i f  not 
e x c l u s i v e l y ,  i n f e c t e d  monocytes (19 ) .  T h e r e f o r e ,  i t  i s  p o s s i b l e  t h a t  
t h e s e  mobile  c e l l s  conceal th e  v i r u s  genome and convey i t  w i th o u t  
d e t e c t i o n  t o  o t h e r  s i t e s .  This may be accomplished by a r e s t r i c t e d  
le v e l  o f  v i r a l  RNA s y n t h e s i s  in  th e  i n f e c t e d  c e l l s ,  th e re b y  l i m i t i n g  
v i r a l  r e l e a s e .  B i o l o g i c a l l y  s i g n i f i c a n t  m u ta t ions  may a l s o  r e s u l t  
from e r r o r s  o f  r e v e r s e  t r a n s c r i p t i o n  by th e  m is tak e -p ro n e  v i r a l  
t r a n c r i p t a s e  (151) .
Monoclonal a n t i b o d i e s  which r e a c t  w i th  a s i n g l e  a n t i g e n i c  
d e te rm in an t  a re  the  most s p e c i f i c  b i o l o g i c a l  probes a v a i l a b l e  to  
d i s c e r n  th e  b i o l o g i c a l  and s t r u c t u r a l  p r o p e r t i e s  o f  v i r a l  p r o t e i n s .  
T h e i r  use to  d e f in e  e p i to p e s  im por tan t  in  s t i m u l a t i o n  o f  n e u t r a l i z i n g  
an t ibody  and t h e i r  r e l e v an c e  in  c o n s t r u c t i n g  an e f f e c t i v e  vacc ine  f o r  
EIAV a re  i n c o n t r o v e r t i b l e .  Our r e s u l t s  showed t h a t  gp90 possesses
d e te r m in a n t ( s )  very  im p o r tan t  in n e u t r a l i z a t i o n  ( e p i to p e s  90-C, 90-D, 
and 90-E) .  The s t u d i e s  w i th  MCAbs a l s o  sugges t  t h a t  gp90 i s  th e  
major g ly c o p r o t e in  a v a i l a b l e  a t  th e  s u r f a c e  of  the  v i r u s  which a c t s  
as a t a r g e t  f o r  n e u t r a l i z i n g  a n t i b o d i e s .  This may i n d i c a t e  t h a t  
c r i t i c a l  e p i to p e s  im por tan t  f o r  n e u t r a l i z a t i o n  a re  c l u s t e r e d  on gp90. 
On th e  o t h e r  hand, gp45, a hydrophobic transmembrane p r o t e i n ,  may 
p lay  a more im por tan t  s t r u c t u r a l  r o l e .  However, po lyc lona l  s e r a  
which a l s o  n e u t r a l i z e  EIAV i n f e c t i v i t y  co n ta in  a n t ib o d ie s  to  m u l t i p l e  
e p i t o p e s  in c lu d in g  those  found on gp45. These may p lay  a r o l e  in 
p r o t e c t i o n  which i s  y e t  to  be de te rm ined .  Immune f a c t o r s  to  gp45 may 
p a r t i c i p a t e  in " c o o p e ra t iv e  n e u t r a l i z a t i o n "  a s y n e r g i s t i c  phenomena 
which r e s u l t s  when two a n t i b o d i e s  cause a g r e a t e r  l o s s  of  i n f e c t i v i t y  
than th e  sum o f  t h e i r  e f f e c t s  i n d i v i d u a l l y  (33 ) .  A l t e r n a t i v e l y  gp45 
may c a r r y  de te rm in an ts  t h a t  i n t e r a c t  w ith  s p e c i f i c a l l y  s e n s i t i z e d  
c y to to x ic  T c e l l s .
N e u t r a l i z a t i o n  s t u d i e s  i n d i c a t e d  t h a t  the  n a tu re  of  th e  c r i t i c a l  
e p i to p e s  f o r  in d u c t io n  o f  n e u t r a l i z i n g  a n t ib o d ie s  in mice may not be 
a f f e c t e d  by t r e a tm e n t  with  deoxychola te  s in ce  mice immunized with 
d i s s o c i a t e d  v i r u s  produced n e u t r a l i z i n g  a n t i b o d i e s .  The e p i to p e s  of  
gp90 which r e a c t e d  with  n e u t r a l i z i n g  MCAbs (82-1C2, 98-1D1, 115-3D7, 
and 128-2B9) appear  to  be con t inuous  s in c e  they  r e s i s t e d  sodium 
dodecyl s u l f a t e  t r e a t m e n t .  T h e i r  n e u t r a l i z i n g  e f f e c t  was 
demonstra ted  to  be independent  o f  complement so u rce .  A d d i t i o n a l ly  
complement seems to  have no e f f e c t  on th e  n e u t r a l i z a t i o n  c a p a b i l i t y  
of  immune horse  serum. Monoclonal a n t i b o d i e s  t h a t  r e a c t e d  w i th  
conserved e p i to p e s  on gp90 o r  gp45 f a i l e d  to  n e u t r a l i z e  EIAV. On the  
o th e r  hand, our r e s u l t s  showed t h a t  th e  v a r i a b l e  reg ions  o f  gp90
o f t e n  con ta ined  n e u t r a l i z i n g  e p i t o p e s .  Three a n t i g e n i c  s i t e s  
( e p i to p e s  90-C, 90-D, and 90-E) fu n c t io n a l  in  n e u t r a l i z a t i o n  could  be 
t e n t a t i v e l y  i d e n t i f i e d  based on th e  immunoreactiv ity  p a t t e r n  o f  gp90. 
However, da ta  provided from to pograph ica l  mapping showed a t  l e a s t  two 
d i s t i n c t  e p i to p e s  im por tan t  f o r  n e u t r a l i z a t i o n  (Chapter IV). These 
s t u d i e s  provided in fo rm at ion  toward i d e n t i f y i n g  th e  immunoreactive 
p r o t e i n s  o f  EIAV through t h e  use  o f  MCAbs. Analyzing th e  e p i to p e s  on 
v i r a l  p r o t e i n s  r e p r e s e n t s  a very  im por tan t  too l  f o r  i d e n t i f y i n g  
c r i t i c a l  s i t e ( s )  involved  in v i r u s  n e u t r a l i z a t i o n .  However, our 
s tudy  has shown t h a t  e p i to p e s  on gp90 which a re  v a r i a b l e  and h ig h ly  
a n t i g e n i c  may r e p r e s e n t  t y p e - s p e c i f i c  e p i to p e s  t h a t  r e a c t  with 
n e u t r a l i z i n g  MCAbs. In t h i s  s tu d y ,  none o f  the  i s o l a t e s  t e s t e d  were 
n e u t r a l i z e d  by any o f  th e  4 n e u t r a l i z i n g  MCAbs. I t  would be of  
i n t e r e s t  to  check whether  o th e r  MCAbs t h a t  n e u t r a l i z e d  homologous 
v i r u s  could  n e u t r a l i z e  he te ro logous  EIAV i s o l a t e s  in  
c r o s s - n e u t r a l i z a t i o n  t e s t s .  I f  c ro s s  n e u t r a l i z a t i o n  o c c u r s ,  then a 
common de te rm inan t  might be i d e n t i f i e d  and serve  as a b a s i s  f o r  a 
su b u n i t  vacc ine  developments .  This would be an idea l  v a cc in e ,  but 
a l t e r n a t i v e  vacc ines  could  be c o n s t r u c t e d  by i n c o r p o r a t in g  
immunogenic fragments  o f  d i f f e r e n t  e p id e m io lo g ic a l ly  s i g n i f i c a n t  
v a r i a n t s .  Our s t u d i e s  showed some c r o s s - r e a c t i v i t y  o f  i s o l a t e s  from 
d i f f e r e n t  an im a ls ,  su g g es t in g  t h a t  t h e r e  may be a f i n i t e  number o f  
changes .  In a d d i t i o n  th e  f requency and s e v e r i t y  o f  c l i n i c a l  ep isodes  
o f  EIA dec rea se  with t ime in  most i n f e c t e d  horses  and they  o f t e n  
become asymptomatic c a r r i e r s  (60 ) .  This c e s s a t i o n  o f  c l i n i c a l  
i l l n e s s  i s  probably  achieved  by the  a b i l i t y  of  i n f e c t e d  animals  to  
mount immune responses  to  a wide enough d i v e r s i t y  of  EIAV s t r a i n s  to
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f i n a l l y  ach ieve  p r o t e c t i v e  immunity.  In t h i s  case  immune responses  
to  th e  v i r u s  con t in u o u s ly  check v i r u s  r e p l i c a t i o n ,  but th e  v i r u s  i s  
no t  e l im in a te d  from i n f e c t e d  h o r s e s .  Both of  t h e se  o b s e r v a t io n s  
i n d i c a t e  t h a t  th e  p o s s i b i l i t y  o f  th e  e x i s t e n c e  o f  a common a n t i g e n i c  
d e te rm in an t  i s  h ig h ,  and i t s  i d e n t i f i c a t i o n  w i l l  undoubtedly lead  to  
th e  p roduc t ion  o f  a group s p e c i f i c  immunogen. Ex tens ive  evidence 
d o es ,  however, w a r ran t  c a u t i o n  when a l i v e  a t t e n u a t e d  vacc ine  i s  
contempla ted  f o r  EIA. This i s  mainly  because  th e  c a r r i e r  s t a t e  would 
be e s t a b l i s h e d  and the  v i r u l e n c e  would undoubtedly be r e s t o r e d  by 
passage  o f  v i r u s  in pon ies  even a f t e r  a t t e n u a t i o n  from long term 
passage  in  t i s s u e  c u l t u r e  (116, 117).
With t h i s  d i s c u s s io n  in mind, I would l i k e  to  o u t l i n e  the  
requ irem ents  rega rd ing  an EIAV vacc ine  which would have to  be 
f u l f i l l e d  in  o rd e r  f o r  th e  vacc ine  to  be a c c e p ta b l e .  Such a vaccine  
would have to  be n o n i n f e c t i o u s ,  p reven t  p e r s i s t e n t  i n f e c t i o n ,  not 
s t i m u l a t e  an t ibody  which might i n t e r f e r e  with the  s e r o l o g i c a l  t e s t  
commonly used to  d e t e c t  EIAV i n f e c t e d  h o r s e s ,  and c o n fe r  p r o t e c t i o n  
a g a i n s t  a l l  p o s s ib l e  a n t i g e n i c  v a r i a n t s  o f  EIAV. F i n a l l y ,  e f f e c t i v e  
c o n t ro l  o f  EIA r e q u i r e s  t h e  i d e n t i f i c a t i o n  of  c e l l s  and t i s s u e s  in 
th e  h o s t  where the  v i r u s  i s  s eq u e s te r e d  a f t e r  th e  i n i t i a l  immune 
re sponse .  I d e n t i f y i n g  t h e s e  c e l l s  and t i s s u e s  in which th e  v i ru s  
seeks  re fuge  from the  immune defenses  and which p rov ide  th e  v i r u s  
with  a p o t e n t i a l  s an c tu a ry  may help  us to  f u r t h e r  unders tand  the  
pa thogenes is  o f  th e  d i s e a s e  and develop more e f f e c t i v e  procedures  f o r  
i t s  c o n t r o l .
CHAPTER IV
ANTIGENIC MAPPING OF THE ENVELOPE PROTEINS OF EQUINE INFECTIOUS 
ANEMIA VIRUS: IDENTIFICATION OF A NEUTRALIZATION DOMAIN AND A
CONSERVED REGION ON GLYCOPROTEIN 90
IV.A. INTRODUCTION 
Equine i n f e c t i o u s  anemia v i r u s ,  a member o f  th e  fam i ly  
R e t r o v i r i d a e ,  subfamily  L e n t i v i r i n a e ,  causes  a n a t u r a l l y  o c cu r r in g  
d i s e a s e  t h a t  i s  o f  g r e a t  economic importance to  t h e  horse  i n d u s t r y  
(6 0 ) .  The v i r u s  c o n ta i n s  two s u r f a c e  g ly c o p r o t e in s  (gp90 and gp45) 
and fo u r  major nong lycosy la ted  i n t e r n a l  p r o t e i n s  r e f e r r e d  to  as p26, 
p l 5 ,  p l l ,  and p9 (100, 120).
A nt igen ic  v a r i a t i o n  occurs  in  EIAV and i s  thought  to  invo lve  
f r e q u e n t  p o in t  m uta t ions  o f  t h e  env gene,  which codes f o r  v i r a l  
s u r f a c e  p r o t e i n s  (61 ,  104).  Genetic  and a n t i g e n i c  v a r i a n t s  o f  EIAV 
have been p r e v io u s ly  demonstra ted  by o l i g o n u c l e o t i d e  and p e p t id e  
mapping and most r e c e n t l y  by monoclonal an t ibody  a n a l y s i s  (54 ,  102, 
121, 122, 129).  The a l t e r a t i o n s ,  which seem to  be conf ined  to  th e  
envelope g l y c o p r o t e i n s ,  may be o f  g r e a t  importance f o r  the  b io logy  
and p a t h o g e n i c i t y  o f  EIAV and may a llow th e  emerging v a r i a n t  to  
escape  from n e u t r a l i z a t i o n  by p r e e x i s t i n g  a n t ib o d y .  Data from 
c h r o n i c a l l y  i n f e c t e d  horses  sugges t  t h a t  p roduc t ion  of  b road ly  
r e a c t i v e  immune responses  to  EIAV might e v e n tu a l ly  o c cu r ,  which could  
r e s u l t  in e f f e c t i v e  g r o u p - s p e c i f i c  immunity. We p r e v io u s ly  d e sc r ib e d  
a panel o f  MCAbs reco g n iz in g  conserved and non-conserved e p i to p e s  on 
both gp90 and gp45 o f  EIAV. S i t e s  t h a t  a re  both prone to  v a r i a t i o n  
and h ig h ly  a n t i g e n i c  may r e p r e s e n t  t y p e - s p e c i f i c  e p i to p e s  o f  gp90 
t h a t  r e a c t  with n e u t r a l i z i n g  MCAbs (54) .  In the  p r e s e n t  r e p o r t ,
m
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s e l e c t e d  MCAbs were used to  map e p i to p e s  o f  EIAV g l y c o p r o t e i n s .  The 
procedures  employed demonst ra ted  th e  p resence  o f  two d i s t i n c t  
e p i to p e s  on gp90 t h a t  a re  impor tan t  in n e u t r a l i z a t i o n .  These e p i to p e s  
may be o f  major  importance f o r  the  p r e p a r a t i o n  o f  a s y n t h e t i c  vacc ine  
f o r  EIA s in ce  c o m p e t i t iv e  ELISA demonstra ted  the  p resence  o f  a common 
n e u t r a l i z a t i o n  domain on gp90. T h e r e f o r e ,  t h i s  p a r t i c u l a r  domain may 
be o f  some b i o l o g i c a l  s i g n i f i c a n c e  in  the  in d u c t io n  o f  p r o t e c t i v e  
immunity.  In a d d i t i o n ,  f r agm en ta t ion  s t u d i e s  o f  gp90 rev ea led  an 
immunoreactive f r ag m en t ( s )  of  12K which c a r r i e s  an e p i to p e  shared by 
v a r io u s  s e r o l o g i c a l l y  d i s t i n c t  EIAV i s o l a t e s .
IV.B. MATERIALS AND METHODS
I V .B . l .  Viruses
The p ro to ty p e  EIAV used in  t h i s  s tudy  was o b ta in ed  by 
p ropaga t ion  in f e t a l  equine  kidney (FEK) c e l l s  o f  th e  c e l l - a d a p t e d  
Wyoming s t r a i n  o f  EIAV (8 8 ) .  All v i r u s  i s o l a t e s  were produced by 
s e r i a l  passage o f  the  p ro to ty p e  s t r a i n  o f  EIAV in She t land  ponies  as 
d e sc r ib e d  p r e v io u s ly  (54 ,  116, 117, 122, 129).  The p ro to ty p e  s t r a i n  
and v i r u s  i s o l a t e s  were propagated  in FEK c e l l s  and were p u r i f i e d  as 
d e sc r ib e d  in  d e t a i l  p r e v io u s ly  (100) .
IV .B .2.  G lycopro te in  p u r i f i c a t i o n
Procedures  f o r  EIAV g ly c o p ro te in  p u r i f i c a t i o n  by l e c t i n  a f f i n i t y  
chromatography have been d e sc r ib e d  in  d e t a i l  p r e v io u s ly  (101) .
IV .B.3.  P roduct ion  of  monoclonal a n t ib o d ie s
The p roduc t ion  and c h a r a c t e r i z a t i o n  o f  th e  murine MCAbs to  EIAV 
g ly c o p r o t e in s  used in  t h i s  s tudy  has been p r e v io u s ly  d e sc r ib e d  (54,  
Chapter II  and I I I ) .  B r i e f l y ,  10 MCAbs were s p e c i f i c  to  gp90 and 8 
t o  gp45 o f  EIAV. Four o f  t h e se  MCAbs to  gp90 n e u t r a l i z e d  i n f e c t i v i t y
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of  p ro to ty p e  EIAV, and 6 p o t e n t i a l  e p i to p e s  o f  gp90 and 2 f o r  gp45 
were sugges ted  on th e  b a s i s  o f  immunoreac t iv i ty  w i th  a b a t t e r y  of 
EIAV s t r a i n s  (F ig .  IV .1).
IV.B.4 .  SDS-PAGE and Western b l o t  a ssay
Procedures  f o r  the  a n a l y s i s  o f  EIAV p r o t e i n s  by SDS-PAGE and 
Western b l o t  with e i t h e r  MCAbs or  r e f e r e n c e  E IA -p o s i t iv e  horse  serum 
have been d e sc r ib e d  (54,  100, 129, Chapter I I  and I I I ) .
IV .B .5. Genera tion  and d e t e c t i o n  o f  gp90 fragments
Fragments of  gp90 were g enera ted  by l i m i t e d  d i g e s t i o n  o f  e i t h e r  
i n t a c t  EIAV (150 yg) o r  l e n t i l - l e c t i n  p u r i f i e d  g ly c o p r o t e in  f r a c t i o n s
o f  EIAV (25 yg) with  10 yg papain  (Sigma Chemical Co. S t .  L ou is ,  M0)
in PBS f o r  2 h a t  37°C ( t o t a l  volume 50 y l ) .  The r e a c t i o n  was
te rm in a te d  by th e  a d d i t i o n  of 40 yl 0.01 M phosphate  b u f f e r ,  pH 7 . 2 ,  
10 yl 10% SDS, 1 yl 2-mercaptoethanol and b o i l i n g  f o r  3 min.
P r o t e o l y t i c  fragments  were then s ep a ra te d  on SDS-PAGE, t r a n s f e r r e d  to  
n i t r o c e l l u l o s e  membranes, and immunoblotted with  e i t h e r  MCAbs or  
r e f e r e n c e  E IA -p o s i t iv e  horse  serum to  i d e n t i f y  t h e  immunoreactive 
f ragm ents .  Western b l o t s  were modif ied  when us ing  MCAbs to  in c lu d e
t h e  a d d i t i o n  of goa t  an t i -mouse  immunoglobulin G (IgG) p r i o r  to  the
1 PRa d d i t i o n  o f  I - l a b e l e d  p r o t e i n  A (1 3 ) .  The immunoreactive fragments  
were i d e n t i f i e d  by au to rad io g rap h y  us ing  Kodak X-Omat f i lm  (XRP-5). 
G lycosy la ted  p e p t id e  fragments  were s t a i n e d  u s ing  concanava l in  A and 
pe rox idase  as  d e sc r ib e d  by Clegg (21) .
IV.B.6.  Enzyme-linked immunosorbent a ssay  -  a d d i t i v i t y  t e s t
P u r i f i e d  EIAV v i r i o n s  were d i s r u p t e d  with  0.5% deoxycho la te  in 
T r i s - s a l i n e  b u f f e r  (0 .02  M/0.1 M), d i l u t e d  in  TEN b u f f e r  ( T r i s  [0 .05  
M], EDTA [0 .001 M], NaCl [0 .15  M]), d ispensed  a t  300 n g /w e l l ,  and
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pro to type
P 3 .1 - 1
P 3 . 2 - 3 P 3 . 2 - 2
P 3 . 3 - 2
P 3 . 3 - 1
P 3 . 2 - 1
P 3 . 3 - 4P 3 . 2 - 4
P 3 . 2 - 5
P 3 . 1 - 3
FIGURE IV .1. O pera t iona l  a n t i g e n i c  map of  16 EIAV i s o l a t e s .
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a llowed to  adsorb  to  a f l a t  bottom Immulon 1 m i c r o t i t e r  p l a t e  
(Dynatech, Tor rance ,  CA) f o r  16 to  20 h a t  37°C in c u b a t io n .  The 
a n t ig e n  was f ix e d  f o r  5 min with  paraformaldehyde (4% W/V, pH 7 .2 )  
and blocked with  5% BSA f o r  2 h a t  room te m p era tu re .  Epitope 
s p e c i f i c i t y  was analyzed  us ing  c o n c e n t r a t i o n s  of  a n t ig e n  and a s c i t i c  
f l u i d s  shown to  produce 50% s a t u r a t i o n  under  th e  r e a c t i o n  c o n d i t io n s  
employed (see  R e s u l t s ) .  A f t e r  3 washings with  TEN b u f f e r ,  50 yl o f  
th e  B - D - g a la c to s id a se - l a b e le d  goa t  an ti -mouse  immunoglobulin 
(Southern  Biotechnology A s s o c i a t e s ,  Birmingham, AL) were added to  
each well  a t  a d i l u t i o n  o f  1 :250, and incubated  f o r  1 h a t  room 
te m p e ra tu re .  A f te r  3 f u r t h e r  washings ,  100 yl of  assay  b u f f e r  
c o n ta in in g  0.1% 0 - n i t r o p h e n y l - $ - D - g a l a c t o s i d e  (0NPG, Sigma Chemical 
Co . ,  S t .  Lou is ,  M0), 10 mM T r i s  b a se ,  io mM sodium c h l o r i d e ,  10 mM 
magnesium c h l o r i d e ,  and 10 mM 2 -m e rc a p to e th a n o l , pH 7 . 5 ,  were added 
to  each w e l l .  A f t e r  i n c u b a t io n  f o r  30 min a t  room te m p e ra tu re ,  50 yl 
o f  1.43 M sodium carb o n a te  were added to  each well to  s top  the  
enzymatic  r e a c t i o n .  Absorpt ion  a t  415 nm was recorded  us ing an 
automated ELISA p l a t e  r e a d e r  (Dynatech).  A b r i g h t  ye l low re a c t io n  
p roduc t  formed in  w e l l s  r e t a i n i n g  enzyme. Each d i l u t i o n  o f  MCAb was 
run in  t r i p l i c a t e  and each exper im ent was r ep ea ted  a t  l e a s t  tw ice .
The r e s u l t s  of  the  a d d i t i v e  ELISA were expressed  q u a n t i t a t i v e l y  
as an " a d d i t i v i t y  index" (A I) .  The AI has been de f ined  (40) f o r  a 
p a i r  o f  a n t i b o d ie s  a s :
AI = 100 ( [ (2A 1+2) / ( A 1 + A2) ]  -  1 ) ,  where A p  A2 and A^+2 
r e p r e s e n t  th e  o p t i c a l  d e n s i t i e s  ob ta ined  with  the  f i r s t  an t ibody  
a lo n e ,  the  second an t ibody  a lo n e ,  and the  two a n t ib o d ie s  t o g e t h e r ,  
r e s p e c t i v e l y .  An AI o f  0-50% was cons ide red  not a d d i t i v e ,  while  an
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AI o f  £50% was c o n s id e red  a d d i t i v e .
IV .B .7.  Competit ion b ind ing  s t u d i e s
These s t u d i e s  compared the  a b i l i t y  o f  un labe led  po lyc lona l  horse  
s e r a  to  compete with  n e u t r a l i z i n g  MCAbs in  b ind ing  to  EIAV 
de te rm in an ts  as measured by ELISA. Densi ty  g r a d i e n t - p u r i f i e d  v i r i o n s  
were d i s r u p t e d  with  0.5% deoxychola te  in T r i s - s a l i n e  b u f f e r  and 
m ain ta ined  a t  200 yg/ml c o n c e n t r a t i o n .  This v i r u s  p re p a r a t io n  was 
d i l u t e d  in  TEN b u f f e r  t o  a c o n c e n t r a t i o n  o f  10 yg p r o t e i n / m l ,  
d ispensed  a t  0 .5  y g / w e l l ,  and incuba ted  f o r  16-20 h a t  37°C in  
96-well  Immulon 1 m i c r o t i t e r  p l a t e s .  The a n t ig e n  was f i x e d  as 
d e sc r ib e d  f o r  th e  a d d i t i v e  ELISA and p l a t e s  were blocked with 3% BSA 
f o r  2 h a t  room t e m p e ra tu re .  P l a t e s  were washed 3 t imes  with  
TEN/0.05% Tween 20 b u f f e r  p r i o r  to  use .  S e r i a l  tw o-fo ld  d i l u t i o n s  o f  
un labe led  po lyc lona l  s e r a  ( r e f e r e n c e  E IA -pos i t ive  horse  serum) were 
performed us ing  TEN b u f f e r  as a d i l u e n t  and adding 50 yl to  each 
w e l l .  In a d d i t i o n ,  EIA-negat ive  horse  s e r a  as well as s e r a  c o l l e c t e d  
e a r l y  (35 days p o s t - i n f e c t i o n )  and l a t e  (203 days p o s t - i n f e c t i o n )  in  
th e  course  o f  an exper imenta l  i n f e c t i o n  o f  a pony (#F135) with  EIAV 
were inc luded  in  th e  t e s t  (Rwambo e t  a l . ,  s u b m i t t e d ) .  A f t e r  a 30 min 
in cu b a t io n  a t  room te m p e ra tu re ,  50 yl o f  MCAb d i l u t e d  in TEN b u f f e r  
was added. The mix ture  o f  po lyc lona l  s e r a  and MCAb was incubated  f o r  
1 h a t  room te m p e ra tu re .  The p l a t e  was washed as b e f o r e ,  and then 
p e r o x id a s e - l a b e l e d  goa t  an t i -mouse  immunoglobulins (Kirkegaard  and 
Perry  L a b o ra to r i e s  I n c . ,  G a i th e r sb u r g ,  MD) was added (50 yl per w e l l )  
a t  a 1:500 d i l u t i o n  in  TEN and incubated  f o r  1 h a t  room temp. The 
p l a t e s  were washed as b e fo re  and developed using the  s u b s t r a t e  ABTS
I
(2 ,  2 - a z i n o - b i s ( 3 - e t h y l b e n z - t h i a z o l i n e - 6 - s u l f o n i c  a c i d ) ,  diammonium
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s a l t  (Sigma).  The r e a c t i o n  was a llowed to  develop f o r  20 min a t  room 
t e m p e r a t u r e ,  and th e  o p t i c a l  d e n s i t y  (O.D.) a t  490 nm was recorded 
wi th  a spec t ropho tom ete r  (Dynatech L a b o r a t o r i e s ) .  Blank w e l l s  
(EIAV-coated w e l l s  exposed to  a l l  r e a g en t s  ex cep t  MCAb) were inc luded  
in  each row o f  the  p l a t e .  Viral  an t ig e n  and MCAbs were p r e t e s t e d  and 
d i l u t e d  to  g ive  an approximate  o p t i c a l  d e n s i t y  o f  0 . 2 - 1 . 0  u n i t s  in 
th e  absence o f  c o m p e t i t io n .
IV.C. RESULTS
I V .C . l .  Epitope mapping
Monoclonal a n t i b o d i e s  s p e c i f i c  f o r  gp90 and gp45 were used in  an 
a d d i t i v e  ELISA t o  de termine  t h e i r  e p i to p e  s p e c i f i c i t i e s .  The t e s t  was 
based on an e s t i m a t i o n  o f  th e  number o f  e p i to p e s  s im u l taneous ly
a v a i l a b l e  t o  a p a i r  of  a n t i b o d i e s  on th e  a n t i g e n .  A key requirement
f o r  t h i s  t e s t  i s  t h a t  th e  an t ig en  coa ted  on w e l l s  o f  the  ELISA p l a t e  
be s a t u r a t e d  with each in d iv id u a l  an t ibody  to  be t e s t e d  a lo n e .  The 
d i l u t i o n  o f  an t ibody  which p rov ides  s a t u r a t i o n  would then be used in 
combinations  with o t h e r  a n t i b o d i e s  to  de termine  th e  r e s u l t s  o f  
s im ul taneous  b inding  of  t h e  a n t i b o d i e s  in t h e  p resence  o f  each o t h e r .  
T h e r e f o r e ,  t i t r a t i o n s  o f  MCAbs were performed to  dete rmine  s a t u r a t i o n  
curves  o f  the  EIAV a n t ig e n  by th e  B -D -ga lac to s idase  ELISA. The 
c o n c e n t r a t i o n  of  EIAV a n t ig e n  and each MCAb were s t a n d a rd iz e d  so t h a t  
th e  o p t i c a l  d e n s i t y  o f  th e  c o l o r i m e t r i c  r e a c t i o n  was approx imate ly  
one h a l f  the  p o s s i b l e  maximum.
The r e s u l t s  o b ta in ed  with  f o u r  n e u t r a l i z i n g  MCAbs t e s t e d
i n d i c a t e d  t h a t  d i l u t i o n s  o f  1 :256,  1 :128 , 1 :256,  and 1:64 o f  MCAbs
82-1C2, 98-1D1, 115-3D7, and 128-2B9, r e s p e c t i v e l y  s a t u r a t e d  the  
e p i to p e s  which each o f  t h e s e  i n d iv id u a l  MCAbs bound s e p a r a t e l y  (F ig .
I l l
IV .2 ) .  The a d d i t i v i t y  ELISA f o r  the  p a i r s  82-1C2 and 128-2B9, 98-1D1 
and 128-2B9, o r  115-3D7 and 128-2B9 gave AIs o f  84%, 72%, and 76%, 
r e s p e c t i v e l y  (Table I V . I ) .  In each c a s e ,  t h e se  s p e c i f i e d  p a i r s  of  
MCAbs appeared to  s im u l ta n eo u s ly  bind gp90 , i . e . ,  they  r e a c te d  with 
d i s t i n c t ,  non-ove r lapp ing  e p i to p e s  o f  gp90. In c o n t r a s t ,  th e  o p t i c a l  
d e n s i t y  recorded  f o r  82-1C2 and 98-1D1, 82-1C2 and 115-3D7, o r  98-1D1 
and 115-3D7 was n e a r ly  equal  to  t h a t  reached f o r  each MCAb s e p a r a t e l y  
(AI va lues  o f  11%, 9%, and 15%, r e s p e c t i v e l y ) .  This  su g g es t s  t h a t  in 
each c a s e ,  th e  two MCAbs competed f o r  th e  same o r  o ve r lapp ing  
a n t i g e n i c  s i t e s  o f  gp90.
Using the  a d d i t i v i t y  t e s t  and index we extended our  comparison 
o f  th e  e p i to p e  b ind ing  s p e c i f i c i t i e s  o f  n o n - n e u t r a l i z i n g  MCAbs 
s p e c i f i c  f o r  gp90. An AI o f  53% was observed with  MCAbs 86-1E3 and 
128-2B9, whi le  no AI va lue  i n d i c a t i v e  o f  a d d i t i v i t y  was seen with  a l l  
o th e r  MCAbs p a i r s  t e s t e d  (Table IV .2 ) .  This su g g es t s  t h a t  th e
b ind ing  o f  MCAbs 86-1E3 ( e p i to p e  90-A) and 128-2B9 ( e p i to p e  90-E) was 
a d d i t i v e ,  and th us  d i s t i n c t  e p i to p e s  were recogn ized .  All o t h e r  
p a i r s  o f  n o n - n e u t r a l i z i n g  a n t i -g p 9 0  MCAbs were no t  a d d i t i v e ,  
s u g g es t in g  th e  r e c o g n i t i o n  o f  s i m i l a r ,  c o n t ig u o u s ,  o r  o v e r lapp ing  
reg io n s  on gp90. S i m i l a r l y ,  r e s u l t s  ob ta ined  with  e i g h t  MCAbs 
s p e c i f i c  f o r  gp45 c l e a r l y  showed t h a t  th e  b inding  o f  MCAb 90-1C1 and
each o f  th e  o t h e r  seven MCAbs: 75-1F2, 92-1E6, 101-2F10, 109-1A6,
117-1C5, 120-1H9, and 105-3C8 was a d d i t i v e  (AI va lues  o f  63%, 68%, 
70%, 60%, 63%, 58%, and 84%, r e s p e c t i v e l y )  (Table IV .3 ) .  These 
r e s u l t s  sugges ted  t h a t  on ly  MCAb 90-1C1 was recogn iz ing  an e p i to p e  on 
gp45 d i s t i n c t  from t h a t  one bound by th e  o t h e r  seven.  In c o n t r a s t ,  
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FIGURE IV .2.  S a t u r a t i o n  curves  o f  th e  coa ted  EIAV a n t ig e n  with  
n e u t r a l i z i n g  monoclonal a n t i b o d i e s :  82-1C2, 115-3D7, 98-1D1 and 
128-2B9.
Table IV .1. A dd i t ive  enzyme-linked immunosorbent assay .
Monoclonal an t ibod ie s^ - Opt ica l  d e n s i t y  
a t  415 nm
2
Expected va lue  
i f  a d d i t i v e
A d d i t i v i t y  
index (%)
82-1C2 + 98-101 0.60 1.08 11
82-1C2 + 115-3D7 0.48 0.88 9
82-1C2 + 128-2B9 0.60 0.65 84
98-1D1 + 115-3D7 0.59 1.02 15
98-1D1 + 128-2B9 0.68 0.79 72
115-307 + 128-2B9 0.52 0.59 76
Each monoclonal an t ibody  was t e s t e d  s e p a r a t e l y  and an o p t i c a l  d e n s i t y  o f  0 .4 7 ,  0 .6 1 ,  0 .4 1 ,  and 0 .18  was 
ob ta ined  a t  s a t u r a t i n g  d i l u t i o n  f o r  MCAb 82-1C2 (1:256 d i l u t i o n ) ,  98-1D1 (1:128 d i l u t i o n ) ,  115-3D7 
(1:256 d i l u t i o n ) ,  and 128-2B9 (1 :64  d i l u t i o n )  r e s p e c t i v e l y .
2
Expected va lue  i s  the  sum o f  th e  o p t i c a l  d e n s i t i e s  ob ta ined  f o r  each a s c i t i c  f l u i d  a lo n e .
Table IV.2. A d d i t iv i ty  index of gp90 s p e c i f i c  monoclonal an t ibodies
Monoclonal
a n t ib o d ie s 86-1E3 87-1E7 82-1C2 115-3D7 128-2B9 85-1E11
86-1E3 ------ 16 9 12 53 13
87-1E7 16 ------ 11 5 9 14
82-1C2 9 11 ------ 9 84 15
115-3D7 12 5 9 ------ 76 17
128-2B9 53 9 84 76 ------ 14
85-1E11 13 14 15 17 14 ------
A d d i t i v i t y  index i s  shown in  %
Table IV.3. A d d i t iv i ty  index of gp45 s p e c i f i c  monoclonal an t ibodies
Monoclonal
a n t ib o d ie s 75-1F2 92-1E6 101-2F10 109-1A6 117-1C5 120-1H9 105-3C8 90-1C1
75-1F2 ------ 15 7 14 20 29 22 63
92-1E6 15 ------ 7 16 23 7 13 68
101-2F10 7 7 ------ 11 14 16 9 70
109-1A6 14 16 11 ------ 9 12 16 60
117-1C5 20 23 14 9 ------ 11 18 63
120-1H9 29 7 16 12 11 ------ 17 58
105-3C8 22 13 9 16 18 17 ------ 84
90-1C1 63 68 70 60 63 58 84 ------
A d d i t i v i t y  index i s  shown in  %.
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a d d i t i v e ,  su gges t ing  t h a t  in each case  th e  two MCAbs competed f o r  the  
same or  over lapp ing  a n t i g e n i c  s i t e  o f  gp45.
IV .C .2. Competi t ive  ELISA
Four n e u t r a l i z i n g  MCAbs, s p e c i f i c  to  gp90, were s tu d i e d  by 
c o m p e t i t iv e  ELISA to  see  whether  e p i to p e s  recognized  by murine MCAbs 
were th e  same o r  d i f f e r e n t  from those  recognized  by po lyc lona l  se ra  
from EIAV-infected h o r s e s .  The r e s u l t s  o f  t h e  fo u r  n e u t r a l i z i n g  
MCAbs a re  p re sen ted  in  F ig .  IV .3 ,  and th e  summary o f  a l l  a ssays  i s  
p re sen ted  in Table IV .4 . .  Polyc lona l  s e ra  c o l l e c t e d  l a t e  in  the  
i n f e c t i o n  as well as r e f e r e n c e  E IA -p o s i t iv e  horse  serum (both  with 
n e u t r a l i z a t i o n  a c t i v i t y )  were found to  compete e f f e c t i v e l y  with  a l l  
f o u r  n e u t r a l i z i n g  MCAbs. This com pet i t ion  can be i n t e r p r e t e d  t o  
i n d i c a t e  e i t h e r  s i m i l a r  e p i t o p e ( s )  r e c o g n i t i o n  o r  t h a t  t h e se  e p i to p e s  
have c lo se  s p a t i a l  r e l a t i o n s h i p s  and c o n s t i t u t e  a s i n g l e  l a r g e  
n e u t r a l i z a t i o n  domain on gp90 of  EIAV. Serum c o l l e c t e d  e a r l y  in the  
i n f e c t i o n ,  i . e . ,  35 days a f t e r  i n f e c t i o n ,  was unable  to  n e u t r a l i z e  
EIAV and f a i l e d  to  cause a s i g n i f i c a n t  i n h i b i t i o n  of  b inding  o f  any 
of  the  fo u r  MCAbs. The e a r l y  serum, however,  was r e a c t i v e  with EIAV 
g ly c o p r o t e in s  gp90 and gp45 in both ELISA and Western b l o t  (F ig .  
IV .4 ) .  A 1:256 d i l u t i o n  of  the  r e f e r e n c e  E IA -pos i t ive  horse  serum, 
on th e  o th e r  hand, n e u t r a l i z e d  100 TCID^q o f  EIAV in a m i c r o t i t e r  
a ssay .  Normal horse  serum, n e g a t iv e  f o r  EIA as t e s t e d  by ELISA, 
Western b l o t ,  agar  gel immunodif fusion,  and n e u t r a l i z a t i o n  t e s t s ,  
f a i l e d  to  i n h i b i t  b ind ing  o f  any o f  th e  MCAbs to  v i r u s  
g l y c o p r o t e i n s .
IV.C .3. Analys is  o f  qp90 fragments
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FIGURE IV .3.  Compet i t ive  i n h i b i t i o n  o f  n e u t r a l i z i n g  MCAbs 82-1C2, 
98-1D1, 115-3D7, and 128-2B9 b ind ing  to  EIAV g ly c o p ro te in  in  s o l i d  
phase-ELISA. S e r i a l  tw o - fo ld  d i l u t i o n s  o f  po lyc lona l  s e ra  ( r e f e r e n c e  
E IA -p o s i t iv e  horse  serum) were t e s t e d  f o r  t h e i r  a b i l i t y  t o  i n h i b i t  th e  
b ind ing  o f  n e u t r a l i z i n g  MCAbs as d e sc r ib e d  in  th e  t e x t .  Symbols: ( □ )  
82-1C2, ( O )  98-1D1, ( 0 )  115-3D7, ( A )  128-2B9. Each d a ta  p o in t  
r e p r e s e n t s  t h e  mean o f  two r e p l i c a t e  assay  d e te r m in a t io n s .
TABLE IV.4.  Summary o f  c o m p e t i t iv e  ELISA
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N e u t r a l i z i n g  monoclonal a n t ib o d ie s  
Clone number
EIA -p o s i t iv e  horse  se ra  
Natura l  Experimental  





^Reference: E IA -p o s i t iv e  serum from a horse  n a t u r a l l y  i n f e c t e d  with
EIAV. Exper imenta l :  serum c o l l e c t e d  35 days ( e a r l y )  and 203 days ( l a t e )  
p o s t - i n f e c t i o n  from a pony e x p e r im en ta l ly  i n f e c t e d  with  EIAV. + 





FIGURE IV .4.  Western b l o t  a n a l y s i s  o f  EIAV. P r o t e i n s  o f  d e n s i t y - g r a d i e n t  
p u r i f i e d  EIAV were s e p a ra te d  by SDS-PAGE, t r a n s f e r r e d  t o  n i t r o c e l l u l o s e  
membrane, and immunoblotted with both n a tu r a l  and exper im enta l  
E IA -pos i t ive  horse  s e r a .  Lane 1 and 2 ,  serum c o l l e c t e d  35 days ( e a r l y )  
and 203 days ( l a t e )  p o s t - i n f e c t i o n  from a pony e x p e r im e n ta l ly  i n f e c t e d  
with  EIAV. Lane 3 ,  E IA -p o s i t iv e  serum from a n a t u r a l l y  i n f e c t e d  horse  
used as a r e f e r e n c e .
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well  as whole v i r u s  were t e s t e d  with r e f e r e n c e  E IA -pos i t ive  horse  
serum and with  both n e u t r a l i z i n g  and n o n - n e u t r a l i z i n g  MCAbs a g a i n s t  
gp90 to  i d e n t i f y  immunoreactive f r a g m e n t ( s ) .  All n e u t r a l i z i n g  MCAbs 
(82-1C2, 98-1D1, 115-3D7 and 128-2B9) and MCAb 86-1E3 showed
r e a c t i v i t y  with  two fragments  o f  12K and 20K. Papain d i g e s t i o n  f o r  
more than 2 h removed i n t a c t  gp90 from whole v i r u s  and genera ted  
immunoreactive p e p t i d e ( s )  (F ig .  IV .5 ) .  The s i z e  o f  th e  r e a c t i v e  
f r agm en t(s )  was no t  f u r t h e r  reduced with  o v e rn ig h t  d i g e s t i o n .  
Western b l o t s  o f  i d e n t i c a l  d i g e s t s  with th e  r e f e r e n c e  EIA -pos i t ive  
horse  serum a l s o  i n d i c a t e d  r e a c t i v i t y  with 12K as well  as a 20K 
fragments  (da ta  not shown). The 20K fragment  appeared to  be an 
in te r m e d ia t e  c leavage  product t h a t  was a l s o  e v id e n t  in  Western b l o t s  
w i th  MCAbs. G lycopro te in  s t a i n i n g  o f  t h e se  b l o t s  i n d i c a t e d  t h a t  the  
l a r g e r  fragment (20K) was c l e a r l y  g ly c o sy la te d  whi le  the  s m a l l e r  one 
(12K) was n o t .
The p ro to ty p e  EIAV and a panel o f  s e r o l o g i c a l l y  d i s t i n c t  
i s o l a t e s  (P 3 .2 -1 ,  P 3 .2 -2 ,  P 3 .2 -3 ,  P 3 .2 -4 ,  and P3.2 -5)  ob ta ined  from 
co n secu t iv e  f e b r i l e  ep isodes  o f  e x p e r im e n ta l ly  i n o c u la te d  ponies  
(54 ,  116, 117, 129) were d ig e s t e d  with papain  and immunoblotted with 
MCAbs to  i d e n t i f y  common immunoreactive f ragm ents .  The 
n o n - n e u t r a l i z i n g  MCAb 86-1E3 re a c te d  with gp90 o f  a l l  EIAV i s o l a t e s  
t e s t e d  in  the  und iges ted  c o n t r o l s  (F ig .  IV .5,  panel B).  However, the  
e p i to p e  recognized  by t h i s  MCAb was p r e s e n t  on the  12K fragment 
g en e ra ted  from the  same v i r u s  i s o l a t e s  (F ig .  IV .5,  panel A).
IV.D. DISCUSSION
Ant igen ic  v a r i a t i o n  i s  a prominant f e a t u r e  o f  EIAV and has been 










FIGURE IV .5. Western b l o t  a n a l y s i s  o f  gp90 fragments  o f  s ev e ra l  
s e r o l o g i c a l l y  d i s t i n c t  i s o l a t e s  o f  EIAV ob ta ined  from c o n secu t iv e  
f e b r i l e  e p i s o d e s .  Fragments o f  gp90 o f  th e se  v i r u s e s  were gene ra ted  by 
papain  d i g e s t i o n ,  s e p a r a t e d  by SDS-PAGE, t r a n s f e r r e d  to  n i t r o c e l l u l o s e  
membrane and immunoblotted with  MCAb 86-1E3. Western b l o t s  o f  papain 
t r e a t e d  (panel  A) and u n t r e a t e d  (panel B) p ro to type  EIAV ( 1 ) ,  a n t i g e n i c  
v a r i a n t s  P3.2-1  ( 2 ) ,  P3 .2-2  ( 3 ) ,  P3 .2-3  ( 4 ) ,  P3.2 -4  ( 5 ) ,  and P3.2-5  (6 ) .
more e p i to p e s  of  the  s u r f a c e  g ly c o p r o t e in s  have been observed among 
s e q u e n t i a l  i s o l a t e s  o f  EIAV during  p e r s i s t e n t  i n f e c t i o n  (54) .  In the  
p r e s e n t  s tu d y ,  we d i s s e c t e d  th e  a n t i g e n i c  s i t e s  o f  the  s u r f a c e  
g ly c o p ro te in s  o f  p ro to ty p e  EIAV. By our methods,  i t  was p o s s i b l e  to  
compare the  e p i to p e  s p e c i f i c i t i e s  o f  ten  MCAbs a g a i n s t  gp90 and e i g h t  
MCAbs a g a i n s t  gp45 o f  EIAV produced by independent c lo n e s .  These 
an a ly se s  r e s u l t e d  in the  i d e n t i f i c a t i o n  o f  6 a n t i g e n i c  e p i t o p e s ,  4 on 
th e  e x t e r i o r  g ly c o p ro te in  (gp90) and 2 on th e  transmembrane p r o t e in  
(gp45) .  The combined r e s u l t s  were th e  b a s i s  f o r  the  c o n s t r u c t i o n  of  
a proposed model f o r  th e  r e l a t i o n s h i p s  and d i s t r i b u t i o n s  o f  e p i to p e s  
on g ly c o p r o t e in s  of  EIAV. According to  th e  p r e d i c t e d  topograph ica l  
model,  e p i to p e s  on gp90 were found to  c l u s t e r  in a t  l e a s t  fou r  
a n t i g e n i c  s i t e s  (F ig .  IV .6 ) .  Three n e u t r a l i z i n g  MCAbs (82-1C2,
98-1D1, and 115-3D7) r e a c t e d  with a s i n g l e  topograph ic  s i t e  termed 
C/D. A second s i t e  (E) which appeared to  be d i s t i n c t  from s i t e  C/D 
was c h a r a c t e r i z e d  by one n e u t r a l i z i n g  MCAb 128-2B9. A t h i r d  s i t e  (A) 
was c h a r a c t e r i z e d  by t h r e e  n o n - n e u t r a l i z i n g  MCAbs (86-1E3, 95-1G8, 
and 114-3A7) t h a t  were a d d i t i v e  with  n e u t r a l i z i n g  MCAb 128-2B9 ( s i t e  
E).  S i t e  A appeared to  be c lo s e  to  s i t e  C/D bu t  d i s t i n c t  from s i t e  
E. The f o u r th  s i t e  B/F was c h a r a c t e r i z e d  by t h r e e  n o n - n e u t r a l i z i n g  
MCAbs (87-1E7, 71-1A9, and 85-1E11) t h a t  were not a d d i t i v e  with a l l  
o t h e r  MCAbs t e s t e d .  These o b s e r v a t io n s  may sugges t  a h igh ly  
ove r lapp ing  b ind ing  s i t e .
Analysis  o f  g p 4 5 - s p e c i f i c  MCAbs showed t h a t  7 ou t  o f  8 MCAbs 
recognized  e i t h e r  the  same, a c o n t ig u o u s ,  o r  an o ve r lapp ing  e p i to p e .  
I n t e r e s t i n g l y ,  p rev ious  s t u d i e s  i n d i c a t e d  t h a t  a l l  seven MCAbs have 
s i m i l a r  s e r o l o g i c a l  s p e c i f i c i t y  (5 4 ) ,  and t h e r e f o r e  i t  i s  p o s s ib l e
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FIGURE IV .6. Schematic model o f  th e  proposed to p o lo g ic a l  a rrangement of  
th e  e p i to p e s  on gp90 o f  EIAV. Hatched a r e a s  i n d i c a t e  o v e r l a p .
t h a t  they  recogn ize  a h ig h ly  conserved e p i to p e  even though th e se  
MCAbs were de r ived  from d i f f e r e n t  fu s io n s  and independent  hybridoma 
c lo n e s .  The r e s u l t s  o f  t h e  a d d i t i v i t y  ELISA i n d i c a t e d  t h a t  a t  l e a s t  
two d i s t i n c t  e p i to p e s  were recognized  on gp45 which p a r a l l e l e d  our 
e a r l i e r  r e s u l t s  (54) and demonst ra te  t h a t  a g iven  s e r o l o g i c a l l y  
d i s t i n c t  s p e c i f i c i t y  in  t h i s  case  was e q u i v a l e n t  t o  a g iven d i s t i n c t  
e p i t o p e .  I t  should  be emphasized t h a t  t h e  panel of  MCAbs used in 
t h i s  s tudy  was g enera ted  by chance bu t  w i th  the  i n t e n t i o n  t h a t  they  
d i s c r i m i n a t e  among EIAV v a r i a n t s .  Epi tope  mapping o f  EIAV using  our 
d i v e r s e  panel o f  MCAbs r e v e a le d  the  p resence  of  a t  l e a s t  2 e p i to p e s  
(one on gp90 and one on gp45) conserved in v a r io u s  s t r a i n s  o f  EIAV. 
The conserved e p i to p e  l o c a l i z e d  on gp90 may r e p r e s e n t  p e p t id e  
segments e s s e n t i a l  f o r  p r o t e i n  s t r u c t u r e  o r  f u n c t i o n ,  whi le  o th e r  
n o n - e s s e n t i a l  s i t e s  a re  more prone to  v a r i a t i o n  and a t  the  same time 
h ig h ly  a n t i g e n i c .  Conserva t ion  o f  e p i to p e s  appears  to  be a prominent 
p ro p e r ty  o f  gp45, which may r e f l e c t  the  f a c t  t h a t  much o f  t h i s  
g ly c o p r o t e in  i s  s eq u e s te r ed  by the  v i r a l  l i p i d  b i l a y e r ,  as  proposed 
f o r  gp41 of  the  human immunodeficiency v i r u s  (4 3 ) .  Most im p o r t a n t l y ,  
however, conserved e p i to p e s  may r e p r e s e n t  v a lu ab le  d i a g n o s t i c  
a n t i g e n s  s in c e  both g l y c o p r o t e in s  a r e  i n t e n s e l y  recognized  by th e  
r e f e r e n c e  E IA -p o s i t iv e  horse  serum and a r e  d e t e c t e d  e a r l i e r  than 
p r e c i p i t a t i n g  a n t i b o d i e s  in  th e  course  o f  an i n f e c t i o n  ( I s s e l ,  
unpubl ished  r e s u l t s ) .
R esu l t s  o f  th e  c o m p e t i t iv e  ELISA demonst ra ted  t h a t  E IA -p o s i t iv e  
horse  serum con ta ined  g p 9 0 - s p e c i f i c  a n t i b o d i e s  d i r e c t e d  a g a i n s t  the  
n e u t r a l i z a t i o n  domain o f  gp90. Polyc lona l  equine  se ra  ( r e f e r e n c e  and 
l a t e  serum) blocked th e  b ind ing  o f  a l l  f o u r  n e u t r a l i z i n g  MCAbs,
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i n d i c a t i n g  t h a t  th e  n e u t r a l i z a t i o n  ep i to p e s  bound by th e se  a n t ib o d ie s  
a re  l o c a l i z e d  presumably in an immunodominant domain on gp90. The 
block o f  n e u t r a l i z i n g  MCAbs was shown to  be s p e c i f i c  s in ce  serum 
c o l l e c t e d  e a r l y  in th e  course  o f  exper im enta l  i n f e c t i o n  (which 
r e a c t e d  with EIAV g ly c o p r o t e in s  in  Western b l o t  a ssay  but had no 
n e u t r a l i z i n g  a c t i v i t y )  d id  not i n h i b i t  t h e  b inding  o f  a l l  fo u r  
n e u t r a l i z i n g  MCAbs. The n e u t r a l i z a t i o n  domain o f  gp90 was a p p a r e n t ly  
o f  s u f f i c i e n t  s i z e  to  i n c o r p o r a t e  more than one o p e r a t i o n a l l y  
d i s t i n c t  e p i to p e .
Severa l  co n c lu s io n s  could  be drawn from our  s t u d i e s .  Our 
s t u d i e s  reveal  a continuum o f  e p i to p e s  which appear to  c o n s i s t  o f  
o ve r lapp ing  s i t e s .  Of t h e  10 g p 9 0 - s p e c i f i c  MCAbs ana lyzed ,  a high 
degree  o f  o v e r lap  was observed which sugges ts  a c l u s t e r  o f  e p i t o p e s .  
T h e re fo re ,  a l a r g e ,  s i n g l e  hete rogeneous  domain i s  apparen t  in our 
model o f  gp90, which in c lu d es  fo u r  d i f f e r e n t  ep i to p e s  based p r i m a r i l y  
on fu n c t io n a l  and s e r o l o g i c a l  s t u d i e s .  Two d i s t i n c t  
(non-over lapp ing)  a n t i g e n i c  s i t e s  were shown to  co n ta in  e p i to p e s  
involved  in  n e u t r a l i z a t i o n ,  demonst ra t ing  t h a t  t h i s  fu n c t io n  i s  no t  
n e c e s s a r i l y  r e s t r i c t e d  t o  a s i n g l e  s i t e  on EIAV g l y c o p r o t e i n s .  
T h e re fo re ,  d i f f e r e n t  s i t e s  on gp90 could have the  p o t e n t i a l  to  be 
s e l e c t e d  f o r  t h e  development o f  a s y n t h e t i c  vacc ine  f o r  EIA. 
Competi t ive  ELISA i n d i c a t e d  t h a t  c e r t a i n  s i t e s  on gp90 a re  
immunogenic both in mice and h o r s e s ,  sugges t ing  t h a t  t h e se  s i t e s  may 
r e p r e s e n t  common immunodominant n e u t r a l i z a t i o n  domains with s ev e ra l  
i n t e r r e l a t e d  e p i to p e s  on gp90. This s i t e  may have a s i g n i f i c a n t  
b io lo g ic a l  importance in t h e  in duc t ion  o f  p r o t e c t i v e  immunity. Some 
g p 9 0 - s p e c i f i c  MCAbs t h a t  have no d e t e c t a b l e  n e u t r a l i z a t i o n  c a p a b i l i t y
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may block th e  b inding  o f  o th e r  n e u t r a l i z i n g  a n t ib o d ie s  s in c e  they  
appear  to  compete with th e  n e u t r a l i z i n g  a n t ib o d ie s  f o r  the  b inding  
s i t e .  The p o s s i b l e  r o l e  o f  such r e a c t i o n s  in  th e  fo rm at ion  o f  
i n f e c t i o u s  immune complexes in  EIA cannot be overlooked (9 6 ) .
Fragmenta tion s t u d i e s  sugges ted  t h a t  t h e  a n t i g e n i c i t y  o f  gp90 
was mainly  l o c a l i z e d  on two fragments  (12K and 20K) t h a t  r e a c t e d  with 
r e f e r e n c e  E IA -pos i t ive  horse  serum and n e u t r a l i z i n g  o r  
n o n - n e u t r a l i z i n g  MCAbs. All fo u r  a n t i g e n i c  s i t e s  o f  gp90 of  
p ro to ty p e  EIAV appeared to  be p r e s e n t  on th e se  two f ragm en ts .  Since 
th e  l a r g e r  fragment  (20K) was shown to  be g l y c o s y l a t e d ,  the  
carbohydra te  moiety may p lay  a r o l e  in masking p o t e n t i a l  e p i to p e s  on 
the  p r o t e i n  backbone t h a t  a re  im por tan t  f o r  p r o t e c t i v e  immunity. 
Recent s t u d i e s  with EIAV sugges t  t h a t  both carbohydra te  and p r o t e i n  
m o ie t i e s  o f  gp90 c o n t r i b u t e  to  i t s  a c t i v i t y .  The predominant 
r e a c t i v i t y ,  however,  appear  to  be a g a i n s t  i t s  p e p t id e  e p i to p e s  (103) .  
Our s t u d i e s  o f  p r o t e o l y t i c  f ragm en ta t ion  o f  the  gp90 component of  
va r io u s  EIAV i s o l a t e s  produced common 12K immunoreactive f ragm ents .  
This 12K p r o t e o l y t i c  f ragm en t(s )  was r e a c t i v e  with n o n - n e u t r a l i z i n g  
MCAbs t h a t  r e a c te d  with  16 EIAV s t r a i n s  (54) and was a l s o  r e a c t i v e  
with  our r e f e r e n c e  E IA -p o s i t iv e  horse  serum. These r e s u l t s  i n d i c a t e  
th e  occur rence  o f  conserved  a n t i g e n i c  d e te rm in an ts  on EIAV 
g ly c o p r o t e in s  which may be b e n e f i c i a l  as p o t e n t i a l  t a r g e t s  f o r  
developing  a b road ly  e f f e c t i v e  immunogen a g a i n s t  EIA. We have 
p r e v io u s ly  shown t h a t  e p i to p e s  on gp90 which a re  v a r i a b l e  and h igh ly  
a n t i g e n i c  may r e p r e s e n t  t y p e - s p e c i f i c  e p i to p e s  t h a t  r e a c t  with 
n e u t r a l i z i n g  MCAbs (5 4 ) .  In the  same s tudy none o f  th e  i s o l a t e s  
t e s t e d  were n e u t r a l i z e d  by any of  the  four  n e u t r a l i z i n g  MCAbs (54) .
In a d d i t i o n ,  each v a r i a n t  of EIAV s tu d ie d  in  our l a b o r a t o r y  was shown 
t o  be d i s t i n c t  by a v a r i e t y  o f  s e r o l o g i c a l  and biochemical procedures  
(54,  102, 122, 129) .  T h e re fo re ,  a l th o u g h ,  n e u t r a l i z i n g  MCAbs may 
p rovide  a h ig h ly  e f f i c i e n t  mode of  p r o t e c t i o n  a g a i n s t  v i r a l  i n f e c t i o n  
in  g e n e r a l ,  they  may not p ro v id e  e f f e c t i v e  guidance  in  t h e  sea rch  f o r  
a b road ly  e f f e c t i v e  v acc ine  a g a i n s t  EIAV. P r o t e c t i o n  a g a i n s t  a 
l e t h a l  v i r u s  i n f e c t i o n  by n o n - n e u t r a l i z i n g  MCAbs was shown with 
v e s i c u l a r  s t o m a t i t i s  v i r u s  (VSV) (8 2 ) .  Moreover,  n o n - n e u t r a l i z i n g  
MCAbs t h a t  r e a c te d  with a c r o s s - r e a c t i v e  e p i to p e  on th e  G -p ro te in s  of 
both VSV-Ind and VSV-NJ s e ro ty p es  was a b le  t o  c o n fe r  p r o t e c t i v e  
immunity a g a i n s t  c h a l l e n g e  with  e i t h e r  s e r o ty p e  (82) .  The f a c t  
t h a t  horses  c h r o n i c a l l y  i n f e c t e d  with EIAV e v e n t u a l l y  develop an 
e f f e c t i v e  broad immunity a g a i n s t  EIAV v a r i a n t s  su g g es t s  th e  e x i s t e n c e  
o f  common e p i t o p e ( s )  among EIAV v a r i a n t s .  Such an approach might be 
a d v i s a b le  f o r  developing  a vacc ine  a g a i n s t  EIAV.
CHAPTER V 
SUMMARY
Monoclonal a n t i b o d i e s  were produced to  the  p ro to ty p e  c e l l - a d a p t e d  
EIAV (Wyoming s t r a i n ) ,  a l e n t i v i r u s .  Mice were immunized with  d i f f e r e n t  
p r e p a r a t io n s  o f  EIAV in  o rd e r  to  g e n e r a te  MCAbs w i th  d i f f e r e n t  
s p e c i f i t i e s .  Twenty t h r e e  hybridomas producing MCAbs were i s o l a t e d  and 
c h a r a c t e r i z e d .  Ten were s p e c i f i c  f o r  th e  major envelope  g ly c o p ro te in  
(gp90) ,  8 f o r  th e  o t h e r  envelope  g ly c o p r o t e in  (gp45) and 5 f o r  th e  major  
group s p e c i f i c  an t ig e n  (p26) .  S e ro lo g ic  r e a c t i v i t i e s  were i n i t i a l l y  
determined by ELISA. However, u l t i m a t e  d e te r m in a t io n  o f  MCAb 
r e a c t i v i t i e s  with EIAV p o ly p ep t id e s  was made by Western b l o t  immunoassay 
and n e u t r a l i z a t i o n  t e s t .  Monoclonal a n t i b o d i e s  which r e a c te d  with  p26 
a l s o  r e a c te d  with a n o th e r  p r o t e i n  o f  an a p p a ren t  m o lecu la r  weight o f  
55,000. The s t u d i e s  sugges ted  t h a t  t h i s  55K p r o t e i n  i s  th e  gag 
p r e c u r so r  o f  EIAV, from which the  i n t e r n a l  p r o t e i n s  (p26, p !5 ,  p l l ,  and 
p9) a re  d e r iv e d .  All MCAbs d i r e c t e d  a g a i n s t  v i r a l  g l y c o p ro t e in s  were 
h ig h ly  s p e c i f i c ,  r e a c t i n g  only to  gp90 o r  gp45. A d d i t i o n a l l y ,  no 
p r o t e i n  o f  m olecu lar  weight h ighe r  than gp90 could be d e t e c t e d  by our 
panel o f  MCAbs.
To s tudy  the  p a t t e r n ,  e x t e n t ,  and mechanism o f  a n t i g e n i c  v a r i a t i o n  
in  EIAV, a n t ig e n s  o f  16 EIAV i s o l a t e s  were analysed  by MCAbs. F i f t e e n  
o f  th e se  v i r u s  i s o l a t e s  were recovered  from plasma samples ob ta ined  
dur ing  d i s c r e t e  f e b r i l e  ep i sodes  in exper imenta l  p o n ie s .  T h i r t e e n  of  
th e se  i s o l a t e s  were g en e ra ted  in ponies  i n f e c t e d  in  p a r a l l e l  w ith  the  
same EIAV inoculum. E igh t  o f  t h e se  i s o l a t e s ,  shown p re v io u s ly  t o  be 
a n t i g e n i c a l l y  d i s t i n c t  in  c r o s s - n e u t r a l i z a t i o n  t e s t s ,  proved to  be
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d i s t i n c t  by a n a l y s i s  w i th  MCAbs. On th e  b a s i s  o f  r e a c t i v i t y  with the  
panel o f  MCAbs, th e  16 d i f f e r e n t  s t r a i n s  o f  EIAV were found to  f a l l  i n to  
12 d i s t i n c t  a n t i g e n i c  g roups .  These d a ta  show t h a t  t h e r e  i s  a l a rg e  
spectrum of  p o s s i b l e  EIAV se ro ty p es  and conf irms t h a t  a n t i g e n i c
v a r i a t i o n  occurs  with  high f requency  in  EIAV. Moreover, th e  d a ta  a l s o  
showed t h a t  v a r i a t i o n  i s  a r a p id  and random p r o c e s s ,  as no p a t t e r n  of  
e v o lu t io n  o f  v a r i a n t s  was e v id e n t  by compar is ion  o f  13 i s o l a t e s  from 
p a r a l l e l  i n f e c t i o n s .
H e te ro g en e i ty  o f  gp90 was documented by i d e n t i f i c a t i o n  o f  nine 
d i f f e r e n t  s e r o l o g i c  g roups .  In s p i t e  o f  v a r i a t i o n s  observed in e p i to p e s  
90-B, 90-C, 90-D, 90-E, and 90-F , a h ig h ly  conserved e p i to p e  o f  gp90
(e p i to p e  90-A) was recogn ized .  In c o n t r a s t ,  on ly  two s e r o lo g ic  groups
o f  gp45 were i d e n t i f i e d .  T h e re fo re ,  c o n se rv a t io n  o f  EIAV a n t i g e n i c  
d e te rm in an ts  v a r i e d  between the  two g l y c o p r o t e i n s ;  gp45 showed a
moderate c o n s e r v a t io n ,  whereas gp90 had l i t t l e  c o n se rv a t io n  among the
d i f f e r e n t  EIAV i s o l a t e s .
Our r e s u l t s  documented e p i to p e  a l t e r a t i o n s  in  th e  v i r i o n  s u r f a c e
g l y c o p r o t e in s  among s e q u e n t i a l  v i r u s  i s o l a t e s  of  EIAV during  p e r s i s t e n t  
i n f e c t i o n .  These were e v i d e n t  by s u b t l e  a n t i g e n i c  d i f f e r e n c e s  among 
i s o l a t e s  and by d e f i n i t i v e  a n t i g e n i c  a l t e r a t i o n s  a t  one o r  more 
e p i t o p e s .  A l t e r a t i o n s  observed in  th e  g ly c o p r o t e in s  involved both 
n e u t r a l i z i n g  and n o n - n e u t r a l i z i n g  e p i to p e s  dur ing  in  v ivo passage o f  the  
v i r u s .  These observed a n t i g e n i c  a l t e r a t i o n s  of  th e  s u r f a c e
g l y c o p r o t e in s  confi rmed p rev ious  r e p o r t s  which demonst ra ted  g e n e t i c  and 
s t r u c t u r a l  changes o f  some of  t h e s e  i s o l a t e s .  T h e re fo re ,  t h e s e  s t u d i e s  
i n d i c a t e  t h a t  a d i s t i n c t  ( g e n e t i c ,  p h en o ty p ic ,  and a n t i g e n i c )  v i r u s  
p o p u la t io n  may predom iM te  dur ing  each f e b r i l e  ep isode  in  a p e r s i s t e n t l y
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i n f e c t e d  pony. Our s t u d i e s  showed t h a t  upon in vivo v i r u s  r e p l i c a t i o n  
and dur ing  s e l e c t i o n  of  one p a r t i c u l a r  i s o l a t e  from i t s  p r o g e n i t o r ,  an 
e p i to p e  may lo s e  i t s  f u n c t io n  in  v i r u s  n e u t r a l i z a t i o n  bu t  r e t a i n  i t s  
a n t i g e n i c  confo rm a t ion .  Our o b s e r v a t io n s  sugges t  t h a t  th e  p roduc t ion  of  
n o n - n e u t r a l i z i n g  a n t i b o d i e s  may p lay  a r o l e  in  t h e  p roduc t ion  of  immune 
complex d i s e a s e .
Our d a ta  su p p o r t  th e  hyp o th es i s  o f  a n t i g e n i c  v a r i a t i o n  as an 
im por tan t  mechanism f o r  th e  p e r s i s t e n c e  and d i s s e m in a t io n  o f  EIAV. 
A n t igen ic  v a r i a t i o n  most l i k e l y  invo lves  f r e q u e n t  p o i n t  m u ta t ions  in th e  
envelope  gene which encodes th e  two main envelope  g l y c o p r o t e i n s ,  gp90 
and gp45. When e p i to p e  a l t e r a t i o n s  occur  and a r e  m an i fe s ted  by 
a l t e r a t i o n s  in a n t i g e n i c i t y  o f  t h e s e  g l y c o p r o t e i n s ,  t h e  emerging new 
v a r i a n t  may not be a f f e c t e d  by immune p r e s s u r e s  which had been e f f e c t i v e  
a g a i n s t  p rev ious  v a r i a n t s .  The new v a r i a n t  then m u l t i p l i e s  in  an 
u n r e s t r i c t e d  f a s h io n  u n t i l  immune responses  to  t h i s  novel v a r i a n t  
e f f e c t i v e l y  check v i r u s  r e p l i c a t i o n .  When t h i s  c y c le  r e p e a t s  i t s e l f  a t  
f r e q u e n t  i n t e r v a l s ,  th e  r e s u l t  i s  th e  c h ro n ic  ( c y c l i c )  form o f  EIA.
Although a l l  18 MCAbs bound to  e i t h e r  gp90 o r  gp45 in  Western b l o t  
a s s a y  only  4 o f  them ( t o  gp90) n e u t r a l i z e d  i n f e c t i v i t y .  Monoclonal 
a n t i b o d i e s  t h a t  r e a c te d  w i th  conserved e p i to p e s  on gp90 and gp45 f a i l e d  
to  n e u t r a l i z e  EIAV. On th e  o t h e r  hand, our  s t u d i e s  sugges t  t h a t  th e  
v a r i a b l e  reg io n s  o f  th e  envelope  gp90 were o f t e n  n e u t r a l i z i n g  e p i t o p e s .  
Each o f  th e  n e u t r a l i z i n g  a n t i b o d i e s  was found to  be d i r e c t e d  a g a i n s t  an 
e p i to p e  o f  gp90 as  demonst ra ted  by Western b l o t  immunoassay. T h e re fo re ,  
t h e  r e s u l t s  showed t h a t  c r i t i c a l  e p i to p e s  im por tan t  f o r  n e u t r a l i z a t i o n  
a r e  c l u s t e r e d  on gp90. Ep i topes  recognized  by n e u t r a l i z i n g  a n t i b o d i e s  
were sugges ted  to  be con t inuous  s in c e  they  r e s i s t e d  t r e a tm e n t  with
sodium dodecyl s u l f a t e .  The 4 MCAbs t h a t  had n e u t r a l i z i n g  a c t i v i t y  
r e a c te d  with  gp90 in  t h r e e  d i f f e r e n t  p a t t e r n s  su gges t ing  d i f f e r e n t  
e p i to p e  r e c o g n i t i o n .  T h e re fo re ,  i t  was p o s s ib l e  to  i d e n t i f y  t h r e e  
t e n t a t i v e  a n t i g e n i c  s i t e s  on gp90 which fu n c t io n  in  n e u t r a l i z a t i o n .  
However, da ta  provided by a d d i t i v e  ELISA, co m p e t i t iv e  ELISA, and Western 
b l o t  a n a l y s i s  i n d i c a t e d  t h a t  a n t i g e n i c  r e a c t i v i t y  o f  gp90 was l o c a l i z e d  
on a t  l e a s t  fo u r  d i s t i n c t  e p i t o p e s ,  two o f  which were im por tan t  in 
n e u t r a l i z a t i o n .  Our s t u d i e s  a l s o  re v e a le d  t h a t  t h e se  e p i to p e s  were 
l o c a l i z e d  on a continuum o f  o ve r lapp ing  a n t i g e n i c  s i t e s  on gp90. On the  
o t h e r  hand, only two d i s t i n c t  non-over lapp ing  e p i to p e s  were i d e n t i f i e d  
on gp45. Competi t ive  b ind ing  s t u d i e s  o f  n e u t r a l i z i n g  MCAbs and 
r e f e r e n c e  E IA -pos i t ive  horse  serum d e l i n e a t e d  th e  presence  o f  a 
n e u t r a l i z a t i o n  domain on gp90 t h a t  appears  to  be immunodominant both in 
n a t u r a l l y  i n f e c t e d  horses  and in mice immunized with EIAV. Limited 
p r o t e o l y t i c  f ragm en ta t ion  o f  the  gp90 component o f  seve ra l  s e r o l o g i c a l l y  
d i s t i n c t  EIAV i s o l a t e s  produced common 12K immunoreactive fragments  t h a t  
c on ta ined  a conserved e p i to p e  (90-A).  These r e s u l t s  i n d i c a t e  the  
occur rence  o f  conserved a n t i g e n i c  r eg ions  on EIAV g ly c o p ro te in s  as well 
as a n e u t r a l i z a t i o n  domain on gp90, which can be used as p o t e n t i a l  
t a r g e t s  f o r  vacc ine  developments .
In summary our r e s u l t s  documented e p i to p e  a l t e r a t i o n s  in  th e  two 
main s u r f a c e  g l y c o p r o t e in s  (gp90 and gp45) o f  EIAV during  p e r s i s t e n t  
i n f e c t i o n .  A l t e r a t i o n s  observed involved both n e u t r a l i z i n g  and 
n o n - n e u t r a l i z i n g  e p i t o p e s .  The v a r i a b l e  r eg ions  o f  th e  envelope 
g l y c o p ro t e in s  a r e  o f t e n  n e u t r a l i z i n g  e p i t o p e s .  The s p e c i f i c  changes 
noted f o r  t h e s e  g l y c o p r o t e in s  r e s u l t e d  in a l t e r e d  a n t i g e n i c i t y  and 
s i g n a l l e d  th e  emergence o f  a n t i g e n i c a l l y  d i s t i n c t  v a r i a n t s .  These
a l t e r a t i o n s  a re  p u r p o r t e d ly  s u f f i c i e n t  to  a l low the  mutant v i r u s e s  to  
t e m p o ra r i ly  escape  immunological i n a c t i v a t i o n .  Thus,  a n t i g e n i c  
v a r i a t i o n  i s  an im por tan t  mechanism f o r  p e r s i s t e n c e  and d is se m in a t io n  of 
EIAV. Most im p o r tan t ly  however,  the  observed a n t i g e n i c  v a r i a t i o n  of 
EIAV may r e p r e s e n t  a major c h a l l en g e  f o r  developing a s u cc e ss fu l  vacc ine  
a g a i n s t  EIA. Continuous e p i to p e s  which were t a r g e t s  f o r  n e u t r a l i z a t i o n  
were demonstra ted to  c l u s t e r  on a domain o f  gp90. In a d d i t i o n ,  a h ig h ly  
conserved reg ion  was a l s o  demonstra ted on gp90 o f  d i f f e r e n t  
s e r o l o g i c a l l y  d i s t i n c t  EIAV i s o l a t e s .  These s t u d i e s  sugges t  d i f f e r e n t  
approaches  t h a t  could be followed to  des ign  a vacc ine  f o r  EIA. For 
example,  i f  conserved e p i to p e s  were i d e n t i f i e d  t h a t  s t i m u l a t e  
c r o s s - p r o t e c t i o n ,  th e  s o l u t i o n  would be s t r a i g h t f o r w a r d .  The importance 
o f  g ly c o s y l a t i o n  of  t h e s e  ep i to p e s  needs to  be c l a r i f i e d  but prev ious  
s t u d i e s  showed t h a t  th e  predominant r e a c t i v i t y  appeared to  be a g a i n s t  
the  p e p t id e  e p i t o p e s .  Second, i f  a common d e te rm inan t  does not e x i s t  
then a c o c k t a i l  o f  t h e  immunogenic fragments  i d e n t i f i e d  by n e u t r a l i z i n g  
MCAbs of  d i f f e r e n t  e p id e m io lo g ic a l ly  s i g n i f i c a n t  v a r i a n t s  could be 
p repared  and e v a lu a te d  once such v a r i a n t s  a re  i d e n t i f i e d .  An e l e g a n t  
approach to  design  such a vaccine  would involve  the  c o n s t r u c t i o n  of  
ISCOM (immunost imulating complex) c o n ta in in g  n e u t r a l i z i n g  ep i to p e s  and 
o t h e r  d e te rm inan ts  l o c a l i z e d  on e i t h e r  the  g l y c o p ro t e in s  gp90, gp45 or  
the  i n t e r n a l  p r o t e i n s  such as p26 t h a t  s t i m u l a t e  c y to to x ic  T c e l l s .  
This novel immunogen would be capable  o f  inducing both humoral and 
c e l l u l a r  immunity.  I f  such an immunogen i s  capab le  o f  p rov id ing  
p r o t e c t i o n  a g a i n s t  i n f e c t i o n  and p reven t  l a t e n c y  then we would have 
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